WAYNE LHOFSTETTERWAYNE L HOFSTETTER9205HOFSTETTER, WAYNE LProfessorprns:coAuthorOfcoauthor ofFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson21623235Marom EM, Milito MA, Moran CA, Liu P, Correa AM, Kim ES, Komaki R, Erasmus JJ, Hofstetter WL, Rice DC, Swisher SGJournal of thoracic oncology : official publication of the International Association for the Study of Lung CancerComputed tomography findings predicting invasiveness of thymoma. J Thorac Oncol. 2011 Jul; 6(7):1274-81.J Thorac Oncol2011-07-01T00:00:002011Computed tomography findings predicting invasiveness of thymoma.19619787Kassis ES, Vaporciyan AA, Swisher SG, Correa AM, Bekele BN, Erasmus JJ, Hofstetter WL, Komaki R, Mehran RJ, Moran CA, Pisters KM, Rice DC, Walsh GL, Roth JAThe Journal of thoracic and cardiovascular surgeryApplication of the revised lung cancer staging system (IASLC Staging Project) to a cancer center population. J Thorac Cardiovasc Surg. 2009 Aug; 138(2):412-418.e1-2.J Thorac Cardiovasc Surg2009-05-28T00:00:002009Application of the revised lung cancer staging system (IASLC Staging Project) to a cancer center population.1400 Pressler StHouston77030-4008TXAuthorship 1674241Authorship 1744122Authorship 1744623Authorship 1773462Authorship 1777215Authorship 1780734Authorship 1780885Authorship 1791004Authorship 1794997Authorship 1796322Authorship 18070010Authorship 1810806Authorship 1814278Authorship 1817374Authorship 1817887Authorship 1817994Authorship 1819044Authorship 1819897Authorship 18235311Authorship 1824024Authorship 18282912Authorship 1832392Authorship 1835013Authorship 1845767Authorship 1853483Authorship 1853602Authorship 18598012Authorship 18641210Authorship 1874282Authorship 1894089Authorship 18943910Authorship 1896531Authorship 1897337Authorship 1898874Authorship 1909835Authorship 19146513Authorship 1917507Authorship 1919262Authorship 1925454Authorship 1934601Authorship 1951454Authorship 1954502Authorship 1959464Authorship 19625679715164Hofstetter WL, Vukasin P, Ortega AE, Anthone G, Beart RWDiseases of the colon and rectumNew technique for mesh repair of paracolostomy hernias. Dis Colon Rectum. 1998 Aug; 41(8):1054-5.Dis Colon Rectum1998-08-01T00:00:001998New technique for mesh repair of paracolostomy hernias.16135925Martin LW, Swisher SG, Hofstetter W, Correa AM, Mehran RJ, Rice DC, Vaporciyan AA, Walsh GL, Roth JAAnnals of surgeryIntrathoracic leaks following esophagectomy are no longer associated with increased mortality. Ann Surg. 2005 Sep; 242(3):392-9; discussion 399-402.Ann Surg2005-09-01T00:00:002005Intrathoracic leaks following esophagectomy are no longer associated with increased mortality.16256794Ascioti AJ, Hofstetter WL, Miller MJ, Rice DC, Swisher SG, Vaporciyan AA, Roth JA, Putnam JB, Smythe WR, Feig BW, Mansfield PF, Pisters PW, Torres MT, Walsh GLThe Journal of thoracic and cardiovascular surgeryLong-segment, supercharged, pedicled jejunal flap for total esophageal reconstruction. J Thorac Cardiovasc Surg. 2005 Nov; 130(5):1391-8.J Thorac Cardiovasc Surg2005-10-13T00:00:002005Long-segment, supercharged, pedicled jejunal flap for total esophageal reconstruction.16399296Malaisrie SC, Hofstetter WL, Correa AM, Ajani JA, Komaki RR, Liao Z, Phan A, Rice DC, Vaporciyan AA, Walsh GL, Lahoti S, Lee JH, Bresalier R, Roth JA, Swisher SGThe Journal of thoracic and cardiovascular surgeryEndoscopic ultrasonography-identified celiac adenopathy remains a poor prognostic factor despite preoperative chemoradiotherapy in esophageal adenocarcinoma. J Thorac Cardiovasc Surg. 2006 Jan; 131(1):65-72.J Thorac Cardiovasc Surg2005-12-05T00:00:002005Endoscopic ultrasonography-identified celiac adenopathy remains a poor prognostic factor despite preoperative chemoradiotherapy in esophageal adenocarcinoma.17126095Herrera LJ, Correa AM, Vaporciyan AA, Hofstetter WL, Rice DC, Swisher SG, Walsh GL, Roth JA, Mehran RJThe Annals of thoracic surgeryIncreased risk of aspiration and pulmonary complications after lung resection in head and neck cancer patients. Ann Thorac Surg. 2006 Dec; 82(6):1982-7; discussion 1987-8.Ann Thorac Surg2006-12-01T00:00:002006Increased risk of aspiration and pulmonary complications after lung resection in head and neck cancer patients.17146785Bruzzi JF, Swisher SG, Truong MT, Munden RF, Hofstetter WL, Macapinlac HA, Correa AM, Mawlawi O, Ajani JA, Komaki RR, Fukami N, Erasmus JJCancerDetection of interval distant metastases: clinical utility of integrated CT-PET imaging in patients with esophageal carcinoma after neoadjuvant therapy. Cancer. 2007 Jan 01; 109(1):125-34.Cancer2007-01-01T00:00:002007Detection of interval distant metastases: clinical utility of integrated CT-PET imaging in patients with esophageal carcinoma after neoadjuvant therapy.17409902Erasmus JJ, Munden RF, Truong MT, Ho JJ, Hofstetter WL, Macapinlac HA, Correa AM, Wu TT, Bruzzi JF, Marom EM, Sabloff BS, Ajani JA, Komaki R, Liao Z, Lee JH, Fukami N, Bresalier R, Swisher SGJournal of thoracic oncology : official publication of the International Association for the Study of Lung CancerPreoperative chemo-radiation-induced ulceration in patients with esophageal cancer: a confounding factor in tumor response assessment in integrated computed tomographic-positron emission tomographic imaging. J Thorac Oncol. 2006 Jun; 1(5):478-86.J Thorac Oncol2006-06-01T00:00:002006Preoperative chemo-radiation-induced ulceration in patients with esophageal cancer: a confounding factor in tumor response assessment in integrated computed tomographic-positron emission tomographic imaging.17548685Izzo JG, Malhotra U, Wu TT, Luthra R, Correa AM, Swisher SG, Hofstetter W, Chao KS, Hung MC, Ajani JACancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive OncologyClinical biology of esophageal adenocarcinoma after surgery is influenced by nuclear factor-kappaB expression. Cancer Epidemiol Biomarkers Prev. 2007 Jun; 16(6):1200-5.Cancer Epidemiol Biomarkers Prev2007-06-01T00:00:002007Clinical biology of esophageal adenocarcinoma after surgery is influenced by nuclear factor-kappaB expression.18059229Abraham SC, Krasinskas AM, Correa AM, Hofstetter WL, Ajani JA, Swisher SG, Wu TTThe American journal of surgical pathologyDuplication of the muscularis mucosae in Barrett esophagus: an underrecognized feature and its implication for staging of adenocarcinoma. Am J Surg Pathol. 2007 Nov; 31(11):1719-25.Am J Surg Pathol2007-11-01T00:00:002007Duplication of the muscularis mucosae in Barrett esophagus: an underrecognized feature and its implication for staging of adenocarcinoma.18535619Hu W, Hofstetter W, Guo W, Li H, Pataer A, Peng HH, Guo ZS, Bartlett DL, Lin A, Swisher SG, Fang BCancer gene therapyJNK-deficiency enhanced oncolytic vaccinia virus replication and blocked activation of double-stranded RNA-dependent protein kinase. Cancer Gene Ther. 2008 Sep; 15(9):616-24.Cancer Gene Ther2008-06-06T00:00:002008JNK-deficiency enhanced oncolytic vaccinia virus replication and blocked activation of double-stranded RNA-dependent protein kinase.18623381Javeri H, Arora R, Correa AM, Hofstetter WL, Lee JH, Liao Z, McAleer MF, Maru D, Bhutani MS, Swisher SG, Izzo JG, Ajani JACancerInfluence of induction chemotherapy and class of cytotoxics on pathologic response and survival after preoperative chemoradiation in patients with carcinoma of the esophagus. Cancer. 2008 Sep 15; 113(6):1302-8.Cancer2008-09-15T00:00:002008Influence of induction chemotherapy and class of cytotoxics on pathologic response and survival after preoperative chemoradiation in patients with carcinoma of the esophagus.19117343Yendamuri S, Swisher SG, Correa AM, Hofstetter W, Ajani JA, Francis A, Maru D, Mehran RJ, Rice DC, Roth JA, Walsh GL, Vaporciyan AACancerEsophageal tumor length is independently associated with long-term survival. Cancer. 2009 Feb 01; 115(3):508-16.Cancer2009-02-01T00:00:002009Esophageal tumor length is independently associated with long-term survival.19463651Fernando HC, Murthy SC, Hofstetter W, Shrager JB, Bridges C, Mitchell JD, Landreneau RJ, Clough ER, Watson TJ, Society of Thoracic SurgeonsThe Annals of thoracic surgeryThe Society of Thoracic Surgeons practice guideline series: guidelines for the management of Barrett's esophagus with high-grade dysplasia. Ann Thorac Surg. 2009 Jun; 87(6):1993-2002.Ann Thorac Surg2009-06-01T00:00:002009The Society of Thoracic Surgeons practice guideline series: guidelines for the management of Barrett's esophagus with high-grade dysplasia.19655604Bolton WD, Rice DC, Correa AM, Hofstetter W, Komaki R, Mehran R, Pisters K, Roth JA, Vaporciyan AA, Walsh GL, Swisher SGThe American surgeonInfluence of age on choice of therapy and surgical outcomes in patients with nonsmall cell lung cancer. Am Surg. 2009 Jul; 75(7):598-603; discussion 603-4.Am Surg2009-07-01T00:00:002009Influence of age on choice of therapy and surgical outcomes in patients with nonsmall cell lung cancer.19699915Blackmon SH, Shah N, Roth JA, Correa AM, Vaporciyan AA, Rice DC, Hofstetter W, Walsh GL, Benjamin R, Pollock R, Swisher SG, Mehran RThe Annals of thoracic surgeryResection of pulmonary and extrapulmonary sarcomatous metastases is associated with long-term survival. Ann Thorac Surg. 2009 Sep; 88(3):877-84; discussion 884-5.Ann Thorac Surg2009-09-01T00:00:002009Resection of pulmonary and extrapulmonary sarcomatous metastases is associated with long-term survival.19737957Hu W, Hofstetter WL, Li H, Zhou Y, He Y, Pataer A, Wang L, Xie K, Swisher SG, Fang BClinical cancer research : an official journal of the American Association for Cancer ResearchPutative tumor-suppressive function of Kruppel-like factor 4 in primary lung carcinoma. Clin Cancer Res. 2009 Sep 15; 15(18):5688-95.Clin Cancer Res2009-09-08T00:00:002009Putative tumor-suppressive function of Kruppel-like factor 4 in primary lung carcinoma.20032718Rizk NP, Ishwaran H, Rice TW, Chen LQ, Schipper PH, Kesler KA, Law S, Lerut TE, Reed CE, Salo JA, Scott WJ, Hofstetter WL, Watson TJ, Allen MS, Rusch VW, Blackstone EHAnnals of surgeryOptimum lymphadenectomy for esophageal cancer. Ann Surg. 2010 Jan; 251(1):46-50.Ann Surg2010-01-01T00:00:002010Optimum lymphadenectomy for esophageal cancer.20112635Kim MP, Hofstetter WLThoracic surgery clinicsTumors of the diaphragm. Thorac Surg Clin. 2009 Nov; 19(4):521-9.Thorac Surg Clin2009-11-01T00:00:002009Tumors of the diaphragm.20881767Gaur P, Sepesi B, Hofstetter WL, Correa AM, Bhutani MS, Vaporciyan AA, Watson TJ, Swisher SG, Members of the MD Anderson Esophageal Cancer Group and the University of Rochester School of MedicinAnnals of surgeryA clinical nomogram predicting pathologic lymph node involvement in esophageal cancer patients. Ann Surg. 2010 Oct; 252(4):611-7.Ann Surg2010-10-01T00:00:002010A clinical nomogram predicting pathologic lymph node involvement in esophageal cancer patients.21456015Suzuki A, Xiao L, Hayashi Y, Macapinlac HA, Welsh J, Lin SH, Lee JH, Bhutani MS, Maru DM, Hofstetter WL, Swisher SG, Ajani JACancerPrognostic significance of baseline positron emission tomography and importance of clinical complete response in patients with esophageal or gastroesophageal junction cancer treated with definitive chemoradiotherapy. Cancer. 2011 Nov 01; 117(21):4823-33.Cancer2011-03-31T00:00:002011Prognostic significance of baseline positron emission tomography and importance of clinical complete response in patients with esophageal or gastroesophageal junction cancer treated with definitive chemoradiotherapy.21602659Estrella JS, Hofstetter WL, Correa AM, Swisher SG, Ajani JA, Lee JH, Bhutani MS, Abraham SC, Rashid A, Maru DMThe American journal of surgical pathologyDuplicated muscularis mucosae invasion has similar risk of lymph node metastasis and recurrence-free survival as intramucosal esophageal adenocarcinoma. Am J Surg Pathol. 2011 Jul; 35(7):1045-53.Am J Surg Pathol2011-07-01T00:00:002011Duplicated muscularis mucosae invasion has similar risk of lymph node metastasis and recurrence-free survival as intramucosal esophageal adenocarcinoma.22102852He Y, Correa AM, Raso MG, Hofstetter WL, Fang B, Behrens C, Roth JA, Zhou Y, Yu L, Wistuba II, Swisher SG, Pataer APloS oneThe role of PKR/eIF2a signaling pathway in prognosis of non-small cell lung cancer. PLoS One. 2011; 6(11):e24855.PLoS One2011-11-10T00:00:002011The role of PKR/eIF2a signaling pathway in prognosis of non-small cell lung cancer.22417808Lin SH, Komaki R, Liao Z, Wei C, Myles B, Guo X, Palmer M, Mohan R, Swisher SG, Hofstetter WL, Ajani JA, Cox JDInternational journal of radiation oncology, biology, physicsProton beam therapy and concurrent chemotherapy for esophageal cancer. Int J Radiat Oncol Biol Phys. 2012 Jul 01; 83(3):e345-51.Int J Radiat Oncol Biol Phys2012-03-13T00:00:002012Proton beam therapy and concurrent chemotherapy for esophageal cancer.22541197Hofstetter WLThe Annals of thoracic surgeryInvited commentary. Ann Thorac Surg. 2012 May; 93(5):1681.Ann Thorac Surg2012-05-01T00:00:002012Invited commentary.22867894Lin SH, Wang L, Myles B, Thall PF, Hofstetter WL, Swisher SG, Ajani JA, Cox JD, Komaki R, Liao ZInternational journal of radiation oncology, biology, physicsPropensity score-based comparison of long-term outcomes with 3-dimensional conformal radiotherapy vs intensity-modulated radiotherapy for esophageal cancer. Int J Radiat Oncol Biol Phys. 2012 Dec 01; 84(5):1078-85.Int J Radiat Oncol Biol Phys2012-08-03T00:00:002012Propensity score-based comparison of long-term outcomes with 3-dimensional conformal radiotherapy vs intensity-modulated radiotherapy for esophageal cancer.23026282Marks JL, Hofstetter WLThe Surgical clinics of North AmericaEsophageal reconstruction with alternative conduits. Surg Clin North Am. 2012 Oct; 92(5):1287-97.Surg Clin North Am2012-08-20T00:00:002012Esophageal reconstruction with alternative conduits.23465677Kim JY, Hofstetter WLSeminars in thoracic and cardiovascular surgeryEsophagectomy after chemoradiation: who and when to operate. Semin Thorac Cardiovasc Surg. 2012; 24(4):288-93.Semin Thorac Cardiovasc Surg2012-01-01T00:00:002012Esophagectomy after chemoradiation: who and when to operate.23643547David E, Thall PF, Kalhor N, Hofstetter WL, Rice DC, Roth JA, Swisher SG, Walsh GL, Vaporciyan AA, Wei C, Mehran RJThe Annals of thoracic surgeryVisceral pleural invasion is not predictive of survival in patients with lung cancer and smaller tumor size. Ann Thorac Surg. 2013 Jun; 95(6):1872-7; discussion 1877.Ann Thorac Surg2013-05-02T00:00:002013Visceral pleural invasion is not predictive of survival in patients with lung cancer and smaller tumor size.23731608Crabtree TD, Kosinski AS, Puri V, Burfeind W, Bharat A, Patterson GA, Hofstetter W, Meyers BFThe Annals of thoracic surgeryEvaluation of the reliability of clinical staging of T2 N0 esophageal cancer: a review of the Society of Thoracic Surgeons database. Ann Thorac Surg. 2013 Aug; 96(2):382-90.Ann Thorac Surg2013-05-31T00:00:002013Evaluation of the reliability of clinical staging of T2 N0 esophageal cancer: a review of the Society of Thoracic Surgeons database.23975663Ajani JA, Xiao L, Roth JA, Hofstetter WL, Walsh G, Komaki R, Liao Z, Rice DC, Vaporciyan AA, Maru DM, Lee JH, Bhutani MS, Eid A, Yao JC, Phan AP, Halpin A, Suzuki A, Taketa T, Thall PF, Swisher SGAnnals of oncology : official journal of the European Society for Medical OncologyA phase II randomized trial of induction chemotherapy versus no induction chemotherapy followed by preoperative chemoradiation in patients with esophageal cancer. Ann Oncol. 2013 Nov; 24(11):2844-9.Ann Oncol2013-08-23T00:00:002013A phase II randomized trial of induction chemotherapy versus no induction chemotherapy followed by preoperative chemoradiation in patients with esophageal cancer.24199707Hofstetter WLThoracic surgery clinicsEvolving therapies in esophageal carcinoma. Thorac Surg Clin. 2013 Nov; 23(4):ix-x.Thorac Surg Clin2013-11-01T00:00:002013Evolving therapies in esophageal carcinoma.24868018Sudo K, Elimova E, Skinner HD, Hofstetter WL, Ajani JAJournal of clinical oncology : official journal of the American Society of Clinical OncologyCritical appraisal of locoregional failure and systemic disease progression after preoperative chemoradiation of esophageal adenocarcinoma. Reply to R. Gertler et al. J Clin Oncol. 2014 Jul 01; 32(19):2112-3.J Clin Oncol2014-05-27T00:00:002014Critical appraisal of locoregional failure and systemic disease progression after preoperative chemoradiation of esophageal adenocarcinoma. Reply to R. Gertler et al.GI Medical OncologyRadiation OncologyThoracic & Cardiovascular SurgeryMD AndersonJAFFER AAJANIJAFFER A AJANI8473AJANI, JAFFER AProfessor20.41480.00222319851research areas14.29080.0168541220coauthor of1433.0380.01960similar to11480selected publicationsSTEPHEN GSWISHERSTEPHEN G SWISHER8671SWISHER, STEPHEN GProfessorDAVID CRICEDAVID C RICE8943RICE, DAVID CProfessorSTEVEN HSESHENGLINSTEVEN HSESHENG LIN9627LIN, STEVEN HSESHENGAssociate ProfessorREZA JOHNMEHRANREZA JOHN MEHRAN9228MEHRAN, REZA JOHNProfessorAuthorship 21493910Authorship 2200071Authorship 2231432Authorship 2235405Authorship 2236382Authorship 2240376Authorship 2247973Authorship 2259241Authorship 2260956Authorship 2261785Authorship 2267677Authorship 2270136Authorship 2270741Authorship 2276632Authorship 2279657Authorship 22815512Authorship 2281823Authorship 2284764Authorship 2292503Authorship 22947110Authorship 22949517Authorship 22986510Authorship 2299283Authorship 2300105Authorship 2303286Authorship 2308726Authorship 2310289Authorship 2310604Authorship 2312502Authorship 23130815Authorship 23139716Authorship 23177814Authorship 2319253Authorship 2320197Authorship 2322752Authorship 2325024Authorship 2328733Authorship 23316913Authorship 2335044Authorship 23361011Authorship 23383815Authorship 2340196Authorship 2340532Authorship 2344098Authorship 2346442Authorship 235221137944031Raboff W, Calobrace MB, Anthony G, Garner D, Greenwald D, Brant A, Hopkins B, Soonthon V, Noonan T, Hofstetter WThe American surgeonMesh reinforcement increases bursting strength of intestinal anastomoses in steroid-treated rabbits. Am Surg. 1994 Oct; 60(10):721-7.Am Surg1994-10-01T00:00:001994Mesh reinforcement increases bursting strength of intestinal anastomoses in steroid-treated rabbits.12192324Hofstetter W, Swisher SG, Correa AM, Hess K, Putnam JB, Ajani JA, Dolormente M, Francisco R, Komaki RR, Lara A, Martin F, Rice DC, Sarabia AJ, Smythe WR, Vaporciyan AA, Walsh GL, Roth JAAnnals of surgeryTreatment outcomes of resected esophageal cancer. Ann Surg. 2002 Sep; 236(3):376-84; discussion 384-5.Ann Surg2002-09-01T00:00:002002Treatment outcomes of resected esophageal cancer.16456809Gu Y, Swisher SG, Ajani JA, Correa AM, Hofstetter WL, Liao Z, Komaki RR, Rashid A, Hamilton SR, Wu TTCancerThe number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation. Cancer. 2006 Mar 01; 106(5):1017-25.Cancer2006-03-01T00:00:002006The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation.16874819Malaisrie SC, Hofstetter WL, Correa AM, Ajani JA, Komaki RR, Rice DC, Vaporciyan AA, Walsh GL, Roth JA, Wu TT, Swisher SGCancerThe addition of induction chemotherapy to preoperative, concurrent chemoradiotherapy improves tumor response in patients with esophageal adenocarcinoma. Cancer. 2006 Sep 01; 107(5):967-74.Cancer2006-09-01T00:00:002006The addition of induction chemotherapy to preoperative, concurrent chemoradiotherapy improves tumor response in patients with esophageal adenocarcinoma.16899607Wang KL, Wu TT, Resetkova E, Wang H, Correa AM, Hofstetter WL, Swisher SG, Ajani JA, Rashid A, Hamilton SR, Albarracin CTClinical cancer research : an official journal of the American Association for Cancer ResearchExpression of annexin A1 in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome. Clin Cancer Res. 2006 Aug 01; 12(15):4598-604.Clin Cancer Res2006-08-01T00:00:002006Expression of annexin A1 in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.17163101Martin LW, Hofstetter W, Swisher SG, Roth JAAdvances in surgeryManagement of intrathoracic leaks following esophagectomy. Adv Surg. 2006; 40:173-90.Adv Surg2006-01-01T00:00:002006Management of intrathoracic leaks following esophagectomy.17643602Hofstetter W, Correa AM, Bekele N, Ajani JA, Phan A, Komaki RR, Liao Z, Maru D, Wu TT, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Francis A, Blackmon S, Swisher SGThe Annals of thoracic surgeryProposed modification of nodal status in AJCC esophageal cancer staging system. Ann Thorac Surg. 2007 Aug; 84(2):365-73; discussion 374-5.Ann Thorac Surg2007-08-01T00:00:002007Proposed modification of nodal status in AJCC esophageal cancer staging system.18059218Abraham SC, Krasinskas AM, Hofstetter WL, Swisher SG, Wu TTThe American journal of surgical pathology"Seedling" mesenchymal tumors (gastrointestinal stromal tumors and leiomyomas) are common incidental tumors of the esophagogastric junction. Am J Surg Pathol. 2007 Nov; 31(11):1629-35.Am J Surg Pathol2007-11-01T00:00:002007"Seedling" mesenchymal tumors (gastrointestinal stromal tumors and leiomyomas) are common incidental tumors of the esophagogastric junction.19059972Rice D, Swisher S, Pisters K, Fossella F, Herbst R, Hofstetter W, Kies M, Komaki R, Lippman S, Mehran R, Roth J, Stewart D, Vaporciyan A, Walsh G, Cox JChestComment on "Treatment of non-small cell lung cancer stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition)". Chest. 2008 Dec; 134(6):1349.Chest2008-12-01T00:00:002008Comment on "Treatment of non-small cell lung cancer stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition)".19130466Javeri H, Xiao L, Rohren E, Komaki R, Hofstetter W, Lee JH, Maru D, Bhutani MS, Swisher SG, Wang X, Ajani JACancerInfluence of the baseline 18F-fluoro-2-deoxy-D-glucose positron emission tomography results on survival and pathologic response in patients with gastroesophageal cancer undergoing chemoradiation. Cancer. 2009 Feb 01; 115(3):624-30.Cancer2009-02-01T00:00:002009Influence of the baseline 18F-fluoro-2-deoxy-D-glucose positron emission tomography results on survival and pathologic response in patients with gastroesophageal cancer undergoing chemoradiation.19289262Smith GL, Smith BD, Buchholz TA, Liao Z, Jeter M, Swisher SG, Hofstetter WL, Ajani JA, McAleer MF, Komaki R, Cox JDInternational journal of radiation oncology, biology, physicsPatterns of care and locoregional treatment outcomes in older esophageal cancer patients: The SEER-Medicare Cohort. Int J Radiat Oncol Biol Phys. 2009 Jun 01; 74(2):482-9.Int J Radiat Oncol Biol Phys2009-03-14T00:00:002009Patterns of care and locoregional treatment outcomes in older esophageal cancer patients: The SEER-Medicare Cohort.19685531Javeri H, Xiao L, Rohren E, Lee JH, Liao Z, Hofstetter W, Maru D, Bhutani MS, Swisher SG, Macapinlac H, Wang X, Ajani JACancerThe higher the decrease in the standardized uptake value of positron emission tomography after chemoradiation, the better the survival of patients with gastroesophageal adenocarcinoma. Cancer. 2009 Nov 15; 115(22):5184-92.Cancer2009-11-15T00:00:002009The higher the decrease in the standardized uptake value of positron emission tomography after chemoradiation, the better the survival of patients with gastroesophageal adenocarcinoma.19699913Rice DC, Steliga MA, Stewart J, Eapen G, Jimenez CA, Lee JH, Hofstetter WL, Marom EM, Mehran RJ, Vaporciyan AA, Walsh GL, Swisher SGThe Annals of thoracic surgeryEndoscopic ultrasound-guided fine needle aspiration for staging of malignant pleural mesothelioma. Ann Thorac Surg. 2009 Sep; 88(3):862-8; discussion 868-9.Ann Thorac Surg2009-09-01T00:00:002009Endoscopic ultrasound-guided fine needle aspiration for staging of malignant pleural mesothelioma.19699930Hofstetter WThe Annals of thoracic surgeryInvited commentary. Ann Thorac Surg. 2009 Sep; 88(3):973.Ann Thorac Surg2009-09-01T00:00:002009Invited commentary.20171141Bose D, Meric-Bernstam F, Hofstetter W, Reardon DA, Flaherty KT, Ellis LMThe Lancet. OncologyVascular endothelial growth factor targeted therapy in the perioperative setting: implications for patient care. Lancet Oncol. 2010 Apr; 11(4):373-82.Lancet Oncol2010-02-18T00:00:002010Vascular endothelial growth factor targeted therapy in the perioperative setting: implications for patient care.20410333Ajani JA, Barthel JS, Bekaii-Saab T, Bentrem DJ, D'Amico TA, Das P, Denlinger C, Fuchs CS, Gerdes H, Hayman JA, Hazard L, Hofstetter WL, Ilson DH, Keswani RN, Kleinberg LR, Korn M, Meredith K, Mulcahy MF, Orringer MB, Osarogiagbon RU, Posey JA, Sasson AR, Scott WJ, Shibata S, Strong VE, Washington MK, Willett C, Wood DE, Wright CD, Yang G, NCCN Gastric Cancer PanelJournal of the National Comprehensive Cancer Network : JNCCNGastric cancer. J Natl Compr Canc Netw. 2010 Apr; 8(4):378-409.J Natl Compr Canc Netw2010-04-01T00:00:002010Gastric cancer.20494031Gaur P, Hofstetter WL, Bekele BN, Correa AM, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Rice TW, Swisher SGThe Annals of thoracic surgeryComparison between established and the Worldwide Esophageal Cancer Collaboration staging systems. Ann Thorac Surg. 2010 Jun; 89(6):1797-1803, 1804.e1-3; discussion 1803-4.Ann Thorac Surg2010-06-01T00:00:002010Comparison between established and the Worldwide Esophageal Cancer Collaboration staging systems.20609777Kim MP, Correa AM, Swisher SG, Hofstetter WL, Mehran RJ, Rice DC, Walsh GL, Erasmus J, Moran C, Vaporciyan AA, Roth JAThe Annals of thoracic surgeryNon-small cell lung cancer resection in lymphoma patients. Ann Thorac Surg. 2010 Jul; 90(1):210-6.Ann Thorac Surg2010-07-01T00:00:002010Non-small cell lung cancer resection in lymphoma patients.20732513Kim MP, Correa AM, Lee J, Rice DC, Roth JA, Mehran RJ, Walsh GL, Ajani JA, Maru DM, Chang JY, Marom EM, Macapinlac HA, Lee JH, Vaporciyan AA, Rice T, Swisher SG, Hofstetter WLThe Annals of thoracic surgeryPathologic T0N1 esophageal cancer after neoadjuvant therapy and surgery: an orphan status. Ann Thorac Surg. 2010 Sep; 90(3):884-90; discussion 890-1.Ann Thorac Surg2010-09-01T00:00:002010Pathologic T0N1 esophageal cancer after neoadjuvant therapy and surgery: an orphan status.20960497Kountourakis P, Correa AM, Hofstetter WL, Lee JH, Bhutani MS, Rice DC, Komaki R, Maru DM, Ross WA, Vaporciyan A, Swisher SG, Ajani JACancerCombined modality therapy of cT2N0M0 esophageal cancer: the University of Texas M. D. Anderson Cancer Center experience. Cancer. 2011 Mar 01; 117(5):925-30.Cancer2010-10-19T00:00:002010Combined modality therapy of cT2N0M0 esophageal cancer: the University of Texas M. D. Anderson Cancer Center experience.21136578Hayashi Y, Correa AM, Hofstetter WL, Vaporciyan AA, Rice DC, Walsh GL, Mehran RJ, Lee JH, Bhutani MS, Dekovich A, Swisher SG, Ajani JACancerThe influence of high body mass index on the prognosis of patients with esophageal cancer after surgery as primary therapy. Cancer. 2010 Dec 15; 116(24):5619-27.Cancer2010-11-08T00:00:002010The influence of high body mass index on the prognosis of patients with esophageal cancer after surgery as primary therapy.21282546Cleeland CS, Wang XS, Shi Q, Mendoza TR, Wright SL, Berry MD, Malveaux D, Shah PK, Gning I, Hofstetter WL, Putnam JB, Vaporciyan AAJournal of clinical oncology : official journal of the American Society of Clinical OncologyAutomated symptom alerts reduce postoperative symptom severity after cancer surgery: a randomized controlled clinical trial. J Clin Oncol. 2011 Mar 10; 29(8):994-1000.J Clin Oncol2011-01-31T00:00:002011Automated symptom alerts reduce postoperative symptom severity after cancer surgery: a randomized controlled clinical trial.21365188Welsh J, Amini A, Likhacheva A, Erasmus J J, Gomez D, Davila M, Mehran RJ, Komaki R, Liao Z, Hofstetter WL, Lee H J, Bhutani MS, Ajani JACurrent oncology reportsUpdate: modern approaches to the treatment of localized esophageal cancer. Curr Oncol Rep. 2011 Jun; 13(3):157-67.Curr Oncol Rep2011-06-01T00:00:002011Update: modern approaches to the treatment of localized esophageal cancer.21507583Swisher SG, Winter KA, Komaki RU, Ajani JA, Wu TT, Hofstetter WL, Konski AA, Willett CGInternational journal of radiation oncology, biology, physicsA Phase II study of a paclitaxel-based chemoradiation regimen with selective surgical salvage for resectable locoregionally advanced esophageal cancer: initial reporting of RTOG 0246. Int J Radiat Oncol Biol Phys. 2012 Apr 01; 82(5):1967-72.Int J Radiat Oncol Biol Phys2011-04-18T00:00:002011A Phase II study of a paclitaxel-based chemoradiation regimen with selective surgical salvage for resectable locoregionally advanced esophageal cancer: initial reporting of RTOG 0246.21541769Kim JY, Hanasono MM, Fleming JB, Berry MD, Hofstetter WLJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary TractCombined esophagectomy and pancreaticoduodenectomy: expanded indication for supercharged jejunal interposition. J Gastrointest Surg. 2011 Oct; 15(10):1893-5.J Gastrointest Surg2011-05-03T00:00:002011Combined esophagectomy and pancreaticoduodenectomy: expanded indication for supercharged jejunal interposition.21606421Ajani JA, Blum MA, Welsh J, Hofstetter WL, Swisher SGJournal of clinical oncology : official journal of the American Society of Clinical OncologyCelebrate or calibrate? We say calibrate. J Clin Oncol. 2011 Jul 01; 29(19):2732; author reply 2732-3.J Clin Oncol2011-05-23T00:00:002011Celebrate or calibrate? We say calibrate.21962263Kim JY, Correa AM, Vaporciyan AA, Roth JA, Mehran RJ, Walsh GL, Rice DC, Ajani JA, Maru DM, Bhutani MS, Welsh J, Marom EM, Swisher SG, Hofstetter WLThe Annals of thoracic surgeryDoes the timing of esophagectomy after chemoradiation affect outcome? Ann Thorac Surg. 2012 Jan; 93(1):207-12; discussion 212-3.Ann Thorac Surg2011-10-01T00:00:002011Does the timing of esophagectomy after chemoradiation affect outcome?22172216Harvin JA, Lahat G, Correa AM, Lee J, Maru D, Ajani J, Marom EM, Welsh J, Bhutani MS, Walsh G, Roth J, Mehran R, Vaporciyan A, Rice D, Swisher S, Hofstetter WThe Journal of thoracic and cardiovascular surgeryNeoadjuvant chemoradiotherapy followed by surgery for esophageal adenocarcinoma: significance of microscopically positive circumferential radial margins. J Thorac Cardiovasc Surg. 2012 Feb; 143(2):412-20.J Thorac Cardiovasc Surg2011-12-14T00:00:002011Neoadjuvant chemoradiotherapy followed by surgery for esophageal adenocarcinoma: significance of microscopically positive circumferential radial margins.22348039He Y, Zhou Z, Hofstetter WL, Zhou Y, Hu W, Guo C, Wang L, Guo W, Pataer A, Correa AM, Lu Y, Wang J, Diao L, Byers LA, Wistuba II, Roth JA, Swisher SG, Heymach JV, Fang BPloS oneAberrant expression of proteins involved in signal transduction and DNA repair pathways in lung cancer and their association with clinical parameters. PLoS One. 2012; 7(2):e31087.PLoS One2012-02-10T00:00:002012Aberrant expression of proteins involved in signal transduction and DNA repair pathways in lung cancer and their association with clinical parameters.22436793Amini A, Xiao L, Allen PK, Suzuki A, Hayashi Y, Liao Z, Hofstetter W, Crane C, Komaki R, Bhutani MS, Lee JH, Ajani JA, Welsh JInternational journal of radiation oncology, biology, physicsCeliac node failure patterns after definitive chemoradiation for esophageal cancer in the modern era. Int J Radiat Oncol Biol Phys. 2012 Jun 01; 83(2):e231-9.Int J Radiat Oncol Biol Phys2012-03-19T00:00:002012Celiac node failure patterns after definitive chemoradiation for esophageal cancer in the modern era.22571880Schier R, Hinkelbein J, Marcus H, Mehran R, El-Zein R, Hofstetter W, Swafford J, Riedel BThe Annals of thoracic surgeryPreoperative microvascular dysfunction: a prospective, observational study expanding risk assessment strategies in major thoracic surgery. Ann Thorac Surg. 2012 Jul; 94(1):226-33.Ann Thorac Surg2012-05-08T00:00:002012Preoperative microvascular dysfunction: a prospective, observational study expanding risk assessment strategies in major thoracic surgery.22644446Thomas RM, Truty MJ, Nogueras-Gonzalez GM, Fleming JB, Vauthey JN, Pisters PW, Lee JE, Rice DC, Hofstetter WL, Wolff RA, Varadhachary GR, Wang H, Katz MHJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary TractSelective reoperation for locally recurrent or metastatic pancreatic ductal adenocarcinoma following primary pancreatic resection. J Gastrointest Surg. 2012 Sep; 16(9):1696-704.J Gastrointest Surg2012-05-30T00:00:002012Selective reoperation for locally recurrent or metastatic pancreatic ductal adenocarcinoma following primary pancreatic resection.22853875Hayashi Y, Xiao L, Suzuki A, Blum MA, Sabloff B, Taketa T, Maru DM, Welsh J, Lin SH, Weston B, Lee JH, Bhutani MS, Hofstetter WL, Swisher SG, Ajani JAEuropean journal of cancer (Oxford, England : 1990)A nomogram associated with high probability of malignant nodes in the surgical specimen after trimodality therapy of patients with oesophageal cancer. Eur J Cancer. 2012 Dec; 48(18):3396-404.Eur J Cancer2012-07-31T00:00:002012A nomogram associated with high probability of malignant nodes in the surgical specimen after trimodality therapy of patients with oesophageal cancer.22921233Marks JL, Hofstetter W, Correa AM, Mehran RJ, Rice D, Roth J, Walsh G, Vaporciyan A, Erasmus J, Chang J, Maru D, Lee JH, Lee J, Ajani JA, Swisher SGThe Annals of thoracic surgerySalvage esophagectomy after failed definitive chemoradiation for esophageal adenocarcinoma. Ann Thorac Surg. 2012 Oct; 94(4):1126-32; discussion 1132-3.Ann Thorac Surg2012-08-24T00:00:002012Salvage esophagectomy after failed definitive chemoradiation for esophageal adenocarcinoma.22964903Taketa T, Correa AM, Suzuki A, Blum MA, Chien P, Lee JH, Welsh J, Lin SH, Maru DM, Erasmus JJ, Bhutani MS, Weston B, Rice DC, Vaporciyan AA, Hofstetter WL, Swisher SG, Ajani JAOncologyOutcome of trimodality-eligible esophagogastric cancer patients who declined surgery after preoperative chemoradiation. Oncology. 2012; 83(5):300-4.Oncology2012-09-04T00:00:002012Outcome of trimodality-eligible esophagogastric cancer patients who declined surgery after preoperative chemoradiation.23063195Blackmon SH, Stephens EH, Correa AM, Hofstetter W, Kim MP, Mehran RJ, Rice DC, Roth JA, Swisher SG, Walsh GL, Vaporciyan AAThe Annals of thoracic surgeryPredictors of recurrent pulmonary metastases and survival after pulmonary metastasectomy for colorectal cancer. Ann Thorac Surg. 2012 Dec; 94(6):1802-9.Ann Thorac Surg2012-10-11T00:00:002012Predictors of recurrent pulmonary metastases and survival after pulmonary metastasectomy for colorectal cancer.23222201Ganeshan DM, Bhosale P, Munden RF, Hofstetter WL, Correa AM, Iyer RJournal of thoracic imagingDiaphragmatic hernia after esophagectomy for esophageal malignancy. J Thorac Imaging. 2013 Sep; 28(5):308-14.J Thorac Imaging2013-09-01T00:00:002013Diaphragmatic hernia after esophagectomy for esophageal malignancy.23350713Murphy CC, Hofstetter WL, Correa AM, Ajani JA, Komaki RU, Swisher SGDiseases of the esophagus : official journal of the International Society for Diseases of the EsophagusUtilization of surgery in trimodality-eligible patients with locally advanced esophageal adenocarcinoma in a nonprotocol setting. Dis Esophagus. 2013 Sep-Oct; 26(7):708-15.Dis Esophagus2013-01-25T00:00:002013Utilization of surgery in trimodality-eligible patients with locally advanced esophageal adenocarcinoma in a nonprotocol setting.23536563Song S, Maru DM, Ajani JA, Chan CH, Honjo S, Lin HK, Correa A, Hofstetter WL, Davila M, Stroehlein J, Mishra LCancer researchLoss of TGF-? adaptor ?2SP activates notch signaling and SOX9 expression in esophageal adenocarcinoma. Cancer Res. 2013 Apr 01; 73(7):2159-69.Cancer Res2013-03-27T00:00:002013Loss of TGF-? adaptor ?2SP activates notch signaling and SOX9 expression in esophageal adenocarcinoma.23659947Lee L, Ronellenfitsch U, Hofstetter WL, Darling G, Gaiser T, Lippert C, Gilbert S, Seely AJ, Mulder DS, Ferri LEJournal of the American College of SurgeonsPredicting lymph node metastases in early esophageal adenocarcinoma using a simple scoring system. J Am Coll Surg. 2013 Aug; 217(2):191-9.J Am Coll Surg2013-05-06T00:00:002013Predicting lymph node metastases in early esophageal adenocarcinoma using a simple scoring system.23752201Varghese TK, Hofstetter WL, Rizk NP, Low DE, Darling GE, Watson TJ, Mitchell JD, Krasna MJThe Annals of thoracic surgeryThe society of thoracic surgeons guidelines on the diagnosis and staging of patients with esophageal cancer. Ann Thorac Surg. 2013 Jul; 96(1):346-56.Ann Thorac Surg2013-06-07T00:00:002013The society of thoracic surgeons guidelines on the diagnosis and staging of patients with esophageal cancer.23810174Ganeshan DM, Correa AM, Bhosale P, Vaporciyan AA, Rice D, Mehran RJ, Walsh GL, Iyer R, Roth JA, Swisher SG, Hofstetter WLThe Annals of thoracic surgeryDiaphragmatic hernia after esophagectomy in 440 patients with long-term follow-up. Ann Thorac Surg. 2013 Oct; 96(4):1138-1145.Ann Thorac Surg2013-06-25T00:00:002013Diaphragmatic hernia after esophagectomy in 440 patients with long-term follow-up.23860252Taketa T, Xiao L, Sudo K, Suzuki A, Wadhwa R, Blum MA, Lee JH, Weston B, Bhutani MS, Skinner H, Komaki R, Maru DM, Rice DC, Swisher SG, Hofstetter WL, Ajani JAOncologyPropensity-based matching between esophagogastric cancer patients who had surgery and who declined surgery after preoperative chemoradiation. Oncology. 2013; 85(2):95-9.Oncology2013-07-16T00:00:002013Propensity-based matching between esophagogastric cancer patients who had surgery and who declined surgery after preoperative chemoradiation.24925190Shiozaki H, Sudo K, Xiao L, Wadhwa R, Elimova E, Hofstetter WL, Skinner HD, Lee JH, Weston B, Bhutani MS, Blum MA, Maru DM, Ajani JAOncologyDistribution and timing of distant metastasis after local therapy in a large cohort of patients with esophageal and esophagogastric junction cancer. Oncology. 2014; 86(5-6):336-9.Oncology2014-06-07T00:00:002014Distribution and timing of distant metastasis after local therapy in a large cohort of patients with esophageal and esophagogastric junction cancer.25038008Patel VR, Hofstetter WL, Correa AM, Agarwal A, Rashid A, Bhutani MS, Lin SH, Ajani JA, Swisher SG, Maru DMThe Annals of thoracic surgerySignet ring cells in esophageal adenocarcinoma predict poor response to preoperative chemoradiation. Ann Thorac Surg. 2014 Sep; 98(3):1064-71.Ann Thorac Surg2014-07-16T00:00:002014Signet ring cells in esophageal adenocarcinoma predict poor response to preoperative chemoradiation.25214559Gao W, Wang M, Wang L, Lu H, Wu S, Dai B, Ou Z, Zhang L, Heymach JV, Gold KA, Minna J, Roth JA, Hofstetter WL, Swisher SG, Fang BJournal of the National Cancer InstituteSelective antitumor activity of ibrutinib in EGFR-mutant non-small cell lung cancer cells. J Natl Cancer Inst. 2014 Sep; 106(9).J Natl Cancer Inst2014-09-10T00:00:002014Selective antitumor activity of ibrutinib in EGFR-mutant non-small cell lung cancer cells.Authorship 2407853Authorship 2412761Authorship 2465382Authorship 2470572Authorship 2488998Authorship 2496772Authorship 2508889Authorship 2509027Authorship 2519599Authorship 2521672Authorship 2522245Authorship 2530292Authorship 2532914Authorship 2535623Authorship 2537702Authorship 25413310Authorship 25488611Authorship 2549786Authorship 2555168Authorship 2560485Authorship 2561978Authorship 2562307Authorship 2563347Authorship 2569246Authorship 25745713Authorship 2579181Authorship 2579993Authorship 25818811Authorship 2588315Authorship 259291Authorship 2598789Authorship 2599585Authorship 26004212Authorship 2602897Authorship 2603846Authorship 26061816Authorship 26073415Authorship 26080414Authorship 2610929Authorship 26116315Authorship 2612138Authorship 2613126Authorship 261718119287900Coburn WM, Russell MA, Hofstetter WLAnnals of emergency medicineSucrose as an aid to manual reduction of incarcerated rectal prolapse. Ann Emerg Med. 1997 Sep; 30(3):347-9.Ann Emerg Med1997-09-01T00:00:001997Sucrose as an aid to manual reduction of incarcerated rectal prolapse.10706295Hofstetter W, Ortega A, Chiang M, Brown B, Paik P, Youn P, Beart RWJournal of laparoendoscopic & advanced surgical techniques. Part AAbdominal insufflation does not cause hematogenous spread of colon cancer. J Laparoendosc Adv Surg Tech A. 2000 Feb; 10(1):1-4.J Laparoendosc Adv Surg Tech A2000-02-01T00:00:002000Abdominal insufflation does not cause hematogenous spread of colon cancer.15849517Swisher SG, Hofstetter W, Wu TT, Correa AM, Ajani JA, Komaki RR, Chirieac L, Hunt KK, Liao Z, Phan A, Rice DC, Vaporciyan AA, Walsh GL, Roth JAAnnals of surgeryProposed revision of the esophageal cancer staging system to accommodate pathologic response (pP) following preoperative chemoradiation (CRT). Ann Surg. 2005 May; 241(5):810-7; discussion 817-20.Ann Surg2005-05-01T00:00:002005Proposed revision of the esophageal cancer staging system to accommodate pathologic response (pP) following preoperative chemoradiation (CRT).16006804Liu L, Hofstetter WL, Rashid A, Swisher SG, Correa AM, Ajani JA, Hamilton SR, Wu TTThe American journal of surgical pathologySignificance of the depth of tumor invasion and lymph node metastasis in superficially invasive (T1) esophageal adenocarcinoma. Am J Surg Pathol. 2005 Aug; 29(8):1079-85.Am J Surg Pathol2005-08-01T00:00:002005Significance of the depth of tumor invasion and lymph node metastasis in superficially invasive (T1) esophageal adenocarcinoma.17197919Wu TT, Chirieac LR, Abraham SC, Krasinskas AM, Wang H, Rashid A, Correa AM, Hofstetter WL, Ajani JA, Swisher SGThe American journal of surgical pathologyExcellent interobserver agreement on grading the extent of residual carcinoma after preoperative chemoradiation in esophageal and esophagogastric junction carcinoma: a reliable predictor for patient outcome. Am J Surg Pathol. 2007 Jan; 31(1):58-64.Am J Surg Pathol2007-01-01T00:00:002007Excellent interobserver agreement on grading the extent of residual carcinoma after preoperative chemoradiation in esophageal and esophagogastric junction carcinoma: a reliable predictor for patient outcome.17403459Swisher SG, Hofstetter WL, Miller MJSeminars in thoracic and cardiovascular surgeryThe supercharged microvascular jejunal interposition. Semin Thorac Cardiovasc Surg. 2007; 19(1):56-65.Semin Thorac Cardiovasc Surg2007-01-01T00:00:002007The supercharged microvascular jejunal interposition.17954086Rice DC, Stevens CW, Correa AM, Vaporciyan AA, Tsao A, Forster KM, Walsh GL, Swisher SG, Hofstetter WL, Mehran RJ, Roth JA, Liao Z, Smythe WRThe Annals of thoracic surgeryOutcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma. Ann Thorac Surg. 2007 Nov; 84(5):1685-92; discussion 1692-3.Ann Thorac Surg2007-11-01T00:00:002007Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma.17975494Yendamuri S, Komaki RR, Correa AM, Allen P, Wynn B, Blackmon S, Hofstetter WL, Rice DC, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Mehran RJJournal of thoracic oncology : official publication of the International Association for the Study of Lung CancerComparison of limited surgery and three-dimensional conformal radiation in high-risk patients with stage I non-small cell lung cancer. J Thorac Oncol. 2007 Nov; 2(11):1022-8.J Thorac Oncol2007-11-01T00:00:002007Comparison of limited surgery and three-dimensional conformal radiation in high-risk patients with stage I non-small cell lung cancer.19021681Izzo JG, Wu X, Wu TT, Huang P, Lee JS, Liao Z, Lee JH, Bhutani MS, Hofstetter W, Maru D, Hung MC, Ajani JADiseases of the esophagus : official journal of the International Society for Diseases of the EsophagusTherapy-induced expression of NF-kappaB portends poor prognosis in patients with localized esophageal cancer undergoing preoperative chemoradiation. Dis Esophagus. 2009; 22(2):127-32.Dis Esophagus2008-11-19T00:00:002008Therapy-induced expression of NF-kappaB portends poor prognosis in patients with localized esophageal cancer undergoing preoperative chemoradiation.19066342Hu W, Hofstetter W, Wei X, Guo W, Zhou Y, Pataer A, Li H, Fang B, Swisher SGThe Journal of pharmacology and experimental therapeuticsDouble-stranded RNA-dependent protein kinase-dependent apoptosis induction by a novel small compound. J Pharmacol Exp Ther. 2009 Mar; 328(3):866-72.J Pharmacol Exp Ther2008-12-09T00:00:002008Double-stranded RNA-dependent protein kinase-dependent apoptosis induction by a novel small compound.19458557Zhang Z, Chen Y, Chen Y, Jeter M, Hofstetter WL, Ajani J, Swisher SG, Chang JY, Allen PK, Cox JD, Komaki R, Liao ZXJournal of thoracic oncology : official publication of the International Association for the Study of Lung CancerOutcomes with esophageal cancer radiation therapy. J Thorac Oncol. 2009 Jul; 4(7):880-8.J Thorac Oncol2009-07-01T00:00:002009Outcomes with esophageal cancer radiation therapy.19476855Callender GG, Grubbs EG, Vu T, Hofstetter WL, Fleming JB, Woodburn KL, Lee JE, Evans DB, Perrier NDJournal of the American College of SurgeonsThe fallen one: the inferior parathyroid gland that descends into the mediastinum. J Am Coll Surg. 2009 May; 208(5):887-93; discussion 893-5.J Am Coll Surg2009-05-01T00:00:002009The fallen one: the inferior parathyroid gland that descends into the mediastinum.19562780Braiteh F, Correa AM, Hofstetter WL, Rice DC, Vaporciyan AA, Walsh GL, Roth JA, Mehran RJ, Swisher SG, Ajani JACancerAssociation of age and survival in patients with gastroesophageal cancer undergoing surgery with or without preoperative therapy. Cancer. 2009 Oct 01; 115(19):4450-8.Cancer2009-10-01T00:00:002009Association of age and survival in patients with gastroesophageal cancer undergoing surgery with or without preoperative therapy.19660349Bolton WD, Hofstetter WL, Francis AM, Correa AM, Ajani JA, Bhutani MS, Erasmus J, Komaki R, Maru DM, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Swisher SGThe Journal of thoracic and cardiovascular surgeryImpact of tumor length on long-term survival of pT1 esophageal adenocarcinoma. J Thorac Cardiovasc Surg. 2009 Oct; 138(4):831-6.J Thorac Cardiovasc Surg2009-04-09T00:00:002009Impact of tumor length on long-term survival of pT1 esophageal adenocarcinoma.20143431Ajani JA, Correa AM, Walsh GL, Komaki R, Lee JH, Vaporciyan AA, Rice DC, Yao JC, Maru DM, Hofstetter WL, Phan AT, Swisher SGCancerTrimodality therapy without a platinum compound for localized carcinoma of the esophagus and gastroesophageal junction. Cancer. 2010 Apr 01; 116(7):1656-63.Cancer2010-04-01T00:00:002010Trimodality therapy without a platinum compound for localized carcinoma of the esophagus and gastroesophageal junction.20629031Patnana SV, Murthy SB, Xiao L, Rohren E, Hofstetter WL, Swisher SG, Liao Z, Lee JH, Bhutani MS, Macapinlac HA, Wang X, Ajani JACancerCritical role of surgery in patients with gastroesophageal carcinoma with a poor prognosis after chemoradiation as defined by positron emission tomography. Cancer. 2010 Oct 01; 116(19):4487-94.Cancer2010-10-01T00:00:002010Critical role of surgery in patients with gastroesophageal carcinoma with a poor prognosis after chemoradiation as defined by positron emission tomography.20651033Gu J, Ajani JA, Hawk ET, Ye Y, Lee JH, Bhutani MS, Hofstetter WL, Swisher SG, Wang KK, Wu XCancer prevention research (Philadelphia, Pa.)Genome-wide catalogue of chromosomal aberrations in barrett's esophagus and esophageal adenocarcinoma: a high-density single nucleotide polymorphism array analysis. Cancer Prev Res (Phila). 2010 Sep; 3(9):1176-86.Cancer Prev Res (Phila)2010-07-22T00:00:002010Genome-wide catalogue of chromosomal aberrations in barrett's esophagus and esophageal adenocarcinoma: a high-density single nucleotide polymorphism array analysis.20732514Swisher SG, Hofstetter W, Komaki R, Correa AM, Erasmus J, Lee JH, Liao Z, Maru D, Mehran R, Patel S, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Ajani JAThe Annals of thoracic surgeryImproved long-term outcome with chemoradiotherapy strategies in esophageal cancer. Ann Thorac Surg. 2010 Sep; 90(3):892-8; discussion 898-9.Ann Thorac Surg2010-09-01T00:00:002010Improved long-term outcome with chemoradiotherapy strategies in esophageal cancer.21037429Vallb?hmer D, H?lscher AH, DeMeester S, DeMeester T, Salo J, Peters J, Lerut T, Swisher SG, Schr?der W, Bollschweiler E, Hofstetter WAnnals of surgeryA multicenter study of survival after neoadjuvant radiotherapy/chemotherapy and esophagectomy for ypT0N0M0R0 esophageal cancer. Ann Surg. 2010 Nov; 252(5):744-9.Ann Surg2010-11-01T00:00:002010A multicenter study of survival after neoadjuvant radiotherapy/chemotherapy and esophagectomy for ypT0N0M0R0 esophageal cancer.21123005Welsh J, Palmer MB, Ajani JA, Liao Z, Swisher SG, Hofstetter WL, Allen PK, Settle SH, Gomez D, Likhacheva A, Cox JD, Komaki RInternational journal of radiation oncology, biology, physicsEsophageal cancer dose escalation using a simultaneous integrated boost technique. Int J Radiat Oncol Biol Phys. 2012 Jan 01; 82(1):468-74.Int J Radiat Oncol Biol Phys2010-12-01T00:00:002010Esophageal cancer dose escalation using a simultaneous integrated boost technique.21305538Mendelson J, Song S, Li Y, Maru DM, Mishra B, Davila M, Hofstetter WL, Mishra LCancerDysfunctional transforming growth factor-? signaling with constitutively active Notch signaling in Barrett's esophageal adenocarcinoma. Cancer. 2011 Aug 15; 117(16):3691-702.Cancer2011-02-08T00:00:002011Dysfunctional transforming growth factor-? signaling with constitutively active Notch signaling in Barrett's esophageal adenocarcinoma.21435923Stephens EH, Blackmon SH, Correa AM, Roth JA, Rice DC, Hofstetter W, Benjamin R, Mehran R, Swisher SG, Walsh GL, Vaporciyan AAJournal of the American College of SurgeonsProgression after chemotherapy is a novel predictor of poor outcomes after pulmonary metastasectomy in sarcoma patients. J Am Coll Surg. 2011 May; 212(5):821-6.J Am Coll Surg2011-03-23T00:00:002011Progression after chemotherapy is a novel predictor of poor outcomes after pulmonary metastasectomy in sarcoma patients.21470796Welsh J, Gomez D, Palmer MB, Riley BA, Mayankkumar AV, Komaki R, Dong L, Zhu XR, Likhacheva A, Liao Z, Hofstetter WL, Ajani JA, Cox JDInternational journal of radiation oncology, biology, physicsIntensity-modulated proton therapy further reduces normal tissue exposure during definitive therapy for locally advanced distal esophageal tumors: a dosimetric study. Int J Radiat Oncol Biol Phys. 2011 Dec 01; 81(5):1336-42.Int J Radiat Oncol Biol Phys2011-04-04T00:00:002011Intensity-modulated proton therapy further reduces normal tissue exposure during definitive therapy for locally advanced distal esophageal tumors: a dosimetric study.21900218Ajani JA, Barthel JS, Bentrem DJ, D'Amico TA, Das P, Denlinger CS, Fuchs CS, Gerdes H, Glasgow RE, Hayman JA, Hofstetter WL, Ilson DH, Keswani RN, Kleinberg LR, Korn WM, Lockhart AC, Mulcahy MF, Orringer MB, Osarogiagbon RU, Posey JA, Sasson AR, Scott WJ, Shibata S, Strong VE, Varghese TK, Warren G, Washington MK, Willett C, Wright CD, National Comprehensive Cancer NetworkJournal of the National Comprehensive Cancer Network : JNCCNEsophageal and esophagogastric junction cancers. J Natl Compr Canc Netw. 2011 Aug 01; 9(8):830-87.J Natl Compr Canc Netw2011-08-01T00:00:002011Esophageal and esophagogastric junction cancers.22115605Thosani N, Singh H, Kapadia A, Ochi N, Lee JH, Ajani J, Swisher SG, Hofstetter WL, Guha S, Bhutani MSGastrointestinal endoscopyDiagnostic accuracy of EUS in differentiating mucosal versus submucosal invasion of superficial esophageal cancers: a systematic review and meta-analysis. Gastrointest Endosc. 2012 Feb; 75(2):242-53.Gastrointest Endosc2011-11-23T00:00:002011Diagnostic accuracy of EUS in differentiating mucosal versus submucosal invasion of superficial esophageal cancers: a systematic review and meta-analysis.22328056Suzuki A, Xiao L, Hayashi Y, Blum MA, Welsh JW, Lin SH, Lee JH, Bhutani MS, Weston B, Maru DM, Rice DC, Swisher SG, Hofstetter WL, Erasmus J, Ajani JAOncologyNomograms for prognostication of outcome in patients with esophageal and gastroesophageal carcinoma undergoing definitive chemoradiotherapy. Oncology. 2012; 82(2):108-13.Oncology2012-02-11T00:00:002012Nomograms for prognostication of outcome in patients with esophageal and gastroesophageal carcinoma undergoing definitive chemoradiotherapy.22786537Hofstetter WLArchives of surgery (Chicago, Ill. : 1960)Lymphadenectomy as a benchmark to surgical quality in esophagectomy: comment on "variation in lymph node examination after esophagectomy for cancer in the United States". Arch Surg. 2012 Jun; 147(6):511-2.Arch Surg2012-06-01T00:00:002012Lymphadenectomy as a benchmark to surgical quality in esophagectomy: comment on "variation in lymph node examination after esophagectomy for cancer in the United States".22831985Ajani JA, Correa AM, Hofstetter WL, Rice DC, Blum MA, Suzuki A, Taketa T, Welsh J, Lin SH, Lee JH, Bhutani MS, Ross WA, Maru DM, Macapinlac HA, Erasmus J, Komaki R, Mehran RJ, Vaporciyan AA, Swisher SGAnnals of oncology : official journal of the European Society for Medical OncologyClinical parameters model for predicting pathologic complete response following preoperative chemoradiation in patients with esophageal cancer. Ann Oncol. 2012 Oct; 23(10):2638-2642.Ann Oncol2012-07-24T00:00:002012Clinical parameters model for predicting pathologic complete response following preoperative chemoradiation in patients with esophageal cancer.22939861Sepesi B, Swisher SG, Walsh GL, Correa A, Mehran RJ, Rice D, Roth J, Vaporciyan A, Hofstetter WLThe Journal of thoracic and cardiovascular surgeryOmental reinforcement of the thoracic esophagogastric anastomosis: an analysis of leak and reintervention rates in patients undergoing planned and salvage esophagectomy. J Thorac Cardiovasc Surg. 2012 Nov; 144(5):1146-50.J Thorac Cardiovasc Surg2012-08-28T00:00:002012Omental reinforcement of the thoracic esophagogastric anastomosis: an analysis of leak and reintervention rates in patients undergoing planned and salvage esophagectomy.22959377Swisher S, Ajani J, Correa A, Komaki R, Hofstetter WLancet (London, England)Minimally invasive versus open oesophagectomy for oesophageal cancer. Lancet. 2012 Sep 08; 380(9845):883; author reply 885-6.Lancet2012-09-08T00:00:002012Minimally invasive versus open oesophagectomy for oesophageal cancer.23527161Seurin D, Lombet A, Babajko S, Godeau F, Ricort JMPloS oneInsulin-like growth factor binding proteins increase intracellular calcium levels in two different cell lines. PLoS One. 2013; 8(3):e59323.PLoS One2013-03-19T00:00:002013Insulin-like growth factor binding proteins increase intracellular calcium levels in two different cell lines.23667204Ajani JA, Bentrem DJ, Besh S, D'Amico TA, Das P, Denlinger C, Fakih MG, Fuchs CS, Gerdes H, Glasgow RE, Hayman JA, Hofstetter WL, Ilson DH, Keswani RN, Kleinberg LR, Korn WM, Lockhart AC, Meredith K, Mulcahy MF, Orringer MB, Posey JA, Sasson AR, Scott WJ, Strong VE, Varghese TK, Warren G, Washington MK, Willett C, Wright CD, McMillian NR, Sundar H, National Comprehensive Cancer NetworkJournal of the National Comprehensive Cancer Network : JNCCNGastric cancer, version 2.2013: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw. 2013 May 01; 11(5):531-46.J Natl Compr Canc Netw2013-05-01T00:00:002013Gastric cancer, version 2.2013: featured updates to the NCCN Guidelines.23677485Godoy MC, Bruzzi JF, Viswanathan C, Truong MT, Guimar?es MD, Hofstetter WL, Erasmus JJ, Marom EMAbdominal imagingMultimodality imaging evaluation of esophageal cancer: staging, therapy assessment, and complications. Abdom Imaging. 2013 Oct; 38(5):974-93.Abdom Imaging2013-10-01T00:00:002013Multimodality imaging evaluation of esophageal cancer: staging, therapy assessment, and complications.23715646Murphy CC, Correa AM, Ajani JA, Komaki RU, Welsh JW, Swisher SG, Hofstetter WLJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary TractSurgery is an essential component of multimodality therapy for patients with locally advanced esophageal adenocarcinoma. J Gastrointest Surg. 2013 Aug; 17(8):1359-69.J Gastrointest Surg2013-05-29T00:00:002013Surgery is an essential component of multimodality therapy for patients with locally advanced esophageal adenocarcinoma.23845841Wang J, Wei C, Tucker SL, Myles B, Palmer M, Hofstetter WL, Swisher SG, Ajani JA, Cox JD, Komaki R, Liao Z, Lin SHInternational journal of radiation oncology, biology, physicsPredictors of postoperative complications after trimodality therapy for esophageal cancer. Int J Radiat Oncol Biol Phys. 2013 Aug 01; 86(5):885-91.Int J Radiat Oncol Biol Phys2013-08-01T00:00:002013Predictors of postoperative complications after trimodality therapy for esophageal cancer.23943906Murphy CC, Incalcaterra JR, Albright HW, Correa AM, Swisher SG, Hofstetter WLJournal of oncology practicePretreatment patient comorbidity and tobacco use increase cost and risk of postoperative complications after esophagectomy at a high-volume cancer center. J Oncol Pract. 2013 Sep; 9(5):233-9.J Oncol Pract2013-07-29T00:00:002013Pretreatment patient comorbidity and tobacco use increase cost and risk of postoperative complications after esophagectomy at a high-volume cancer center.23994746Suzuki A, Xiao L, Taketa T, Sudo K, Wadhwa R, Blum MA, Skinner H, Komaki R, Weston B, Lee JH, Bhutani MS, Rice DC, Maru DM, Erasmus J, Swisher SG, Hofstetter WL, Ajani JAAnnals of oncology : official journal of the European Society for Medical OncologyResults of the baseline positron emission tomography can customize therapy of localized esophageal adenocarcinoma patients who achieve a clinical complete response after chemoradiation. Ann Oncol. 2013 Nov; 24(11):2854-9.Ann Oncol2013-08-29T00:00:002013Results of the baseline positron emission tomography can customize therapy of localized esophageal adenocarcinoma patients who achieve a clinical complete response after chemoradiation.24022442Francis AM, Sepesi B, Correa AM, Blum MA, Erasmus JJ, Lee JH, Maru DM, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Welsh JW, Swisher SG, Hofstetter WL, University of Texas MD Anderson Esophageal Cancer GroupAnnals of surgeryThe influence of histopathologic tumor viability on long-term survival and recurrence rates following neoadjuvant therapy for esophageal adenocarcinoma. Ann Surg. 2013 Sep; 258(3):500-7.Ann Surg2013-09-01T00:00:002013The influence of histopathologic tumor viability on long-term survival and recurrence rates following neoadjuvant therapy for esophageal adenocarcinoma.24051869Wadhwa R, Taketa T, Correa AM, Sudo K, Campagna MC, Blum MA, Komaki R, Skinner H, Lee JH, Bhutani MS, Weston B, Maru DM, Rice DC, Swisher S, Hofstetter WL, Ajani JAOncologyIncidence of brain metastases after trimodality therapy in patients with esophageal or gastroesophageal cancer: implications for screening and surveillance. Oncology. 2013; 85(4):204-7.Oncology2013-09-19T00:00:002013Incidence of brain metastases after trimodality therapy in patients with esophageal or gastroesophageal cancer: implications for screening and surveillance.24130049Lu H, Wang L, Gao W, Meng J, Dai B, Wu S, Minna J, Roth JA, Hofstetter WL, Swisher SG, Fang BMolecular cancer therapeuticsIGFBP2/FAK pathway is causally associated with dasatinib resistance in non-small cell lung cancer cells. Mol Cancer Ther. 2013 Dec; 12(12):2864-73.Mol Cancer Ther2013-10-15T00:00:002013IGFBP2/FAK pathway is causally associated with dasatinib resistance in non-small cell lung cancer cells.24145339Sudo K, Taketa T, Correa AM, Campagna MC, Wadhwa R, Blum MA, Komaki R, Lee JH, Bhutani MS, Weston B, Skinner HD, Maru DM, Rice DC, Swisher SG, Hofstetter WL, Ajani JAJournal of clinical oncology : official journal of the American Society of Clinical OncologyLocoregional failure rate after preoperative chemoradiation of esophageal adenocarcinoma and the outcomes of salvage strategies. J Clin Oncol. 2013 Dec 01; 31(34):4306-10.J Clin Oncol2013-10-21T00:00:002013Locoregional failure rate after preoperative chemoradiation of esophageal adenocarcinoma and the outcomes of salvage strategies.24210755Ajani JA, Wang X, Song S, Suzuki A, Taketa T, Sudo K, Wadhwa R, Hofstetter WL, Komaki R, Maru DM, Lee JH, Bhutani MS, Weston B, Baladandayuthapani V, Yao Y, Honjo S, Scott AW, Skinner HD, Johnson RL, Berry DMolecular oncologyALDH-1 expression levels predict response or resistance to preoperative chemoradiation in resectable esophageal cancer patients. Mol Oncol. 2014 Feb; 8(1):142-9.Mol Oncol2013-10-28T00:00:002013ALDH-1 expression levels predict response or resistance to preoperative chemoradiation in resectable esophageal cancer patients.24366692Gold KA, Kim ES, Liu DD, Yuan P, Behrens C, Solis LM, Kadara H, Rice DC, Wistuba II, Swisher SG, Hofstetter WL, Lee JJ, Hong WKClinical cancer research : an official journal of the American Association for Cancer ResearchPrediction of survival in resected non-small cell lung cancer using a protein expression-based risk model: implications for personalized chemoprevention and therapy. Clin Cancer Res. 2014 Apr 01; 20(7):1946-54.Clin Cancer Res2013-12-23T00:00:002013Prediction of survival in resected non-small cell lung cancer using a protein expression-based risk model: implications for personalized chemoprevention and therapy.Authorship 2663413Authorship 2663559Authorship 2673642Authorship 2675618Authorship 2678502Authorship 2683102Authorship 2692102Authorship 2693551Authorship 2694125Authorship 26946912Authorship 2700091Authorship 2702363Authorship 2703621Authorship 2711931Authorship 2720092Authorship 2720469Authorship 272128516305830Rice DC, Erasmus JJ, Stevens CW, Vaporciyan AA, Wu JS, Tsao AS, Walsh GL, Swisher SG, Hofstetter WL, Ordonez NG, Smythe WRThe Annals of thoracic surgeryExtended surgical staging for potentially resectable malignant pleural mesothelioma. Ann Thorac Surg. 2005 Dec; 80(6):1988-92; discussion 1992-3.Ann Thorac Surg2005-12-01T00:00:002005Extended surgical staging for potentially resectable malignant pleural mesothelioma.16308005Martin LW, Correa AM, Hofstetter W, Hong WK, Komaki R, Putnam JB, Rice DC, Smythe WR, Swisher SG, Vaporciyan AA, Walsh GL, Roth JAThe Journal of thoracic and cardiovascular surgeryThe evolution of treatment outcomes for resected stage IIIA non-small cell lung cancer over 16 years at a single institution. J Thorac Cardiovasc Surg. 2005 Dec; 130(6):1601-10.J Thorac Cardiovasc Surg2005-12-01T00:00:002005The evolution of treatment outcomes for resected stage IIIA non-small cell lung cancer over 16 years at a single institution.17211865Wang KL, Wu TT, Choi IS, Wang H, Resetkova E, Reseetkova E, Correa AM, Hofstetter WL, Swisher SG, Ajani JA, Rashid A, Albarracin CTCancerExpression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome. Cancer. 2007 Feb 15; 109(4):658-67.Cancer2007-02-15T00:00:002007Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.17667046Bhutani MS, Hofstetter WJournal of clinical gastroenterologyTransesophageal EUS and EUS-FNA for lung cancer: where do we go from here? J Clin Gastroenterol. 2007 Aug; 41(7):644-6.J Clin Gastroenterol2007-08-01T00:00:002007Transesophageal EUS and EUS-FNA for lung cancer: where do we go from here?18072264Cen P, Hofstetter WL, Lee JH, Ross WA, Wu TT, Swisher SG, Davila M, Rashid A, Correa AM, Ajani JACancerValue of endoscopic ultrasound staging in conjunction with the evaluation of lymphovascular invasion in identifying low-risk esophageal carcinoma. Cancer. 2008 Feb 01; 112(3):503-10.Cancer2008-02-01T00:00:002008Value of endoscopic ultrasound staging in conjunction with the evaluation of lymphovascular invasion in identifying low-risk esophageal carcinoma.18205187Cen P, Hofstetter WL, Correa AM, Wu TT, Lee JH, Ross WA, Davilla M, Swisher SG, Fukami N, Rashid A, Maru D, Ajani JACancerLymphovascular invasion as a tool to further subclassify T1b esophageal adenocarcinoma. Cancer. 2008 Mar 01; 112(5):1020-7.Cancer2008-03-01T00:00:002008Lymphovascular invasion as a tool to further subclassify T1b esophageal adenocarcinoma.19734842Goodarzi M, Correa AM, Ajani JA, Swisher SG, Hofstetter WL, Guha S, Deavers MT, Rashid A, Maru DMModern pathology : an official journal of the United States and Canadian Academy of Pathology, IncAnti-phosphorylated histone H3 expression in Barrett's esophagus, low-grade dysplasia, high-grade dysplasia, and adenocarcinoma. Mod Pathol. 2009 Dec; 22(12):1612-21.Mod Pathol2009-09-04T00:00:002009Anti-phosphorylated histone H3 expression in Barrett's esophagus, low-grade dysplasia, high-grade dysplasia, and adenocarcinoma.20215880Zhou Y, Hofstetter WL, He Y, Hu W, Pataer A, Wang L, Wang J, Zhou Y, Yu L, Fang B, Swisher SGCancer biology & therapyKLF4 inhibition of lung cancer cell invasion by suppression of SPARC expression. Cancer Biol Ther. 2010 Apr 01; 9(7):507-13.Cancer Biol Ther2010-04-01T00:00:002010KLF4 inhibition of lung cancer cell invasion by suppression of SPARC expression.20955881Kim JY, Hofstetter WLThe Surgical clinics of North AmericaTumors of the mediastinum and chest wall. Surg Clin North Am. 2010 Oct; 90(5):1019-40.Surg Clin North Am2010-08-05T00:00:002010Tumors of the mediastinum and chest wall.21040152Mehran R, Rice D, El-Zein R, Huang JL, Vaporciyan A, Goodyear A, Mehta A, Correa A, Walsh G, Roth J, Swisher S, Hofstetter WDiseases of the esophagus : official journal of the International Society for Diseases of the EsophagusMinimally invasive esophagectomy versus open esophagectomy, a symptom assessment study. Dis Esophagus. 2011 Apr; 24(3):147-52.Dis Esophagus2010-10-11T00:00:002010Minimally invasive esophagectomy versus open esophagectomy, a symptom assessment study.21871305Hofstetter WLThe Annals of thoracic surgeryInvited commentary. Ann Thorac Surg. 2011 Sep; 92(3):1097-8.Ann Thorac Surg2011-09-01T00:00:002011Invited commentary.22150920Hayashi Y, Correa AM, Hofstetter WL, Vaporciyan AA, Mehran RJ, Rice DC, Suzuki A, Lee JH, Bhutani MS, Welsh J, Lin SH, Maru DM, Swisher SG, Ajani JADiseases of the esophagus : official journal of the International Society for Diseases of the EsophagusPatients with high body mass index tend to have lower stage of esophageal carcinoma at diagnosis. Dis Esophagus. 2012 Sep-Oct; 25(7):614-22.Dis Esophagus2011-12-09T00:00:002011Patients with high body mass index tend to have lower stage of esophageal carcinoma at diagnosis.22632488Hofstetter WLThe Annals of thoracic surgeryInvited commentary. Ann Thorac Surg. 2012 Jun; 93(6):1867.Ann Thorac Surg2012-06-01T00:00:002012Invited commentary.23304031Hofstetter WTexas Heart Institute journalCurrent and future options for treating esophageal cancer: a paradigm shift toward organ-sparing therapies. Tex Heart Inst J. 2012; 39(6):846-7.Tex Heart Inst J2012-01-01T00:00:002012Current and future options for treating esophageal cancer: a paradigm shift toward organ-sparing therapies.23621168Wang J, Myles B, Wei C, Chang JY, Hofstetter WL, Ajani JA, Swisher SG, Cox JD, Komaki R, Liao Z, Lin SHDiseases of the esophagus : official journal of the International Society for Diseases of the EsophagusObesity and outcomes in patients treated with chemoradiotherapy for esophageal carcinoma. Dis Esophagus. 2014 Feb-Mar; 27(2):168-75.Dis Esophagus2013-04-26T00:00:002013Obesity and outcomes in patients treated with chemoradiotherapy for esophageal carcinoma.24197760Amini A, Ajani J, Komaki R, Allen PK, Minsky BD, Blum M, Xiao L, Suzuki A, Hofstetter W, Swisher S, Gomez D, Liao Z, Lee JH, Bhutani MS, Welsh JWAnnals of surgical oncologyFactors associated with local-regional failure after definitive chemoradiation for locally advanced esophageal cancer. Ann Surg Oncol. 2014 Jan; 21(1):306-14.Ann Surg Oncol2013-11-07T00:00:002013Factors associated with local-regional failure after definitive chemoradiation for locally advanced esophageal cancer.24199698Davila ML, Hofstetter WLThoracic surgery clinicsEndoscopic management of Barrett's esophagus with high-grade dysplasia and early-stage esophageal adenocarcinoma. Thorac Surg Clin. 2013 Nov; 23(4):479-89.Thorac Surg Clin2013-11-01T00:00:002013Endoscopic management of Barrett's esophagus with high-grade dysplasia and early-stage esophageal adenocarcinoma.Authorship 2731054Authorship 2739555Authorship 2740683Authorship 2744518Authorship 2748164Authorship 275075717462404Blackmon SH, Correa AM, Wynn B, Hofstetter WL, Martin LW, Mehran RJ, Rice DC, Swisher SG, Walsh GL, Roth JA, Vaporciyan AAThe Annals of thoracic surgeryPropensity-matched analysis of three techniques for intrathoracic esophagogastric anastomosis. Ann Thorac Surg. 2007 May; 83(5):1805-13; discussion 1813.Ann Thorac Surg2007-05-01T00:00:002007Propensity-matched analysis of three techniques for intrathoracic esophagogastric anastomosis.20699623Murthy SB, Patnana SV, Xiao L, Rohren E, Hofstetter WL, Swisher SG, Liao Z, Lee JH, Bhutani MS, Macapinlac HA, Wang X, Ajani JAOncologyThe standardized uptake value of 18-fluorodeoxyglucose positron emission tomography after chemoradiation and clinical outcome in patients with localized gastroesophageal carcinoma. Oncology. 2010; 78(5-6):316-22.Oncology2010-08-11T00:00:002010The standardized uptake value of 18-fluorodeoxyglucose positron emission tomography after chemoradiation and clinical outcome in patients with localized gastroesophageal carcinoma.20803613Gaur P, Sepesi B, Hofstetter WL, Correa AM, Bhutani MS, Watson TJ, Swisher SG, M. D. Anderson Esophageal Cancer Group, University of Rochester School of Medicine and Dentistry Foregut GroupCancerEndoscopic esophageal tumor length: a prognostic factor for patients with esophageal cancer. Cancer. 2011 Jan 01; 117(1):63-9.Cancer2010-08-27T00:00:002010Endoscopic esophageal tumor length: a prognostic factor for patients with esophageal cancer.21950818Twaddell WS, Wu PC, Verhage RJ, Feith M, Ilson DH, Schuhmacher CP, Luketich JD, Br?cher B, Vallb?hmer D, Hofstetter WL, Krasna MJ, Kandioler D, Schneider PM, Wijnhoven BP, Sontag SJAnnals of the New York Academy of SciencesBarrett's esophagus: treatments of adenocarcinomas II. Ann N Y Acad Sci. 2011 Sep; 1232:265-91.Ann N Y Acad Sci2011-09-01T00:00:002011Barrett's esophagus: treatments of adenocarcinomas II.22729036Nunez MI, Behrens C, Woods DM, Lin H, Suraokar M, Kadara H, Hofstetter W, Kalhor N, Lee JJ, Franklin W, Stewart DJ, Wistuba IIJournal of thoracic oncology : official publication of the International Association for the Study of Lung CancerHigh expression of folate receptor alpha in lung cancer correlates with adenocarcinoma histology and EGFR [corrected] mutation. J Thorac Oncol. 2012 May; 7(5):833-40.J Thorac Oncol2012-05-01T00:00:002012High expression of folate receptor alpha in lung cancer correlates with adenocarcinoma histology and EGFR [corrected] mutation.23247658Cheedella NK, Suzuki A, Xiao L, Hofstetter WL, Maru DM, Taketa T, Sudo K, Blum MA, Lin SH, Welch J, Lee JH, Bhutani MS, Rice DC, Vaporciyan AA, Swisher SG, Ajani JAAnnals of oncology : official journal of the European Society for Medical OncologyAssociation between clinical complete response and pathological complete response after preoperative chemoradiation in patients with gastroesophageal cancer: analysis in a large cohort. Ann Oncol. 2013 May; 24(5):1262-6.Ann Oncol2012-12-17T00:00:002012Association between clinical complete response and pathological complete response after preoperative chemoradiation in patients with gastroesophageal cancer: analysis in a large cohort.Authorship 2791819Authorship 2817534Authorship 2837527Authorship 2878247Authorship 28790713Authorship 2896376Authorship 2901931Authorship 29062317Authorship 2909051Authorship 29098510Authorship 2911385Authorship 29128210Authorship 29170315Authorship 2917644Authorship 2921044Authorship 29248219Authorship 2925271Authorship 2926503Authorship 2936987Authorship 2946299Authorship 29473718Authorship 2947806Authorship 2951107Authorship 29529015Authorship 29596215Authorship 2961066Authorship 29770310Authorship 29829510Authorship 29849810Authorship 2988332Authorship 3005041Authorship 3006092Authorship 3023921Authorship 3025731Authorship 3063591Authorship 3068233Authorship 3069952Authorship 3078682Authorship 3088264Authorship 3090615Authorship 3091684Authorship 3096421Authorship 3099463Authorship 3102713Authorship 3107612Authorship 3109634Authorship 31482851409676Hofstetter W, Wetterwald A, Cecchini MC, Felix R, Fleisch H, Mueller CProceedings of the National Academy of Sciences of the United States of AmericaDetection of transcripts for the receptor for macrophage colony-stimulating factor, c-fms, in murine osteoclasts. Proc Natl Acad Sci U S A. 1992 Oct 15; 89(20):9637-41.Proc Natl Acad Sci U S A1992-10-15T00:00:001992Detection of transcripts for the receptor for macrophage colony-stimulating factor, c-fms, in murine osteoclasts.2204254Felix R, Cecchini MG, Hofstetter W, Elford PR, Stutzer A, Fleisch HJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral ResearchImpairment of macrophage colony-stimulating factor production and lack of resident bone marrow macrophages in the osteopetrotic op/op mouse. J Bone Miner Res. 1990 Jul; 5(7):781-9.J Bone Miner Res1990-07-01T00:00:001990Impairment of macrophage colony-stimulating factor production and lack of resident bone marrow macrophages in the osteopetrotic op/op mouse.2676479Guenther HL, Hofstetter W, Stutzer A, M?hlbauer R, Fleisch HEndocrinologyEvidence for heterogeneity of the osteoblastic phenotype determined with clonal rat bone cells established from transforming growth factor-beta-induced cell colonies grown anchorage independently in semisolid medium. Endocrinology. 1989 Oct; 125(4):2092-102.Endocrinology1989-10-01T00:00:001989Evidence for heterogeneity of the osteoblastic phenotype determined with clonal rat bone cells established from transforming growth factor-beta-induced cell colonies grown anchorage independently in semisolid medium.3889690Bologa L, Hofstetter W, Schonenberger K, Jacque C, Herschkowitz NNeurochemical researchDouble ligand ELISA technique for the estimation of antibodies to brain tissue antigens in patients with neurological disorders. Neurochem Res. 1985 Apr; 10(4):469-81.Neurochem Res1985-04-01T00:00:001985Double ligand ELISA technique for the estimation of antibodies to brain tissue antigens in patients with neurological disorders.7577158Felix R, Genolet CL, L?wik C, Cecchini MG, Hofstetter WBoneCytokine production by calvariae of osteopetrotic mice. Bone. 1995 Jul; 17(1):5-9.Bone1995-07-01T00:00:001995Cytokine production by calvariae of osteopetrotic mice.7817818Thi?baud D, Guenther HL, Porret A, Burckhardt P, Fleisch H, Hofstetter WJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral ResearchRegulation of collagen type I and biglycan mRNA levels by hormones and growth factors in normal and immortalized osteoblastic cell lines. J Bone Miner Res. 1994 Sep; 9(9):1347-54.J Bone Miner Res1994-09-01T00:00:001994Regulation of collagen type I and biglycan mRNA levels by hormones and growth factors in normal and immortalized osteoblastic cell lines.7939685Grigoriadis AE, Wang ZQ, Cecchini MG, Hofstetter W, Felix R, Fleisch HA, Wagner EFScience (New York, N.Y.)c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science. 1994 Oct 21; 266(5184):443-8.Science1994-10-21T00:00:001994c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling.8554922Hofstetter W, Wetterwald A, Cecchini MG, Mueller C, Felix RBoneDetection of transcripts and binding sites for colony-stimulating factor-1 during bone development. Bone. 1995 Aug; 17(2):145-51.Bone1995-08-01T00:00:001995Detection of transcripts and binding sites for colony-stimulating factor-1 during bone development.8894143Sommer B, Bickel M, Hofstetter W, Wetterwald ABoneExpression of matrix proteins during the development of mineralized tissues. Bone. 1996 Oct; 19(4):371-80.Bone1996-10-01T00:00:001996Expression of matrix proteins during the development of mineralized tissues.9101364Hou P, Sato T, Hofstetter W, Foged NTJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral ResearchIdentification and characterization of the insulin-like growth factor I receptor in mature rabbit osteoclasts. J Bone Miner Res. 1997 Apr; 12(4):534-40.J Bone Miner Res1997-04-01T00:00:001997Identification and characterization of the insulin-like growth factor I receptor in mature rabbit osteoclasts.9718195Halasy-Nagy J, Hofstetter WJournal of bone and mineral research : the official journal of the American Society for Bone and Mineral ResearchExpression of colony-stimulating factor-1 in vivo during the formation of osteoclasts. J Bone Miner Res. 1998 Aug; 13(8):1267-74.J Bone Miner Res1998-08-01T00:00:001998Expression of colony-stimulating factor-1 in vivo during the formation of osteoclasts.9916777Palmer G, Zhao J, Bonjour J, Hofstetter W, Caverzasio JBoneIn vivo expression of transcripts encoding the Glvr-1 phosphate transporter/retrovirus receptor during bone development. Bone. 1999 Jan; 24(1):1-7.Bone1999-01-01T00:00:001999In vivo expression of transcripts encoding the Glvr-1 phosphate transporter/retrovirus receptor during bone development.16641914Lau YS, Sabokbar A, Giele H, Cerundolo V, Hofstetter W, Athanasou NABritish journal of cancerMalignant melanoma and bone resorption. Br J Cancer. 2006 May 22; 94(10):1496-503.Br J Cancer2006-05-22T00:00:002006Malignant melanoma and bone resorption.17720725Gengenbacher M, Sebald HJ, Villiger PM, Hofstetter W, Seitz MAnnals of the rheumatic diseasesInfliximab inhibits bone resorption by circulating osteoclast precursor cells in patients with rheumatoid arthritis and ankylosing spondylitis. Ann Rheum Dis. 2008 May; 67(5):620-4.Ann Rheum Dis2007-08-24T00:00:002007Infliximab inhibits bone resorption by circulating osteoclast precursor cells in patients with rheumatoid arthritis and ankylosing spondylitis.20178096Wernike E, Montjovent MO, Liu Y, Wismeijer D, Hunziker EB, Siebenrock KA, Hofstetter W, Klenke FMEuropean cells & materialsVEGF incorporated into calcium phosphate ceramics promotes vascularisation and bone formation in vivo. Eur Cell Mater. 2010 Feb 22; 19:30-40.Eur Cell Mater2010-02-22T00:00:002010VEGF incorporated into calcium phosphate ceramics promotes vascularisation and bone formation in vivo.24069370Guo C, Lu H, Gao W, Wang L, Lu K, Wu S, Pataer A, Huang M, El-Zein R, Lin T, Roth JA, Mehran R, Hofstetter W, Swisher SG, Wu X, Fang BPloS oneInsulin-like growth factor binding protein-2 level is increased in blood of lung cancer patients and associated with poor survival. PLoS One. 2013; 8(9):e74973.PLoS One2013-09-17T00:00:002013Insulin-like growth factor binding protein-2 level is increased in blood of lung cancer patients and associated with poor survival.24152134Dhupar R, Correa AM, Ajani J, Betancourt S, Mehran RJ, Swisher SG, Hofstetter WLDiseases of the esophagus : official journal of the International Society for Diseases of the EsophagusConcordance of studies for nodal staging is prognostic for worse survival in esophageal cancer. Dis Esophagus. 2014 Nov-Dec; 27(8):770-6.Dis Esophagus2013-10-24T00:00:002013Concordance of studies for nodal staging is prognostic for worse survival in esophageal cancer.24736077Juloori A, Tucker SL, Komaki R, Liao Z, Correa AM, Swisher SG, Hofstetter WL, Lin SHJournal of thoracic oncology : official publication of the International Association for the Study of Lung CancerInfluence of preoperative radiation field on postoperative leak rates in esophageal cancer patients after trimodality therapy. J Thorac Oncol. 2014 Apr; 9(4):534-40.J Thorac Oncol2014-04-01T00:00:002014Influence of preoperative radiation field on postoperative leak rates in esophageal cancer patients after trimodality therapy.24876940Hofstetter WLJournal of thoracic diseaseSalvage esophagectomy. J Thorac Dis. 2014 May; 6 Suppl 3:S341-9.J Thorac Dis2014-05-01T00:00:002014Salvage esophagectomy.25063008Hofstetter WAnnals of surgical oncologyTreatment of clinical T2N0M0 esophageal cancer. Ann Surg Oncol. 2014 Nov; 21(12):3713-4.Ann Surg Oncol2014-07-26T00:00:002014Treatment of clinical T2N0M0 esophageal cancer.25091571Skinner HD, Lee JH, Bhutani MS, Weston B, Hofstetter W, Komaki R, Shiozaki H, Wadhwa R, Sudo K, Elimova E, Song S, Ye Y, Huang M, Ajani J, Wu XCancerA validated miRNA profile predicts response to therapy in esophageal adenocarcinoma. Cancer. 2014 Dec 01; 120(23):3635-41.Cancer2014-08-04T00:00:002014A validated miRNA profile predicts response to therapy in esophageal adenocarcinoma.25099446Taketa T, Sudo K, Correa AM, Wadhwa R, Shiozaki H, Elimova E, Campagna MC, Blum MA, Skinner HD, Komaki RU, Lee JH, Bhutani MS, Weston BR, Rice DC, Swisher SG, Maru DM, Hofstetter WL, Ajani JAJournal of the National Comprehensive Cancer Network : JNCCNPost-chemoradiation surgical pathology stage can customize the surveillance strategy in patients with esophageal adenocarcinoma. J Natl Compr Canc Netw. 2014 Aug; 12(8):1139-44.J Natl Compr Canc Netw2014-08-01T00:00:002014Post-chemoradiation surgical pathology stage can customize the surveillance strategy in patients with esophageal adenocarcinoma.25157774Cuellar SL, Carter BW, Macapinlac HA, Ajani JA, Komaki R, Welsh JW, Lee JH, Swisher SG, Correa AM, Erasmus JJ, Hofstetter WLJournal of thoracic oncology : official publication of the International Association for the Study of Lung CancerClinical staging of patients with early esophageal adenocarcinoma: does FDG-PET/CT have a role? J Thorac Oncol. 2014 Aug; 9(8):1202-6.J Thorac Oncol2014-08-01T00:00:002014Clinical staging of patients with early esophageal adenocarcinoma: does FDG-PET/CT have a role?25182964Wu S, Wang L, Huang X, Cao M, Hu J, Li H, Zhang H, Sun X, Meng QH, Hofstetter WL, Roth JA, Swisher SG, Fang BBioorganic & medicinal chemistryProdrug oncrasin-266 improves the stability, pharmacokinetics, and safety of NSC-743380. Bioorg Med Chem. 2014 Oct 01; 22(19):5234-40.Bioorg Med Chem2014-08-14T00:00:002014Prodrug oncrasin-266 improves the stability, pharmacokinetics, and safety of NSC-743380.25225435Sudo K, Xiao L, Wadhwa R, Shiozaki H, Elimova E, Taketa T, Blum MA, Lee JH, Bhutani MS, Weston B, Ross WA, Komaki R, Rice DC, Swisher SG, Hofstetter WL, Maru DM, Skinner HD, Ajani JAJournal of clinical oncology : official journal of the American Society of Clinical OncologyImportance of surveillance and success of salvage strategies after definitive chemoradiation in patients with esophageal cancer. J Clin Oncol. 2014 Oct 20; 32(30):3400-5.J Clin Oncol2014-09-15T00:00:002014Importance of surveillance and success of salvage strategies after definitive chemoradiation in patients with esophageal cancer.25243545Shewale JB, Correa AM, Baker CM, Villafane-Ferriol N, Hofstetter WL, Jordan VS, Kehlet H, Lewis KM, Mehran RJ, Summers BL, Schaub D, Wilks SA, Swisher SG, University of Texas MD Anderson Esophageal Cancer Collaborative GroupAnnals of surgeryImpact of a Fast-track Esophagectomy Protocol on Esophageal Cancer Patient Outcomes and Hospital Charges. Ann Surg. 2015 Jun; 261(6):1114-23.Ann Surg2015-06-01T00:00:002015Impact of a Fast-track Esophagectomy Protocol on Esophageal Cancer Patient Outcomes and Hospital Charges.25262396Little AG, Lerut AE, Harpole DH, Hofstetter WL, Mitchell JD, Altorki NK, Krasna MJThe Annals of thoracic surgeryThe Society of Thoracic Surgeons practice guidelines on the role of multimodality treatment for cancer of the esophagus and gastroesophageal junction. Ann Thorac Surg. 2014 Nov; 98(5):1880-5.Ann Thorac Surg2014-09-26T00:00:002014The Society of Thoracic Surgeons practice guidelines on the role of multimodality treatment for cancer of the esophagus and gastroesophageal junction.25444907Hao C, Wang L, Peng S, Cao M, Li H, Hu J, Huang X, Liu W, Zhang H, Wu S, Pataer A, Heymach JV, Eterovic AK, Zhang Q, Shaw KR, Chen K, Futreal A, Wang M, Hofstetter W, Mehran R, Rice D, Roth JA, Sepesi B, Swisher SG, Vaporciyan A, Walsh GL, Johnson FM, Fang BCancer lettersGene mutations in primary tumors and corresponding patient-derived xenografts derived from non-small cell lung cancer. Cancer Lett. 2015 Feb 01; 357(1):179-185.Cancer Lett2014-11-18T00:00:002014Gene mutations in primary tumors and corresponding patient-derived xenografts derived from non-small cell lung cancer.25455469Hofstetter WLThe Journal of thoracic and cardiovascular surgeryInvolved radial margins: mountain or molehill? J Thorac Cardiovasc Surg. 2015 Feb; 149(2):556-7.J Thorac Cardiovasc Surg2014-10-20T00:00:002014Involved radial margins: mountain or molehill?25497068Kim MP, Correa AM, Hofstetter W, Mehran R, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Erasmus JJ, Swisher SGThe Annals of thoracic surgeryLimitations of 18F-2-deoxy-D-glucose positron emission tomography in N1 detection in patients with pathologic stage II-N1 and implications for management. Ann Thorac Surg. 2015 Feb; 99(2):414-20.Ann Thorac Surg2014-12-11T00:00:002014Limitations of 18F-2-deoxy-D-glucose positron emission tomography in N1 detection in patients with pathologic stage II-N1 and implications for management.25607756Low DE, Alderson D, Cecconello I, Chang AC, Darling GE, D'Journo XB, Griffin SM, H?lscher AH, Hofstetter WL, Jobe BA, Kitagawa Y, Kucharczuk JC, Law SY, Lerut TE, Maynard N, Pera M, Peters JH, Pramesh CS, Reynolds JV, Smithers BM, van Lanschot JJAnnals of surgeryInternational Consensus on Standardization of Data Collection for Complications Associated With Esophagectomy: Esophagectomy Complications Consensus Group (ECCG). Ann Surg. 2015 Aug; 262(2):286-94.Ann Surg2015-08-01T00:00:002015International Consensus on Standardization of Data Collection for Complications Associated With Esophagectomy: Esophagectomy Complications Consensus Group (ECCG).25642337Lin SH, Wang J, Allen PK, Correa AM, Maru DM, Swisher SG, Hofstetter WL, Liao Z, Ajani JAJournal of gastrointestinal oncologyA nomogram that predicts pathologic complete response to neoadjuvant chemoradiation also predicts survival outcomes after definitive chemoradiation for esophageal cancer. J Gastrointest Oncol. 2015 Feb; 6(1):45-52.J Gastrointest Oncol2015-02-01T00:00:002015A nomogram that predicts pathologic complete response to neoadjuvant chemoradiation also predicts survival outcomes after definitive chemoradiation for esophageal cancer.25691612Ajani JA, D'Amico TA, Almhanna K, Bentrem DJ, Besh S, Chao J, Das P, Denlinger C, Fanta P, Fuchs CS, Gerdes H, Glasgow RE, Hayman JA, Hochwald S, Hofstetter WL, Ilson DH, Jaroszewski D, Jasperson K, Keswani RN, Kleinberg LR, Korn WM, Leong S, Lockhart AC, Mulcahy MF, Orringer MB, Posey JA, Poultsides GA, Sasson AR, Scott WJ, Strong VE, Varghese TK, Washington MK, Willett CG, Wright CD, Zelman D, McMillian N, Sundar H, National comprehensive cancer networkJournal of the National Comprehensive Cancer Network : JNCCNEsophageal and esophagogastric junction cancers, version 1.2015. J Natl Compr Canc Netw. 2015 Feb; 13(2):194-227.J Natl Compr Canc Netw2015-02-01T00:00:002015Esophageal and esophagogastric junction cancers, version 1.2015.25739674Song S, Honjo S, Jin J, Chang SS, Scott AW, Chen Q, Kalhor N, Correa AM, Hofstetter WL, Albarracin CT, Wu TT, Johnson RL, Hung MC, Ajani JAClinical cancer research : an official journal of the American Association for Cancer ResearchThe Hippo Coactivator YAP1 Mediates EGFR Overexpression and Confers Chemoresistance in Esophageal Cancer. Clin Cancer Res. 2015 Jun 01; 21(11):2580-90.Clin Cancer Res2015-03-04T00:00:002015The Hippo Coactivator YAP1 Mediates EGFR Overexpression and Confers Chemoresistance in Esophageal Cancer.25765719Neishaboori N, Wadhwa R, Nogueras-Gonz?lez GM, Elimova E, Shiozaki H, Sudo K, Charalampakis N, Hiremath A, Lee JH, Bhutani MS, Weston B, Blum MA, Rogers JE, Garris JL, Rice DC, Komaki R, Swisher SG, Skinner HD, Hofstetter WL, Ajani JAOncologyDistribution of Resistant Esophageal Adenocarcinoma in the Resected Specimens of Clinical Stage III Patients after Chemoradiation: Its Clinical Implications. Oncology. 2015; 89(2):65-9.Oncology2015-03-05T00:00:002015Distribution of Resistant Esophageal Adenocarcinoma in the Resected Specimens of Clinical Stage III Patients after Chemoradiation: Its Clinical Implications.25765098Shiozaki H, Slack R, Sudo K, Elimova E, Wadhwa R, Chen HC, Skinner HD, Komaki R, Lee JH, Weston B, Bhutani MS, Blum MA, Rogers JE, Maru DM, Hofstetter WL, Ajani JAOncologyGeographic distribution of regional metastatic nodes affects the outcome of trimodality-eligible patients with esophageal adenocarcinoma. Oncology. 2015; 88(6):332-6.Oncology2015-02-28T00:00:002015Geographic distribution of regional metastatic nodes affects the outcome of trimodality-eligible patients with esophageal adenocarcinoma.25777421He LR, Qiao W, Liao ZX, Komaki R, Ho L, Hofstetter WL, Lin SHBMC cancerImpact of comorbidities and use of common medications on cancer and non-cancer specific survival in esophageal carcinoma. BMC Cancer. 2015; 15:1095.BMC Cancer2015-03-09T00:00:002015Impact of comorbidities and use of common medications on cancer and non-cancer specific survival in esophageal carcinoma.25798539Guo C, Hao C, Shao R, Fang B, Correa AM, Hofstetter WL, Roth JA, Behrens C, Kalhor N, Wistuba II, Swisher SG, Pataer AOncotargetRNA-dependent protein kinase (PKR) depletes nutrients, inducing phosphorylation of AMP-activated kinase in lung cancer. Oncotarget. 2015 May 10; 6(13):11114-24.Oncotarget2015-05-10T00:00:002015RNA-dependent protein kinase (PKR) depletes nutrients, inducing phosphorylation of AMP-activated kinase in lung cancer.26233274Dhupar R, Rice RD, Correa AM, Weston BR, Bhutani MS, Maru DM, Betancourt SL, Rice DC, Swisher SG, Hofstetter WLThe Annals of thoracic surgeryEndoscopic Ultrasound Estimates for Tumor Depth at the Gastroesophageal Junction Are Inaccurate: Implications for the Liberal Use of Endoscopic Resection. Ann Thorac Surg. 2015 Nov; 100(5):1812-6.Ann Thorac Surg2015-07-30T00:00:002015Endoscopic Ultrasound Estimates for Tumor Depth at the Gastroesophageal Junction Are Inaccurate: Implications for the Liberal Use of Endoscopic Resection.26279367Antonoff MB, Hofstetter WL, Correa AM, Bell JM, Sepesi B, Rice DC, Vaporciyan AA, Walsh GL, Mehran RJ, Swisher SG, Meyers BFThe Annals of thoracic surgeryClinical Prediction of Pathologic Complete Response in Superior Sulcus Non-Small Cell Lung Cancer. Ann Thorac Surg. 2016 Jan; 101(1):211-7.Ann Thorac Surg2015-08-14T00:00:002015Clinical Prediction of Pathologic Complete Response in Superior Sulcus Non-Small Cell Lung Cancer.26321501Elimova E, Wang X, Etchebehere E, Shiozaki H, Shimodaira Y, Wadhwa R, Planjery V, Charalampakis N, Blum MA, Hofstetter W, Lee JH, Weston BR, Bhutani MS, Rogers JE, Maru D, Skinner HD, Macapinlac HA, Ajani JAEuropean journal of cancer (Oxford, England : 1990)18-fluorodeoxy-glucose positron emission computed tomography as predictive of response after chemoradiation in oesophageal cancer patients. Eur J Cancer. 2015 Nov; 51(17):2545-52.Eur J Cancer2015-08-28T00:00:00201518-fluorodeoxy-glucose positron emission computed tomography as predictive of response after chemoradiation in oesophageal cancer patients.26408330Boys JA, Worrell SG, Chandrasoma P, Vallone JG, Maru DM, Zhang L, Blackmon SH, Dickinson KJ, Dunst CM, Hofstetter WL, Lada MJ, Louie BE, Molena D, Watson TJ, DeMeester SRJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary TractCan the Risk of Lymph Node Metastases Be Gauged in Endoscopically Resected Submucosal Esophageal Adenocarcinomas? A Multi-Center Study. J Gastrointest Surg. 2016 Jan; 20(1):6-12; discussion 12.J Gastrointest Surg2015-09-25T00:00:002015Can the Risk of Lymph Node Metastases Be Gauged in Endoscopically Resected Submucosal Esophageal Adenocarcinomas? A Multi-Center Study.26543627Hofstetter WLJournal of thoracic diseaseThe enigmatic esophageal anastomosis. J Thorac Dis. 2015 Sep; 7(9):E344-6.J Thorac Dis2015-09-01T00:00:002015The enigmatic esophageal anastomosis.26564243Kneuertz PJ, Hofstetter WL, Chiang YJ, Das P, Blum M, Elimova E, Mansfield P, Ajani J, Badgwell BAnnals of surgical oncologyLong-Term Survival in Patients with Gastroesophageal Junction Cancer Treated with Preoperative Therapy: Do Thoracic and Abdominal Approaches Differ? Ann Surg Oncol. 2016 Feb; 23(2):626-32.Ann Surg Oncol2015-11-12T00:00:002015Long-Term Survival in Patients with Gastroesophageal Junction Cancer Treated with Preoperative Therapy: Do Thoracic and Abdominal Approaches Differ?26652513Hofstetter W, Vaporciyan AThe Annals of thoracic surgeryInvited Commentary. Ann Thorac Surg. 2015 Dec; 100(6):2024-5.Ann Thorac Surg2015-12-01T00:00:002015Invited Commentary.26716023Hofstetter WLJournal of thoracic diseaseWhat can we expect from the book Esophageal Cancer? J Thorac Dis. 2015 Nov; 7(11):1880-1.J Thorac Dis2015-11-01T00:00:002015What can we expect from the book Esophageal Cancer?74Professor10Assistant Professor21Chair14Associate ProfessorMARA BANTONOFFMARA B ANTONOFF11880ANTONOFF, MARA BAssistant ProfessorMedicine-Epidemiology & Populat Sci26784546Chen J, Yao ZX, Chen JS, Gi YJ, Mu?oz NM, Kundra S, Herlong HF, Jeong YS, Goltsov A, Ohshiro K, Mistry NA, Zhang J, Su X, Choufani S, Mitra A, Li S, Mishra B, White J, Rashid A, Wang AY, Javle M, Davila M, Michaely P, Weksberg R, Hofstetter WL, Finegold MJ, Shay JW, Machida K, Tsukamoto H, Mishra LThe Journal of clinical investigationTGF-?/?2-spectrin/CTCF-regulated tumor suppression in human stem cell disorder Beckwith-Wiedemann syndrome. J Clin Invest. 2016 Feb; 126(2):527-42.J Clin Invest2016-01-19T00:00:002016TGF-?/?2-spectrin/CTCF-regulated tumor suppression in human stem cell disorder Beckwith-Wiedemann syndrome.26850487Sudo K, Wang X, Xiao L, Wadhwa R, Shiozaki H, Elimova E, Rice DC, Lee JH, Weston B, Bhutani MS, Hiremath A, Charalampakis N, Komaki R, Blum MA, Swisher SG, Maru DM, Skinner HD, Garris JL, Rogers JE, Hofstetter WL, Ajani JAJournal of the National Comprehensive Cancer Network : JNCCNA Nomogram to Predict Distant Metastases After Multimodality Therapy for Patients With Localized Esophageal Cancer. J Natl Compr Canc Netw. 2016 02; 14(2):173-9.J Natl Compr Canc Netw2016-02-01T00:00:002016A Nomogram to Predict Distant Metastases After Multimodality Therapy for Patients With Localized Esophageal Cancer.Authorship 841326Authorship 841411Authorship 841511Authorship 841637Authorship 843556Authorship 843790Authorship 843842Authorship 844119Authorship 845026Authorship 845550Authorship 845688Authorship 846533Authorship 846886Authorship 848967Authorship 849251Authorship 850349Authorship 850840Authorship 851230Authorship 851433Authorship 854344Authorship 854703Authorship 854821Authorship 855823Authorship 857081Authorship 858565Authorship 858912Authorship 859381Authorship 860182Authorship 860463Authorship 860492Authorship 862274Authorship 862560Authorship 862891Authorship 863424Authorship 863845Authorship 863887Authorship 864399Authorship 864760Authorship 865114Authorship 865429Authorship 865575Authorship 86651222565611Welsh J, Settle SH, Amini A, Xiao L, Suzuki A, Hayashi Y, Hofstetter W, Komaki R, Liao Z, Ajani JACancerFailure patterns in patients with esophageal cancer treated with definitive chemoradiation. Cancer. 2012 May 15; 118(10):2632-40.Cancer2011-10-05T00:00:002011Failure patterns in patients with esophageal cancer treated with definitive chemoradiation.Authorship 867886Annals of Surgical OncologyLong-Term Survival in Patients with Gastroesophageal Junction Cancer Treated with Preoperative Therapy. Annals of Surgical Oncology. 23:626-632.Long-Term Survival in Patients with Gastroesophageal Junction Cancer Treated with Preoperative TherapyJournal of Gastrointestinal SurgeryCan the Risk of Lymph Node Metastases Be Gauged in Endoscopically Resected Submucosal Esophageal Adenocarcinomas? A Multi-Center Study. Journal of Gastrointestinal Surgery. Can the Risk of Lymph Node Metastases Be Gauged in Endoscopically Resected Submucosal Esophageal Adenocarcinomas? A Multi-Center StudyJournal of Thoracic DiseaseThe enigmatic esophageal anastomosis. Journal of Thoracic Disease. 7:E344-E346.The enigmatic esophageal anastomosisAnnals of SurgeryDiscussants. Annals of Surgery. 258:506.DiscussantsDiseases of the EsophagusRecommendations for neoadjuvant pathologic staging (ypTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals. Diseases of the Esophagus. 29:906-912.Recommendations for neoadjuvant pathologic staging (ypTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manualsAnnals of Thoracic SurgeryThe Influence of Reconstructive Technique on Perioperative Pulmonary and Infectious Outcomes Following Chest Wall Resection. Annals of Thoracic Surgery. 102:1653-1659.The Influence of Reconstructive Technique on Perioperative Pulmonary and Infectious Outcomes Following Chest Wall ResectionClinical Cancer ResearchThe hippo coactivator YAP1 mediates EGFR overexpression and confers chemoresistance in esophageal cancer. Clinical Cancer Research. 21:2580-2590.The hippo coactivator YAP1 mediates EGFR overexpression and confers chemoresistance in esophageal cancerAnnals of Thoracic SurgeryResults of Postdischarge Nursing Telephone Assessments. Annals of Thoracic Surgery. Results of Postdischarge Nursing Telephone AssessmentsAnnals of Thoracic SurgeryDiscussion. Annals of Thoracic Surgery. 90:919.DiscussionJournal of Thoracic DiseaseWhat can we expect from the book Esophageal Cancer?. Journal of Thoracic Disease. 7:1880-1881.What can we expect from the book Esophageal Cancer?OncotargetRNA-dependent protein kinase (PKR) depletes nutrients, inducing phosphorylation of AMP-activated kinase in lung cancer. Oncotarget. 6:11114-11124.RNA-dependent protein kinase (PKR) depletes nutrients, inducing phosphorylation of AMP-activated kinase in lung cancerAdvanced Studies in MedicineThe importance of staging and accurate initial diagnosis. Advanced Studies in Medicine. 6.The importance of staging and accurate initial diagnosisJNCCN Journal of the National Comprehensive Cancer NetworkGastric Cancer, Version 3.2016; Clinical Practice Guidelines in Oncology. JNCCN Journal of the National Comprehensive Cancer Network. 14:1286-1312.Gastric Cancer, Version 3.2016; Clinical Practice Guidelines in OncologyDiseases of the EsophagusRecommendations for pathologic staging (pTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals. Diseases of the Esophagus. 29:897-905.Recommendations for pathologic staging (pTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manualsOncology (Switzerland)Distribution of Resistant Esophageal Adenocarcinoma in the Resected Specimens of Clinical Stage III Patients after Chemoradiation. Oncology (Switzerland). Distribution of Resistant Esophageal Adenocarcinoma in the Resected Specimens of Clinical Stage III Patients after ChemoradiationEsophageal Cancer. 211-230.Esophageal CancerJNCCN Journal of the National Comprehensive Cancer NetworkA nomogram to predict distant metastases after multimodality therapy for patients with localized esophageal cancer. JNCCN Journal of the National Comprehensive Cancer Network. 14:173-179.A nomogram to predict distant metastases after multimodality therapy for patients with localized esophageal cancerEuropean Journal of Nuclear Medicine and Molecular ImagingThe value of <sup>18</sup>F-FDG PET before and after induction chemotherapy for the early prediction of a poor pathologic response to subsequent preoperative chemoradiotherapy in oesophageal adenocarcinoma. European Journal of Nuclear Medicine and Molecular Imaging. 1-10.The value of <sup>18</sup>F-FDG PET before and after induction chemotherapy for the early prediction of a poor pathologic response to subsequent preoperative chemoradiotherapy in oesophageal adenocarcinomaJournal of Cardiothoracic and Vascular AnesthesiaIdentification of Risk Factors Associated With Postoperative Acute Kidney Injury After Esophagectomy for Esophageal Cancer. Journal of Cardiothoracic and Vascular Anesthesia. Identification of Risk Factors Associated With Postoperative Acute Kidney Injury After Esophagectomy for Esophageal CancerAnnals of Surgical OncologyCo-morbidities Rather than Age Impact Outcomes in Patients Receiving Preoperative Therapy for Gastroesophageal Adenocarcinoma. Annals of Surgical Oncology. 1-11.Co-morbidities Rather than Age Impact Outcomes in Patients Receiving Preoperative Therapy for Gastroesophageal AdenocarcinomaJournal of Gastrointestinal OncologyA nomogram that predicts pathologic complete response to neoadjuvant chemoradiation also predicts survival outcomes after definitive chemoradiation for esophageal cancer. Journal of Gastrointestinal Oncology. 6:45-52.A nomogram that predicts pathologic complete response to neoadjuvant chemoradiation also predicts survival outcomes after definitive chemoradiation for esophageal cancerJournal of Thoracic OncologyErratum. Journal of Thoracic Oncology. 7:1065.ErratumAnnals of SurgeryEsophageal Cancer. Annals of Surgery. Esophageal CancerJournal of Nuclear MedicineThe incremental value of subjective and quantitative assessment of <sup>18</sup>F-FDG PET for the prediction of pathologic complete response to preoperative chemoradiotherapy in esophageal cancer. Journal of Nuclear Medicine. 57:691-700.The incremental value of subjective and quantitative assessment of <sup>18</sup>F-FDG PET for the prediction of pathologic complete response to preoperative chemoradiotherapy in esophageal cancerAmerican Journal of Clinical Oncology: Cancer Clinical TrialsFactors predictive of improved outcomes with multimodality local therapy after palliative chemotherapy for stage IV esophageal cancer. American Journal of Clinical Oncology: Cancer Clinical Trials. Factors predictive of improved outcomes with multimodality local therapy after palliative chemotherapy for stage IV esophageal cancerAnnals of SurgeryImpact of a fast-track esophagectomy protocol on esophageal cancer patient outcomes and hospital charges. Annals of Surgery. 261:1114-1123.Impact of a fast-track esophagectomy protocol on esophageal cancer patient outcomes and hospital chargesEsophageal cancer. 177-187.Esophageal cancerEuropean Journal of RadiologyEarly clinical esophageal adenocarcinoma (cT1). European Journal of Radiology. 88:56-60.Early clinical esophageal adenocarcinoma (cT1)Diseases of the EsophagusRecommendations for clinical staging (cTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals. Diseases of the Esophagus. 29:913-919.Recommendations for clinical staging (cTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manualsOncology (Switzerland)Metastatic Gastroesophageal Adenocarcinoma Patients Treated with Systemic Therapy Followed by Consolidative Local Therapy. Oncology (Switzerland). 91:55-60.Metastatic Gastroesophageal Adenocarcinoma Patients Treated with Systemic Therapy Followed by Consolidative Local TherapyJournal of Gastrointestinal SurgeryEsophagectomy Following Endoscopic Resection of Submucosal Esophageal Cancer. Journal of Gastrointestinal Surgery. 1-6.Esophagectomy Following Endoscopic Resection of Submucosal Esophageal CancerJournal of Thoracic DiseaseSalvage esophagectomy. Journal of Thoracic Disease. 6.Salvage esophagectomyEsophagusSonographic characteristics of locoregional lymph nodes that can predict the presence of metastatic carcinoma by endoscopic ultrasound-guided fine needle aspiration in patients with carcinomas of the esophagus/gastroesophageal junction. Esophagus. 1-8.Sonographic characteristics of locoregional lymph nodes that can predict the presence of metastatic carcinoma by endoscopic ultrasound-guided fine needle aspiration in patients with carcinomas of the esophagus/gastroesophageal junctionGastrointestinal EndoscopyResponse. Gastrointestinal Endoscopy. 76:1073-1075.ResponseJournal of Clinical InvestigationTGF-β/β2-spectrin/CTCF-regulated tumor suppression in human stem cell disorder Beckwith-Wiedemann syndrome. Journal of Clinical Investigation. 126:527-542.TGF-β/β2-spectrin/CTCF-regulated tumor suppression in human stem cell disorder Beckwith-Wiedemann syndromeJournal of the American Society of CytopathologyEvolving role of endoscopic ultrasonography-guided fine-needle aspiration in tumor staging and treatment of patients with carcinomas of the upper gastrointestinal tract. Journal of the American Society of Cytopathology. 3:29-36.Evolving role of endoscopic ultrasonography-guided fine-needle aspiration in tumor staging and treatment of patients with carcinomas of the upper gastrointestinal tractAmerican Journal of Hematology/ OncologyThe role of PI3K/PTEN/AKT/mTOR genetic variation in clinical outcomes following chemoradiotherapy for esophageal cancer. American Journal of Hematology/ Oncology. 8.The role of PI3K/PTEN/AKT/mTOR genetic variation in clinical outcomes following chemoradiotherapy for esophageal cancerDiseases of the EsophagusAn age-period-cohort analysis of obesity and incident esophageal adenocarcinoma among white males. Diseases of the Esophagus. An age-period-cohort analysis of obesity and incident esophageal adenocarcinoma among white malesCancerAuthor reply [4]. Cancer. 109:1449.Author reply [4]Journal of Thoracic and Cardiovascular SurgeryOmental reinforcement of the thoracic esophagogastric anastomosis. Journal of Thoracic and Cardiovascular Surgery. Omental reinforcement of the thoracic esophagogastric anastomosisSalvage esophagectomy for persistent disease after definitive chemoradiotherapy. 233-240.Salvage esophagectomy for persistent disease after definitive chemoradiotherapyCancerErratum. Cancer. 115:2024.ErratumEuropean Journal of Cancer18-fluorodeoxy-glucose positron emission computed tomography as predictive of response after chemoradiation in oesophageal cancer patients. European Journal of Cancer. 18-fluorodeoxy-glucose positron emission computed tomography as predictive of response after chemoradiation in oesophageal cancer patients28638160Akkanti B, Rajagopal K, Patel KP, Aravind S, Nunez-Centanu E, Hussain R, Shabari FR, Hofstetter WL, Vaporciyan AA, Banjac IS, Kar B, Gregoric ID, Loyalka PThe journal of extra-corporeal technologyLow-Flow Extracorporeal Carbon Dioxide Removal Using the Hemolung Respiratory Dialysis System? to Facilitate Lung-Protective Mechanical Ventilation in Acute Respiratory Distress Syndrome. J Extra Corpor Technol. 2017 06; 49(2):112-114.J Extra Corpor Technol2017-06-01T00:00:002017Low-Flow Extracorporeal Carbon Dioxide Removal Using the Hemolung Respiratory Dialysis System? to Facilitate Lung-Protective Mechanical Ventilation in Acute Respiratory Distress Syndrome.18758299Yendamuri S, Vaporciyan AA, Zaidi T, Feng L, Fernandez R, Bekele NB, Hofstetter WL, Jiang F, Mehran RJ, Rice DC, Spitz MR, Swisher SG, Walsh GL, Roth JA, Katz RLJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer3p22.1 and 10q22.3 deletions detected by fluorescence in situ hybridization (FISH): a potential new tool for early detection of non-small cell lung Cancer (NSCLC). J Thorac Oncol. 2008 Sep; 3(9):979-84.J Thorac Oncol2008-09-01T00:00:0020083p22.1 and 10q22.3 deletions detected by fluorescence in situ hybridization (FISH): a potential new tool for early detection of non-small cell lung Cancer (NSCLC).19464452Bolton WD, Rice DC, Goodyear A, Correa AM, Erasmus J, Hofstetter W, Komaki R, Mehran R, Pisters K, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Weaver J, Rhines LThe Journal of thoracic and cardiovascular surgerySuperior sulcus tumors with vertebral body involvement: a multimodality approach. J Thorac Cardiovasc Surg. 2009 Jun; 137(6):1379-87.J Thorac Cardiovasc Surg2009-06-01T00:00:002009Superior sulcus tumors with vertebral body involvement: a multimodality approach.22939245Blackmon SH, Correa AM, Skoracki R, Chevray PM, Kim MP, Mehran RJ, Rice DC, Roth JA, Swisher SG, Vaporciyan AA, Yu P, Walsh GL, Hofstetter WLThe Annals of thoracic surgerySupercharged pedicled jejunal interposition for esophageal replacement: a 10-year experience. Ann Thorac Surg. 2012 Oct; 94(4):1104-11; discussion 1111-3.Ann Thorac Surg2012-08-29T00:00:002012Supercharged pedicled jejunal interposition for esophageal replacement: a 10-year experience.22950385Skinner HD, McCurdy MR, Echeverria AE, Lin SH, Welsh JW, O'Reilly MS, Hofstetter WL, Ajani JA, Komaki R, Cox JD, Sandulache VC, Myers JN, Guerrero TMActa oncologica (Stockholm, Sweden)Metformin use and improved response to therapy in esophageal adenocarcinoma. Acta Oncol. 2013 Jun; 52(5):1002-9.Acta Oncol2012-09-05T00:00:002012Metformin use and improved response to therapy in esophageal adenocarcinoma.29178133Wang JF, Pu X, Zhang X, Chen K, Xi Y, Wang J, Mao X, Zhang J, Heymach JV, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Meng QH, Shaw KR, Eterovic AK, Fang BCancerVariants with a low allele frequency detected in genomic DNA affect the accuracy of mutation detection in cell-free DNA by next-generation sequencing. Cancer. 2018 03 01; 124(5):1061-1069.Cancer2017-11-27T00:00:002017Variants with a low allele frequency detected in genomic DNA affect the accuracy of mutation detection in cell-free DNA by next-generation sequencing.Authorship 88727424Authorship 8883918Authorship 88902820Authorship 88951111D004938Disorders35231490.370259Esophageal NeoplasmsD004943Anatomy1065420.747088Esophagogastric JunctionD016629Procedures1198860.699684EsophagectomyD000230Disorders102777770.261801AdenocarcinomaAuthorship 9029776Authorship 9050428Authorship 9066631Authorship 9068244Authorship 90736216Authorship 9074024Authorship 9077287Authorship 9078244Authorship 90883820Authorship 9096373Authorship 9097608Authorship 90999212Authorship 9104819Authorship 9106947Authorship 91124314Authorship 9116487Authorship 9118526Authorship 9124414Authorship 9128732Authorship 9132353Authorship 9137197Authorship 9138975Authorship 9142358Authorship 91432818Authorship 9143528Authorship 9146146Authorship 9147435Authorship 91480317Authorship 91493312Authorship 9152097Authorship 91522511Authorship 9159805Authorship 9160089Authorship 9165982Authorship 9172725Authorship 9188414Authorship 91929720Authorship 9195298Authorship 91967721Authorship 91995018Authorship 92009611Authorship 9203106Authorship 9203445Authorship 9212154Authorship 9212164Authorship 9212173Authorship 9218869Authorship 9226855Authorship 9227566Authorship 9230134Authorship 9232236Authorship 9235137Authorship 9238055Authorship 9238184Authorship 9239415Authorship 9240243Authorship 9242133Authorship 9243087Authorship 9243518Authorship 9248947Authorship 9248961Authorship 92493913Authorship 9253312Authorship 9255239Authorship 9256287Authorship 92566110Authorship 9260307Authorship 9261883Authorship 9263779Authorship 9264959Authorship 9268583Authorship 9275248Authorship 9279287Authorship 92796620Authorship 9280152Authorship 9281328Authorship 9283841Authorship 92857816Authorship 9286366Authorship 9302255Authorship 9322739Authorship 9355333Authorship 9362675Authorship 9363445Authorship 9380717Authorship 9382912Authorship 9388651Authorship 940305324710122Wang J, Suri JS, Allen PK, Liao Z, Komaki R, Ho L, Hofstetter WL, Lin SHAmerican journal of clinical oncologyFactors Predictive of Improved Outcomes With Multimodality Local Therapy After Palliative Chemotherapy for Stage IV Esophageal Cancer. Am J Clin Oncol. 2016 06; 39(3):228-35.Am J Clin Oncol2016-06-01T00:00:002016Factors Predictive of Improved Outcomes With Multimodality Local Therapy After Palliative Chemotherapy for Stage IV Esophageal Cancer.26558532Hofstetter WLJAMA surgeryPreoperative Chemoradiation in an Era of Suboptimal Clinical Staging. JAMA Surg. 2016 Mar; 151(3):245-6.JAMA Surg2016-03-01T00:00:002016Preoperative Chemoradiation in an Era of Suboptimal Clinical Staging.26680311Sepesi B, Schmidt HE, Lada M, Correa AM, Walsh GL, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Ajani JA, Watson TJ, Swisher SG, Low DE, Hofstetter WLThe Annals of thoracic surgerySurvival in Patients With Esophageal Adenocarcinoma Undergoing Trimodality Therapy Is Independent of Regional Lymph Node Location. Ann Thorac Surg. 2016 Mar; 101(3):1075-80; Discussion 1080-1.Ann Thorac Surg2015-12-08T00:00:002015Survival in Patients With Esophageal Adenocarcinoma Undergoing Trimodality Therapy Is Independent of Regional Lymph Node Location.26716915Lin SH, Zhang N, Godby J, Wang J, Marsh GD, Liao Z, Komaki R, Ho L, Hofstetter WL, Swisher SG, Mehran RJ, Buchholz TA, Elting LS, Giordano SHCancerRadiation modality use and cardiopulmonary mortality risk in elderly patients with esophageal cancer. Cancer. 2016 Mar 15; 122(6):917-28.Cancer2015-12-30T00:00:002015Radiation modality use and cardiopulmonary mortality risk in elderly patients with esophageal cancer.26795288van Rossum PS, Fried DV, Zhang L, Hofstetter WL, van Vulpen M, Meijer GJ, Court LE, Lin SHJournal of nuclear medicine : official publication, Society of Nuclear MedicineThe Incremental Value of Subjective and Quantitative Assessment of 18F-FDG PET for the Prediction of Pathologic Complete Response to Preoperative Chemoradiotherapy in Esophageal Cancer. J Nucl Med. 2016 05; 57(5):691-700.J Nucl Med2016-01-21T00:00:002016The Incremental Value of Subjective and Quantitative Assessment of 18F-FDG PET for the Prediction of Pathologic Complete Response to Preoperative Chemoradiotherapy in Esophageal Cancer.26916717Spicer JD, Stiles BM, Sudarshan M, Correa AM, Ferri LE, Altorki NK, Hofstetter WLThe Annals of thoracic surgeryPreoperative Chemoradiation Therapy Versus Chemotherapy in Patients Undergoing Modified En Bloc Esophagectomy for Locally Advanced Esophageal Adenocarcinoma: Is Radiotherapy Beneficial? Ann Thorac Surg. 2016 Apr; 101(4):1262-9; discussion 1969-70.Ann Thorac Surg2016-02-23T00:00:002016Preoperative Chemoradiation Therapy Versus Chemotherapy in Patients Undergoing Modified En Bloc Esophagectomy for Locally Advanced Esophageal Adenocarcinoma: Is Radiotherapy Beneficial?27083250Antonoff MB, Ragalie W, Correa AM, Spicer JD, Sepesi B, Roth JA, Walsh GL, Hofstetter WL, Swisher SG, Rice DC, Vaporciyan AA, Mehran RJThe Annals of thoracic surgeryResults of Postdischarge Nursing Telephone Assessments: Persistent Symptoms Common Among Pulmonary Resection Patients. Ann Thorac Surg. 2016 Jul; 102(1):276-81.Ann Thorac Surg2016-04-12T00:00:002016Results of Postdischarge Nursing Telephone Assessments: Persistent Symptoms Common Among Pulmonary Resection Patients.27511188van Rossum PSN, Fried DV, Zhang L, Hofstetter WL, Ho L, Meijer GJ, Carter BW, Court LE, Lin SHEuropean journal of nuclear medicine and molecular imagingThe value of 18F-FDG PET before and after induction chemotherapy for the early prediction of a poor pathologic response to subsequent preoperative chemoradiotherapy in oesophageal adenocarcinoma. Eur J Nucl Med Mol Imaging. 2017 01; 44(1):71-80.Eur J Nucl Med Mol Imaging2016-08-11T00:00:002016The value of 18F-FDG PET before and after induction chemotherapy for the early prediction of a poor pathologic response to subsequent preoperative chemoradiotherapy in oesophageal adenocarcinoma.27120436Shiozaki H, Slack RS, Chen HC, Elimova E, Planjery V, Charalampakis N, Wadhwa R, Shimodaira Y, Skinner H, Lee JH, Weston B, Bhutani MS, Blum-Murphy M, Rogers JE, Maru DM, Matamoros A, Sagebiel T, Estrella JS, Das P, Hofstetter WL, Mares JE, Mizrak Kaya D, Harada K, Lin Q, Minsky BD, Badgwell BD, Ajani JAOncologyMetastatic Gastroesophageal Adenocarcinoma Patients Treated with Systemic Therapy Followed by Consolidative Local Therapy: A Nomogram Associated with Long-Term Survivors. Oncology. 2016; 91(1):55-60.Oncology2016-04-28T00:00:002016Metastatic Gastroesophageal Adenocarcinoma Patients Treated with Systemic Therapy Followed by Consolidative Local Therapy: A Nomogram Associated with Long-Term Survivors.27561633Molena D, Schlottmann F, Boys JA, Blackmon SH, Dickinson KJ, Dunst CM, Hofstetter WL, Lada MJ, Louie BE, Mungo B, Watson TJ, DeMeester SRJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary TractEsophagectomy Following Endoscopic Resection of Submucosal Esophageal Cancer: a Highly Curative Procedure Even with Nodal Metastases. J Gastrointest Surg. 2017 01; 21(1):62-67.J Gastrointest Surg2016-08-25T00:00:002016Esophagectomy Following Endoscopic Resection of Submucosal Esophageal Cancer: a Highly Curative Procedure Even with Nodal Metastases.27720491Konda P, Ai D, Guerra CE, Rodriguez-Restrepo A, Mehran RJ, Rice D, Hofstetter W, Heir J, Kwater P, Gottumukkala V, Hernandez M, Cata JPJournal of cardiothoracic and vascular anesthesiaIdentification of Risk Factors Associated With Postoperative Acute Kidney Injury After Esophagectomy for Esophageal Cancer. J Cardiothorac Vasc Anesth. 2017 Apr; 31(2):474-481.J Cardiothorac Vasc Anesth2016-07-21T00:00:002016Identification of Risk Factors Associated With Postoperative Acute Kidney Injury After Esophagectomy for Esophageal Cancer.27729298Swisher SG, Moughan J, Komaki RU, Ajani JA, Wu TT, Hofstetter WL, Konski AA, Willett CGJournal of thoracic oncology : official publication of the International Association for the Study of Lung CancerFinal Results of NRG Oncology RTOG 0246: An?Organ-Preserving Selective Resection Strategy in?Esophageal Cancer Patients Treated with Definitive?Chemoradiation. J Thorac Oncol. 2017 02; 12(2):368-374.J Thorac Oncol2016-10-08T00:00:002016Final Results of NRG Oncology RTOG 0246: An?Organ-Preserving Selective Resection Strategy in?Esophageal Cancer Patients Treated with Definitive?Chemoradiation.27731547Rice TW, Chen LQ, Hofstetter WL, Smithers BM, Rusch VW, Wijnhoven BP, Chen KL, Davies AR, D'Journo XB, Kesler KA, Luketich JD, Ferguson MK, R?s?nen JV, van Hillegersberg R, Fang W, Durand L, Cecconello I, Allum WH, Cerfolio RJ, Pera M, Griffin SM, Burger R, Liu JF, Allen MS, Law S, Watson TJ, Darling GE, Scott WJ, Duranceau A, Denlinger CE, Schipper PH, Lerut TE, Orringer MB, Ishwaran H, Apperson-Hansen C, DiPaola LM, Semple ME, Blackstone EHDiseases of the esophagus : official journal of the International Society for Diseases of the EsophagusWorldwide Esophageal Cancer Collaboration: pathologic staging data. Dis Esophagus. 2016 Oct; 29(7):724-733.Dis Esophagus2016-10-01T00:00:002016Worldwide Esophageal Cancer Collaboration: pathologic staging data.27731548Rice TW, Lerut TE, Orringer MB, Chen LQ, Hofstetter WL, Smithers BM, Rusch VW, van Lanschot J, Chen KN, Davies AR, D'Journo XB, Kesler KA, Luketich JD, Ferguson MK, R?s?nen JV, van Hillegersberg R, Fang W, Durand L, Allum WH, Cecconello I, Cerfolio RJ, Pera M, Griffin SM, Burger R, Liu JF, Allen MS, Law S, Watson TJ, Darling GE, Scott WJ, Duranceau A, Denlinger CE, Schipper PH, Ishwaran H, Apperson-Hansen C, DiPaola LM, Semple ME, Blackstone EHDiseases of the esophagus : official journal of the International Society for Diseases of the EsophagusWorldwide Esophageal Cancer Collaboration: neoadjuvant pathologic staging data. Dis Esophagus. 2016 Oct; 29(7):715-723.Dis Esophagus2016-10-01T00:00:002016Worldwide Esophageal Cancer Collaboration: neoadjuvant pathologic staging data.27731549Rice TW, Apperson-Hansen C, DiPaola LM, Semple ME, Lerut TE, Orringer MB, Chen LQ, Hofstetter WL, Smithers BM, Rusch VW, Wijnhoven BP, Chen KN, Davies AR, D'Journo XB, Kesler KA, Luketich JD, Ferguson MK, R?s?nen JV, van Hillegersberg R, Fang W, Durand L, Allum WH, Cecconello I, Cerfolio RJ, Pera M, Griffin SM, Burger R, Liu JF, Allen MS, Law S, Watson TJ, Darling GE, Scott WJ, Duranceau A, Denlinger CE, Schipper PH, Ishwaran H, Blackstone EHDiseases of the esophagus : official journal of the International Society for Diseases of the EsophagusWorldwide Esophageal Cancer Collaboration: clinical staging data. Dis Esophagus. 2016 Oct; 29(7):707-714.Dis Esophagus2016-10-01T00:00:002016Worldwide Esophageal Cancer Collaboration: clinical staging data.27794500Welsh JW, Seyedin SN, Allen PK, Hofstetter WL, Ajani JA, Chang JY, Gomez DR, Amini A, Swisher SG, Blum MA, Younes AI, Nguyen QN, Minsky BD, Erasmus JJ, Lee JH, Bhutani M, Komaki RUJournal of thoracic oncology : official publication of the International Association for the Study of Lung CancerLocal Control and Toxicity of a Simultaneous Integrated Boost for Dose Escalation in Locally Advanced Esophageal Cancer: Interim Results from a Prospective Phase I/II Trial. J Thorac Oncol. 2017 02; 12(2):375-382.J Thorac Oncol2016-10-26T00:00:002016Local Control and Toxicity of a Simultaneous Integrated Boost for Dose Escalation in Locally Advanced Esophageal Cancer: Interim Results from a Prospective Phase I/II Trial.27862652Murphy CC, Yang YC, Shaheen NJ, Hofstetter WL, Sandler RSDiseases of the esophagus : official journal of the International Society for Diseases of the EsophagusAn age-period-cohort analysis of obesity and incident esophageal adenocarcinoma among white males. Dis Esophagus. 2017 02 01; 30(3):1-8.Dis Esophagus2017-02-01T00:00:002017An age-period-cohort analysis of obesity and incident esophageal adenocarcinoma among white males.27697982Ajani JA, D'Amico TA, Almhanna K, Bentrem DJ, Chao J, Das P, Denlinger CS, Fanta P, Farjah F, Fuchs CS, Gerdes H, Gibson M, Glasgow RE, Hayman JA, Hochwald S, Hofstetter WL, Ilson DH, Jaroszewski D, Johung KL, Keswani RN, Kleinberg LR, Korn WM, Leong S, Linn C, Lockhart AC, Ly QP, Mulcahy MF, Orringer MB, Perry KA, Poultsides GA, Scott WJ, Strong VE, Washington MK, Weksler B, Willett CG, Wright CD, Zelman D, McMillian N, Sundar HJournal of the National Comprehensive Cancer Network : JNCCNGastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2016 10; 14(10):1286-1312.J Natl Compr Canc Netw2016-10-01T00:00:002016Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology.28189209Betancourt Cuellar SL, Sabloff B, Carter BW, Benveniste MF, Correa AM, Maru DM, Ajani JA, Erasmus JJ, Hofstetter WLEuropean journal of radiologyEarly clinical esophageal adenocarcinoma (cT1): Utility of CT in regional nodal metastasis detection and can the clinical accuracy be improved? Eur J Radiol. 2017 Mar; 88:56-60.Eur J Radiol2017-01-03T00:00:002017Early clinical esophageal adenocarcinoma (cT1): Utility of CT in regional nodal metastasis detection and can the clinical accuracy be improved?27770339Charalampakis N, Xiao L, Lin Q, Elimova E, Shimodaira Y, Harada K, Rogers JE, Mares J, Amlashi FG, Minsky BD, Das P, Hofstetter WL, Matamoros A, Sagebiel TL, Blum-Murphy MA, Lee JH, Weston B, Bhutani MS, Mansfield PF, Estrella JS, Badgwell BD, Ajani JAAnnals of surgical oncologyCo-morbidities Rather than Age Impact Outcomes in Patients Receiving Preoperative Therapy for Gastroesophageal Adenocarcinoma. Ann Surg Oncol. 2017 Aug; 24(8):2291-2301.Ann Surg Oncol2016-10-21T00:00:002016Co-morbidities Rather than Age Impact Outcomes in Patients Receiving Preoperative Therapy for Gastroesophageal Adenocarcinoma.27905170Rice TW, Ishwaran H, Kelsen DP, Hofstetter WL, Apperson-Hansen C, Blackstone EH, Worldwide Esophageal Cancer Collaboration InvestigatorsDiseases of the esophagus : official journal of the International Society for Diseases of the EsophagusRecommendations for neoadjuvant pathologic staging (ypTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals. Dis Esophagus. 2016 Nov; 29(8):906-912.Dis Esophagus2016-11-01T00:00:002016Recommendations for neoadjuvant pathologic staging (ypTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals.27905171Rice TW, Ishwaran H, Blackstone EH, Hofstetter WL, Kelsen DP, Apperson-Hansen C, Worldwide Esophageal Cancer Collaboration InvestigatorsDiseases of the esophagus : official journal of the International Society for Diseases of the EsophagusRecommendations for clinical staging (cTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals. Dis Esophagus. 2016 Nov; 29(8):913-919.Dis Esophagus2016-11-01T00:00:002016Recommendations for clinical staging (cTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals.27905172Rice TW, Ishwaran H, Hofstetter WL, Kelsen DP, Apperson-Hansen C, Blackstone EH, Worldwide Esophageal Cancer Collaboration InvestigatorsDiseases of the esophagus : official journal of the International Society for Diseases of the EsophagusRecommendations for pathologic staging (pTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals. Dis Esophagus. 2016 Nov; 29(8):897-905.Dis Esophagus2016-11-01T00:00:002016Recommendations for pathologic staging (pTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals.28009736Rice TW, Ishwaran H, Hofstetter WL, Schipper PH, Kesler KA, Law S, Lerut EM, Denlinger CE, Salo JA, Scott WJ, Watson TJ, Allen MS, Chen LQ, Rusch VW, Cerfolio RJ, Luketich JD, Duranceau A, Darling GE, Pera M, Apperson-Hansen C, Blackstone EHAnnals of surgeryEsophageal Cancer: Associations With (pN+) Lymph Node Metastases. Ann Surg. 2017 01; 265(1):122-129.Ann Surg2017-01-01T00:00:002017Esophageal Cancer: Associations With (pN+) Lymph Node Metastases.28434844Carter BW, Erasmus JJ, Truong MT, Shepard JO, Hofstetter W, Clarke R, Munden RF, Steele JRJournal of the American College of Radiology : JACRQuality and Value of Subspecialty Reinterpretation of Thoracic CT Scans of Patients Referred to a Tertiary Cancer?Center. J Am Coll Radiol. 2017 Aug; 14(8):1109-1118.J Am Coll Radiol2017-04-21T00:00:002017Quality and Value of Subspecialty Reinterpretation of Thoracic CT Scans of Patients Referred to a Tertiary Cancer?Center.28495066Antonoff MB, Correa AM, Sepesi B, Nguyen QN, Walsh GL, Swisher SG, Vaporciyan AA, Mehran RJ, Hofstetter WL, Rice DCThe Journal of thoracic and cardiovascular surgerySalvage pulmonary resection after stereotactic body radiotherapy: A feasible and safe option for local failure in selected patients. J Thorac Cardiovasc Surg. 2017 08; 154(2):689-699.J Thorac Cardiovasc Surg2017-04-14T00:00:002017Salvage pulmonary resection after stereotactic body radiotherapy: A feasible and safe option for local failure in selected patients.28556024Rice TW, Gress DM, Patil DT, Hofstetter WL, Kelsen DP, Blackstone EHCA: a cancer journal for cliniciansCancer of the esophagus and esophagogastric junction-Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017 07 08; 67(4):304-317.CA Cancer J Clin2017-05-26T00:00:002017Cancer of the esophagus and esophagogastric junction-Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual.28351804Xi M, Liao Z, Deng W, Xu C, Komaki R, Blum M, Hofstetter WL, Ho L, Lin SHJournal of thoracic oncology : official publication of the International Association for the Study of Lung CancerA Prognostic Scoring Model for the Utility of Induction Chemotherapy Prior to Neoadjuvant Chemoradiotherapy in Esophageal Cancer. J Thorac Oncol. 2017 06; 12(6):1001-1010.J Thorac Oncol2017-03-27T00:00:002017A Prognostic Scoring Model for the Utility of Induction Chemotherapy Prior to Neoadjuvant Chemoradiotherapy in Esophageal Cancer.28366460Bassuner JK, Rice DC, Antonoff MB, Correa AM, Walsh GL, Vaporciyan AA, Garg N, Sepesi B, Swisher SG, Hofstetter WL, Roth JA, Mehran RJThe Annals of thoracic surgeryPolytetrafluoroethylene or Acellular Dermal Matrix for Diaphragmatic Reconstruction? Ann Thorac Surg. 2017 Jun; 103(6):1710-1714.Ann Thorac Surg2017-03-31T00:00:002017Polytetrafluoroethylene or Acellular Dermal Matrix for Diaphragmatic Reconstruction?28728163Wadhwa R, Wang X, Baladandayuthapani V, Liu B, Shiozaki H, Shimodaira Y, Lin Q, Elimova E, Hofstetter WL, Swisher SG, Rice DC, Maru DM, Kalhor N, Bhutani MS, Weston B, Lee JH, Skinner HD, Scott AW, Kaya DM, Harada K, Berry D, Song S, Ajani JABritish journal of cancerNuclear expression of Gli-1 is predictive of pathologic complete response to chemoradiation in trimodality treated oesophageal cancer patients. Br J Cancer. 2017 Aug 22; 117(5):648-655.Br J Cancer2017-07-20T00:00:002017Nuclear expression of Gli-1 is predictive of pathologic complete response to chemoradiation in trimodality treated oesophageal cancer patients.28404924Tong Z, Chatterjee D, Deng D, Veeranki O, Mejia A, Ajani JA, Hofstetter W, Lin S, Guha S, Kopetz S, Krishnan S, Maru DOncotargetAntitumor effects of cyclin dependent kinase 9 inhibition in esophageal adenocarcinoma. Oncotarget. 2017 Apr 25; 8(17):28696-28710.Oncotarget2017-04-25T00:00:002017Antitumor effects of cyclin dependent kinase 9 inhibition in esophageal adenocarcinoma.28522744Xi M, Liao Z, Hofstetter WL, Komaki R, Ho L, Lin SHJournal of nuclear medicine : official publication, Society of Nuclear Medicine18F-FDG PET Response After Induction Chemotherapy Can Predict Who Will Benefit from Subsequent Esophagectomy After Chemoradiotherapy for Esophageal Adenocarcinoma. J Nucl Med. 2017 11; 58(11):1756-1763.J Nucl Med2017-05-18T00:00:00201718F-FDG PET Response After Induction Chemotherapy Can Predict Who Will Benefit from Subsequent Esophagectomy After Chemoradiotherapy for Esophageal Adenocarcinoma.28643144Ikoma N, Blum M, Estrella JS, Das P, Hofstetter WL, Fournier KF, Mansfield P, Ajani JA, Badgwell BDGastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer AssociationEvaluation of the American Joint Committee on Cancer 8th edition staging system for gastric cancer patients after preoperative therapy. Gastric Cancer. 2018 Jan; 21(1):74-83.Gastric Cancer2017-06-22T00:00:002017Evaluation of the American Joint Committee on Cancer 8th edition staging system for gastric cancer patients after preoperative therapy.28455149Moreno AC, Verma V, Hofstetter WL, Lin SHJournal of thoracic oncology : official publication of the International Association for the Study of Lung CancerPatterns of Care and Treatment Outcomes of Elderly?Patients with Stage I Esophageal Cancer: Analysis of the National Cancer Data Base. J Thorac Oncol. 2017 07; 12(7):1152-1160.J Thorac Oncol2017-04-25T00:00:002017Patterns of Care and Treatment Outcomes of Elderly?Patients with Stage I Esophageal Cancer: Analysis of the National Cancer Data Base.28683449Mizrak Kaya D, Wang X, Harada K, Blum Murphy MA, Das P, Minsky BD, Estrella JS, Lin Q, Amlashi FG, Lee JH, Weston B, Bhutani MS, Matamoros A, Sagebiel T, Wu CC, Rogers JE, Thomas I, Maru DM, Skinner HD, Badgwell BD, Hofstetter WL, Ajani JAOncology101 Long-Term Survivors Who Had Metastatic Gastroesophageal Cancer and Received Local Consolidative Therapy. Oncology. 2017; 93(4):243-248.Oncology2017-07-06T00:00:002017101 Long-Term Survivors Who Had Metastatic Gastroesophageal Cancer and Received Local Consolidative Therapy.28685276Mizrak Kaya D, Dong X, Nogueras-Gonz?lez GM, Xu Y, Estrella JS, Harada K, Lopez A, Amlashi FG, Hofstetter WL, Maru DM, Nguyen QN, Lee JH, Weston B, Bhutani MS, Erasmus JJ, Thomas I, Rogers JE, Song S, Ajani JAMedical oncology (Northwood, London, England)Post-trimodality expression levels of metadherin (MTDH) as a prognostic biomarker for esophageal adenocarcinoma patients. Med Oncol. 2017 Aug; 34(8):135.Med Oncol2017-07-06T00:00:002017Post-trimodality expression levels of metadherin (MTDH) as a prognostic biomarker for esophageal adenocarcinoma patients.28687396Xi M, Xu C, Liao Z, Hofstetter WL, Blum Murphy M, Maru DM, Bhutani MS, Lee JH, Weston B, Komaki R, Lin SHRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and OncologyThe impact of histology on recurrence patterns in esophageal cancer treated with definitive chemoradiotherapy. Radiother Oncol. 2017 08; 124(2):318-324.Radiother Oncol2017-07-04T00:00:002017The impact of histology on recurrence patterns in esophageal cancer treated with definitive chemoradiotherapy.28801853Harada K, Dong X, Estrella JS, Correa AM, Xu Y, Hofstetter WL, Sudo K, Onodera H, Suzuki K, Suzuki A, Johnson RL, Wang Z, Song S, Ajani JAGastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer AssociationTumor-associated macrophage infiltration is highly associated with PD-L1 expression in gastric adenocarcinoma. Gastric Cancer. 2018 Jan; 21(1):31-40.Gastric Cancer2017-08-11T00:00:002017Tumor-associated macrophage infiltration is highly associated with PD-L1 expression in gastric adenocarcinoma.28948368In H, Ravetch E, Langdon-Embry M, Palis B, Ajani JA, Hofstetter WL, Kelsen DP, Sano TGastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer AssociationThe newly proposed clinical and post-neoadjuvant treatment staging classifications for gastric adenocarcinoma for the American Joint Committee on Cancer (AJCC) staging. Gastric Cancer. 2018 Jan; 21(1):1-9.Gastric Cancer2017-09-25T00:00:002017The newly proposed clinical and post-neoadjuvant treatment staging classifications for gastric adenocarcinoma for the American Joint Committee on Cancer (AJCC) staging.28987393Atay SM, Correa AM, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh G, Antonoff MBThe Annals of thoracic surgeryPerioperative Outcomes of Patients Undergoing Lobectomy on Clopidogrel. Ann Thorac Surg. 2017 Dec; 104(6):1821-1828.Ann Thorac Surg2017-10-05T00:00:002017Perioperative Outcomes of Patients Undergoing Lobectomy on Clopidogrel.29125331Betancourt Cuellar SL, Palacio DP, Wu CC, Carter BW, Correa AM, Hofstetter WL, Marom EMThe British journal of radiology18FDG-PET/CT is useful in the follow-up of surgically treated patients with oesophageal adenocarcinoma. Br J Radiol. 2018 Feb; 91(1082):20170341.Br J Radiol2017-11-28T00:00:00201718FDG-PET/CT is useful in the follow-up of surgically treated patients with oesophageal adenocarcinoma.29108314Shimodaira Y, Slack RS, Harada K, Bhutani MS, Elimova E, Staerkel GA, Sneige N, Erasmus J, Shiozaki H, Charalampakis N, Planjery V, Kaya DM, Amlashi FG, Blum MA, Skinner HD, Minsky BD, Maru DM, Hofstetter WL, Swisher SG, Mares JE, Rogers JE, Lin QD, Ross WA, Weston B, Lee JH, Ajani JAOncotargetUtility of endoscopic ultrasound-guided fine-needle aspiration of regional lymph nodes that are proximal to and far from the primary distal esophageal carcinoma. Oncotarget. 2017 Oct 03; 8(45):79356-79365.Oncotarget2017-05-23T00:00:002017Utility of endoscopic ultrasound-guided fine-needle aspiration of regional lymph nodes that are proximal to and far from the primary distal esophageal carcinoma.29114598Shi A, Liao Z, Allen PK, Ho L, Murphy MB, Maru DM, Swisher SG, Hofstetter WL, Mehran RJ, Cox JD, Komaki R, Lin SHAdvances in radiation oncologyLong-term survival and toxicity outcomes of intensity modulated radiation therapy for the treatment of esophageal cancer: A large single-institutional cohort study. Adv Radiat Oncol. 2017 Jul-Sep; 2(3):316-324.Adv Radiat Oncol2017-04-19T00:00:002017Long-term survival and toxicity outcomes of intensity modulated radiation therapy for the treatment of esophageal cancer: A large single-institutional cohort study.29179897Betancourt Cuellar SL, Palacio DP, Benveniste MF, Carter BW, Hofstetter WL, Marom EMSeminars in ultrasound, CT, and MRPositron Emission Tomography/Computed Tomography in Esophageal Carcinoma: Applications and Limitations. Semin Ultrasound CT MR. 2017 Dec; 38(6):571-583.Semin Ultrasound CT MR2017-08-08T00:00:002017Positron Emission Tomography/Computed Tomography in Esophageal Carcinoma: Applications and Limitations.29179900Betancourt Cuellar SL, Heller L, Palacio DP, Hofstetter WL, Marom EMSeminars in ultrasound, CT, and MRIntra- and Extra-Thoracic Muscle Flaps and Chest Wall Reconstruction Following Resection of Thoracic Tumors. Semin Ultrasound CT MR. 2017 Dec; 38(6):604-615.Semin Ultrasound CT MR2017-08-08T00:00:002017Intra- and Extra-Thoracic Muscle Flaps and Chest Wall Reconstruction Following Resection of Thoracic Tumors.28628563Xi M, Hallemeier CL, Merrell KW, Liao Z, Murphy MAB, Ho L, Hofstetter WL, Mehran R, Lee JH, Bhutani MS, Weston B, Maru DM, Komaki R, Ajani JA, Lin SHAnnals of surgeryRecurrence Risk Stratification After Preoperative Chemoradiation of Esophageal Adenocarcinoma. Ann Surg. 2018 08; 268(2):289-295.Ann Surg2018-08-01T00:00:002018Recurrence Risk Stratification After Preoperative Chemoradiation of Esophageal Adenocarcinoma.28817374Nelson DB, Rice DC, Niu J, Atay S, Vaporciyan AA, Antonoff M, Hofstetter WL, Walsh GL, Swisher SG, Roth JA, Tsao A, Gomez D, Giordano SH, Mehran R, Sepesi BJournal of clinical oncology : official journal of the American Society of Clinical OncologyLong-Term Survival Outcomes of Cancer-Directed Surgery for Malignant Pleural Mesothelioma: Propensity Score Matching Analysis. J Clin Oncol. 2017 Oct 10; 35(29):3354-3362.J Clin Oncol2017-08-17T00:00:002017Long-Term Survival Outcomes of Cancer-Directed Surgery for Malignant Pleural Mesothelioma: Propensity Score Matching Analysis.28881878Pence K, Correa AM, Chan E, Khaitan P, Hofstetter W, Kim MPDiseases of the esophagus : official journal of the International Society for Diseases of the EsophagusManagement of esophageal gastrointestinal stromal tumor: review of one hundred seven patients. Dis Esophagus. 2017 Dec 01; 30(12):1-5.Dis Esophagus2017-12-01T00:00:002017Management of esophageal gastrointestinal stromal tumor: review of one hundred seven patients.28885712Blum Murphy M, Xiao L, Patel VR, Maru DM, Correa AM, G Amlashi F, Liao Z, Komaki R, Lin SH, Skinner HD, Vaporciyan A, Walsh GL, Swisher SG, Sepesi B, Lee JH, Bhutani MS, Weston B, Hofstetter WL, Ajani JACancerPathological complete response in patients with esophageal cancer after the trimodality approach: The association with baseline variables and survival-The University of Texas MD Anderson Cancer Center experience. Cancer. 2017 Nov 01; 123(21):4106-4113.Cancer2017-09-08T00:00:002017Pathological complete response in patients with esophageal cancer after the trimodality approach: The association with baseline variables and survival-The University of Texas MD Anderson Cancer Center experience.29136404Ajani JA, Estrella JS, Chen Q, Correa AM, Ma L, Scott AW, Jin J, Liu B, Xie M, Sudo K, Shiozaki H, Badgwell B, Weston B, Lee JH, Bhutani MS, Onodera H, Suzuki K, Suzuki A, Ding S, Hofstetter WL, Johnson RL, Bresalier RS, Song SBritish journal of cancerGalectin-3 expression is prognostic in diffuse type gastric adenocarcinoma, confers aggressive phenotype, and can be targeted by YAP1/BET inhibitors. Br J Cancer. 2018 01; 118(1):52-61.Br J Cancer2017-11-14T00:00:002017Galectin-3 expression is prognostic in diffuse type gastric adenocarcinoma, confers aggressive phenotype, and can be targeted by YAP1/BET inhibitors.29248170Shiraishi Y, Fang P, Xu C, Song J, Krishnan S, Koay EJ, Mehran RJ, Hofstetter WL, Blum-Murphy M, Ajani JA, Komaki R, Minsky B, Mohan R, Hsu CC, Hobbs BP, Lin SHRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and OncologySevere lymphopenia during neoadjuvant chemoradiation for esophageal cancer: A propensity matched analysis of the relative risk of proton versus photon-based radiation therapy. Radiother Oncol. 2018 07; 128(1):154-160.Radiother Oncol2017-12-14T00:00:002017Severe lymphopenia during neoadjuvant chemoradiation for esophageal cancer: A propensity matched analysis of the relative risk of proton versus photon-based radiation therapy.29393964Ikoma N, Cormier JN, Feig B, Du XL, Yamal JM, Hofstetter W, Das P, Ajani JA, Roland CL, Fournier K, Royal R, Mansfield P, Badgwell BDCancerRacial disparities in preoperative chemotherapy use in gastric cancer patients in the United States: Analysis of the National Cancer Data Base, 2006-2014. Cancer. 2018 03 01; 124(5):998-1007.Cancer2018-02-02T00:00:002018Racial disparities in preoperative chemotherapy use in gastric cancer patients in the United States: Analysis of the National Cancer Data Base, 2006-2014.29548588Sepesi B, Ye Y, Mitchell KG, Zhang L, Gu J, Ji L, Antonoff MB, Hofstetter WL, Rice DC, Mehran RJ, Walsh GL, Vaporciyan AA, Swisher SG, Roth JA, Wu XThe Journal of thoracic and cardiovascular surgeryGenetic variants in cytokine signaling pathways and clinical outcomes in early-stage lung cancer patients. J Thorac Cardiovasc Surg. 2018 06; 155(6):2635-2645.e15.J Thorac Cardiovasc Surg2018-02-15T00:00:002018Genetic variants in cytokine signaling pathways and clinical outcomes in early-stage lung cancer patients.29530770Van Haren RM, Mehran RJ, Mena GE, Correa AM, Antonoff MB, Baker CM, Woodard TC, Hofstetter WL, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Rice DCThe Annals of thoracic surgeryEnhanced Recovery Decreases Pulmonary and Cardiac Complications After Thoracotomy for Lung Cancer. Ann Thorac Surg. 2018 07; 106(1):272-279.Ann Thorac Surg2018-03-09T00:00:002018Enhanced Recovery Decreases Pulmonary and Cardiac Complications After Thoracotomy for Lung Cancer.29534957Nelson DB, Godoy MCB, Benveniste MF, Shewale JB, Spicer JD, Mitchell KG, Hofstetter WL, Mehran RJ, Rice DC, Sepesi B, Walsh GL, Vaporciyan AA, Swisher SG, Roth JA, Antonoff MBThe Annals of thoracic surgeryClinicoradiographic Predictors of Aggressive Biology in Lung Cancer With Ground Glass Components. Ann Thorac Surg. 2018 07; 106(1):235-241.Ann Thorac Surg2018-03-11T00:00:002018Clinicoradiographic Predictors of Aggressive Biology in Lung Cancer With Ground Glass Components.29605441Nelson DB, Dhupar R, Katkhuda R, Correa A, Goltsov A, Maru D, Sepesi B, Antonoff MB, Mehran RJ, Rice DC, Vaporciyan AA, Davila M, Davila R, Betancourt S, Ajani J, Hofstetter WLThe Journal of thoracic and cardiovascular surgeryOutcomes after endoscopic mucosal resection or esophagectomy for submucosal esophageal adenocarcinoma. J Thorac Cardiovasc Surg. 2018 07; 156(1):406-413.e3.J Thorac Cardiovasc Surg2018-03-12T00:00:002018Outcomes after endoscopic mucosal resection or esophagectomy for submucosal esophageal adenocarcinoma.29605600Hofstetter WThe Annals of thoracic surgeryOpen Modified En Bloc Ivor Lewis Esophagectomy: How I Teach It. Ann Thorac Surg. 2018 06; 105(6):1583-1588.Ann Thorac Surg2018-03-30T00:00:002018Open Modified En Bloc Ivor Lewis Esophagectomy: How I Teach It.29748883Ikoma N, Estrella JS, Hofstetter W, Das P, Minsky BD, Ajani JA, Fournier KF, Mansfield P, Badgwell BDAnnals of surgical oncologyNodal Downstaging in Gastric Cancer Patients: Promising Survival if ypN0 is Achieved. Ann Surg Oncol. 2018 Jul; 25(7):2012-2017.Ann Surg Oncol2018-05-10T00:00:002018Nodal Downstaging in Gastric Cancer Patients: Promising Survival if ypN0 is Achieved.29843157Amlashi FG, Wang X, Davila RE, Maru DM, Bhutani MS, Lee JH, Weston BR, Mizrak Kaya D, Vassilakopoulou M, Harada K, Blum Murphy MA, Rice DC, Hofstetter WL, Davila M, Nguyen QN, Ajani JAOncologyBarrett's Esophagus after Bimodality Therapy in Patients with Esophageal Adenocarcinoma. Oncology. 2018; 95(2):81-90.Oncology2018-05-29T00:00:002018Barrett's Esophagus after Bimodality Therapy in Patients with Esophageal Adenocarcinoma.29223420Goltsov AA, Fang B, Pandita TK, Maru DM, Swisher SG, Hofstetter WLThe Annals of thoracic surgeryHER2 Confers Resistance to Foretinib Inhibition of MET-Amplified Esophageal Adenocarcinoma Cells. Ann Thorac Surg. 2018 Feb; 105(2):363-370.Ann Thorac Surg2017-12-07T00:00:002017HER2 Confers Resistance to Foretinib Inhibition of MET-Amplified Esophageal Adenocarcinoma Cells.29359314Murray TA, Yuan Y, Thall PF, Elizondo JH, Hofstetter WLBiometricsA utility-based design for randomized comparative trials with ordinal outcomes and prognostic subgroups. Biometrics. 2018 09; 74(3):1095-1103.Biometrics2018-01-22T00:00:002018A utility-based design for randomized comparative trials with ordinal outcomes and prognostic subgroups.29432718Shewale JB, Nelson DB, Rice DC, Sepesi B, Hofstetter WL, Mehran RJ, Vaporciyan AA, Walsh GL, Swisher SG, Roth JA, Antonoff MBThe Annals of thoracic surgeryNatural History of Ground-Glass Lesions Among Patients With Previous Lung Cancer. Ann Thorac Surg. 2018 06; 105(6):1671-1677.Ann Thorac Surg2018-02-09T00:00:002018Natural History of Ground-Glass Lesions Among Patients With Previous Lung Cancer.29569125Goense L, van Rossum PSN, Xi M, Maru DM, Carter BW, Meijer GJ, Ho L, van Hillegersberg R, Hofstetter WL, Lin SHAnnals of surgical oncologyPreoperative Nomogram to Risk Stratify Patients for the Benefit of Trimodality Therapy in Esophageal Adenocarcinoma. Ann Surg Oncol. 2018 Jun; 25(6):1598-1607.Ann Surg Oncol2018-03-22T00:00:002018Preoperative Nomogram to Risk Stratify Patients for the Benefit of Trimodality Therapy in Esophageal Adenocarcinoma.29663014Goense L, Ruurda JP, Carter BW, Fang P, Ho L, Meijer GJ, van Hillegersberg R, Hofstetter WL, Lin SHEuropean journal of nuclear medicine and molecular imagingPrediction and diagnosis of interval metastasis after neoadjuvant chemoradiotherapy for oesophageal cancer using 18F-FDG PET/CT. Eur J Nucl Med Mol Imaging. 2018 09; 45(10):1742-1751.Eur J Nucl Med Mol Imaging2018-04-16T00:00:002018Prediction and diagnosis of interval metastasis after neoadjuvant chemoradiotherapy for oesophageal cancer using 18F-FDG PET/CT.29730720Ikoma N, Das P, Hofstetter W, Ajani JA, Estrella JS, Chen HC, Wang X, Callender RA, Zhu C, Roland CL, Fournier KF, Cormier JN, Mansfield P, Badgwell BDGastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer AssociationPreoperative chemoradiation therapy induces primary-tumor complete response more frequently than chemotherapy alone in gastric cancer: analyses of the National Cancer Database 2006-2014 using propensity score matching. Gastric Cancer. 2018 11; 21(6):1004-1013.Gastric Cancer2018-05-05T00:00:002018Preoperative chemoradiation therapy induces primary-tumor complete response more frequently than chemotherapy alone in gastric cancer: analyses of the National Cancer Database 2006-2014 using propensity score matching.29206677Low DE, Kuppusamy MK, Alderson D, Cecconello I, Chang AC, Darling G, Davies A, D'Journo XB, Gisbertz SS, Griffin SM, Hardwick R, Hoelscher A, Hofstetter W, Jobe B, Kitagawa Y, Law S, Mariette C, Maynard N, Morse CR, Nafteux P, Pera M, Pramesh CS, Puig S, Reynolds JV, Schroeder W, Smithers M, Wijnhoven BPLAnnals of surgeryBenchmarking Complications Associated with Esophagectomy. Ann Surg. 2019 02; 269(2):291-298.Ann Surg2019-02-01T00:00:002019Benchmarking Complications Associated with Esophagectomy.29211849Nelson DB, Rice DC, Niu J, Atay SM, Vaporciyan AA, Antonoff MB, Hofstetter WL, Walsh GL, Swisher SG, Roth JA, Tsao AS, Gomez DR, Giordano SH, Mehran RJ, Sepesi BEuropean journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic SurgeryPredictors of trimodality therapy and trends in therapy for malignant pleural mesothelioma. Eur J Cardiothorac Surg. 2018 05 01; 53(5):960-966.Eur J Cardiothorac Surg2018-05-01T00:00:002018Predictors of trimodality therapy and trends in therapy for malignant pleural mesothelioma.29217088Cascone T, Gold KA, Swisher SG, Liu DD, Fossella FV, Sepesi B, Pataer A, Weissferdt A, Kalhor N, Vaporciyan AA, Hofstetter WL, Wistuba II, Heymach JV, Kim ES, William WNThe Annals of thoracic surgeryInduction Cisplatin Docetaxel Followed by Surgery and Erlotinib in Non-Small Cell Lung Cancer. Ann Thorac Surg. 2018 Feb; 105(2):418-424.Ann Thorac Surg2017-12-06T00:00:002017Induction Cisplatin Docetaxel Followed by Surgery and Erlotinib in Non-Small Cell Lung Cancer.29218623Harada K, Wang X, Shimodaira Y, Sagebiel T, Bhutani MS, Lee JH, Weston B, Elimova E, Lin Q, Amlashi FG, Mizrak Kaya D, Lopez A, Blum Murphy MA, Roth JA, Swisher SG, Skinner HD, Hofstetter WL, Rogers JE, Thomas I, Maru DM, Komaki R, Walsh G, Ajani JATargeted oncologyEarly Metabolic Change after Induction Chemotherapy Predicts Histologic Response and Prognosis in Patients with Esophageal Cancer: Secondary Analysis of a Randomized Trial. Target Oncol. 2018 02; 13(1):99-106.Target Oncol2018-02-01T00:00:002018Early Metabolic Change after Induction Chemotherapy Predicts Histologic Response and Prognosis in Patients with Esophageal Cancer: Secondary Analysis of a Randomized Trial.29280461Xi M, Xu C, Liao Z, Chang JY, Gomez DR, Jeter M, Cox JD, Komaki R, Mehran R, Blum MA, Hofstetter WL, Maru DM, Bhutani MS, Lee JH, Weston B, Ajani JA, Lin SHInternational journal of radiation oncology, biology, physicsComparative Outcomes After Definitive Chemoradiotherapy Using Proton Beam Therapy Versus Intensity Modulated Radiation Therapy for Esophageal Cancer: A Retrospective, Single-Institutional Analysis. Int J Radiat Oncol Biol Phys. 2017 11 01; 99(3):667-676.Int J Radiat Oncol Biol Phys2017-06-27T00:00:002017Comparative Outcomes After Definitive Chemoradiotherapy Using Proton Beam Therapy Versus Intensity Modulated Radiation Therapy for Esophageal Cancer: A Retrospective, Single-Institutional Analysis.29334555Xi M, Yang Y, Zhang L, Yang H, Merrell KW, Hallemeier CL, Shen RK, Haddock MG, Hofstetter WL, Maru DM, Ho L, Wu CC, Liu M, Lin SHAnnals of surgeryMulti-institutional Analysis of Recurrence and Survival After Neoadjuvant Chemoradiotherapy of Esophageal Cancer: Impact of Histology on Recurrence Patterns and Outcomes. Ann Surg. 2019 04; 269(4):663-670.Ann Surg2019-04-01T00:00:002019Multi-institutional Analysis of Recurrence and Survival After Neoadjuvant Chemoradiotherapy of Esophageal Cancer: Impact of Histology on Recurrence Patterns and Outcomes.29414520Palacio D, Marom EM, Correa A, Betancourt-Cuellar SL, Hofstetter WLClinical imagingDiagnosing conduit leak after esophagectomy for esophageal cancer by computed tomography leak protocol and standard esophagram: Is old school still the best? Clin Imaging. 2018 Sep - Oct; 51:23-29.Clin Imaging2018-01-31T00:00:002018Diagnosing conduit leak after esophagectomy for esophageal cancer by computed tomography leak protocol and standard esophagram: Is old school still the best?29481581Louie BE, Hofstetter W, Triadafilopoulos G, Weusten BLDiseases of the esophagus : official journal of the International Society for Diseases of the EsophagusEvaluation of a novel cryoballoon swipe ablation system in bench, porcine, and human esophagus models. Dis Esophagus. 2018 Aug 01; 31(8).Dis Esophagus2018-08-01T00:00:002018Evaluation of a novel cryoballoon swipe ablation system in bench, porcine, and human esophagus models.29485606Schaverien MV, Hofstetter WL, Selber JCPlastic and reconstructive surgeryVascularized Jejunal Mesenteric Lymph Node Transfer for Lymphedema: A Novel Approach. Plast Reconstr Surg. 2018 03; 141(3):468e-469e.Plast Reconstr Surg2018-03-01T00:00:002018Vascularized Jejunal Mesenteric Lymph Node Transfer for Lymphedema: A Novel Approach.29757780Du KN, Feng L, Newhouse A, Mehta J, Lasala J, Mena GE, Hofstetter WL, Cata JPAnesthesia and analgesiaEffects of Intraoperative Opioid Use on Recurrence-Free and Overall Survival in Patients With Esophageal Adenocarcinoma and Squamous Cell Carcinoma. Anesth Analg. 2018 07; 127(1):210-216.Anesth Analg2018-07-01T00:00:002018Effects of Intraoperative Opioid Use on Recurrence-Free and Overall Survival in Patients With Esophageal Adenocarcinoma and Squamous Cell Carcinoma.29932887Goense L, Merrell KW, Arnett AL, Hallemeier CL, Meijer GJ, Ruurda JP, Hofstetter WL, van Hillegersberg R, Lin SHThe Annals of thoracic surgeryValidation of a Nomogram Predicting Survival After Trimodality Therapy for Esophageal Cancer. Ann Thorac Surg. 2018 11; 106(5):1541-1547.Ann Thorac Surg2018-06-19T00:00:002018Validation of a Nomogram Predicting Survival After Trimodality Therapy for Esophageal Cancer.29934005Hofstetter WLThe Journal of thoracic and cardiovascular surgeryThe artificial trachea: A mission of creativity, perspiration, and perseverance. J Thorac Cardiovasc Surg. 2018 09; 156(3):1273-1274.J Thorac Cardiovasc Surg2018-05-28T00:00:002018The artificial trachea: A mission of creativity, perspiration, and perseverance.30054780Ikoma N, Estrella JS, Hofstetter WL, Ajani JA, Fournier KF, Mansfield PF, Skibber JM, Badgwell BDJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary TractSurgeon Assessment of Gastric Cancer Lymph Node Specimens with a Video of Technique. J Gastrointest Surg. 2018 11; 22(11):2013-2019.J Gastrointest Surg2018-07-27T00:00:002018Surgeon Assessment of Gastric Cancer Lymph Node Specimens with a Video of Technique.30118712Nelson DB, Lapid DJ, Mitchell KG, Correa AM, Hofstetter WL, Mehran RJ, Rice DC, Sepesi B, Walsh GL, Vaporciyan AA, Swisher SG, Roth JA, Antonoff MBThe Annals of thoracic surgeryPerioperative Outcomes for Stage I Non-Small Cell Lung Cancer: Differences Between Men and Women. Ann Thorac Surg. 2018 11; 106(5):1499-1503.Ann Thorac Surg2018-08-15T00:00:002018Perioperative Outcomes for Stage I Non-Small Cell Lung Cancer: Differences Between Men and Women.30109699Shewale JB, Mitchell KG, Nelson DB, Conley AP, Rice DC, Antonoff MB, Hofstetter WL, Walsh GL, Swisher SG, Roth JA, Mehran RJ, Vaporciyan AA, Weissferdt A, Sepesi BJournal of surgical oncologyPredictors of survival after resection of primary sarcomas of the chest wall-A large, single-institution series. J Surg Oncol. 2018 Sep; 118(3):518-524.J Surg Oncol2018-08-15T00:00:002018Predictors of survival after resection of primary sarcomas of the chest wall-A large, single-institution series.29705797Elimova E, Wang X, Qiao W, Sudo K, Wadhwa R, Shiozaki H, Shimodaira Y, Planjery V, Charalampakis N, Lee JH, Weston BR, Bhutani MS, Komaki R, Rice DC, Swisher SG, Blum MA, Rogers JE, Skinner HD, Maru DM, Hofstetter WL, Ajani JAOncologyActionable Locoregional Relapses after Therapy of Localized Esophageal Cancer: Insights from a Large Cohort. Oncology. 2018; 94(6):345-353.Oncology2018-04-27T00:00:002018Actionable Locoregional Relapses after Therapy of Localized Esophageal Cancer: Insights from a Large Cohort.29949666Ikoma N, Hofstetter WL, Estrella JS, Das P, Minsky BD, Fournier KF, Mansfield PF, Ajani JA, Badgwell BDJournal of surgical oncologyThe ypT category does not impact overall survival in node negative gastric cancer. J Surg Oncol. 2018 Jun; 117(8):1721-1728.J Surg Oncol2018-06-27T00:00:002018The ypT category does not impact overall survival in node negative gastric cancer.30746212Kim MP, Correa AM, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Erasmus JJ, Swisher SGJournal of thoracic diseaseOccult stage IIIA-N2 patients have excellent overall survival with initial surgery. J Thorac Dis. 2018 Dec; 10(12):6670-6676.J Thorac Dis2018-12-01T00:00:002018Occult stage IIIA-N2 patients have excellent overall survival with initial surgery.30508527Nelson DB, Tam AL, Mitchell KG, Rice DC, Mehran RJ, Sepesi B, Antonoff MB, Vaporciyan AA, Hofstetter WLThe Annals of thoracic surgeryLocal Recurrence After Microwave Ablation of Lung Malignancies: A Systematic Review. Ann Thorac Surg. 2019 06; 107(6):1876-1883.Ann Thorac Surg2018-11-30T00:00:002018Local Recurrence After Microwave Ablation of Lung Malignancies: A Systematic Review.30642620Hofstetter WLThe Journal of thoracic and cardiovascular surgeryCommentary: Maximizing response and outcomes in multimodality therapy for locally advanced esophageal adenocarcinoma. J Thorac Cardiovasc Surg. 2019 04; 157(4):1694-1695.J Thorac Cardiovasc Surg2018-12-19T00:00:002018Commentary: Maximizing response and outcomes in multimodality therapy for locally advanced esophageal adenocarcinoma.30621725Luo W, Hofstetter WL, Tan DDiagnostic pathologyGastroesophageal junction Paneth cell carcinoma with extensive cystic and secretory features - case report and literature review. Diagn Pathol. 2019 Jan 08; 14(1):1.Diagn Pathol2019-01-08T00:00:002019Gastroesophageal junction Paneth cell carcinoma with extensive cystic and secretory features - case report and literature review.30635188Nelson DB, Tayob N, Mitchell KG, Correa AM, Hofstetter WL, Sepesi B, Walsh GL, Vaporciyan AA, Swisher SG, Antonoff MB, Roth JA, Rice DC, Vauthey JN, Mehran RJThe Journal of thoracic and cardiovascular surgerySurgical margins and risk of local recurrence after wedge resection of colorectal pulmonary metastases. J Thorac Cardiovasc Surg. 2019 04; 157(4):1648-1655.J Thorac Cardiovasc Surg2018-11-26T00:00:002018Surgical margins and risk of local recurrence after wedge resection of colorectal pulmonary metastases.30612991Van Haren RM, Correa AM, Sepesi B, Rice DC, Hofstetter WL, Mehran RJ, Vaporciyan AA, Walsh GL, Roth JA, Swisher SG, Antonoff MBThe Annals of thoracic surgeryGround Glass Lesions on Chest Imaging: Evaluation of Reported Incidence in Cancer Patients Using Natural Language Processing. Ann Thorac Surg. 2019 03; 107(3):936-940.Ann Thorac Surg2018-10-26T00:00:002018Ground Glass Lesions on Chest Imaging: Evaluation of Reported Incidence in Cancer Patients Using Natural Language Processing.Department of MedicineMedicine-Gastroenterology & HepatolBaylor College of MedicineHASHEMEL-SERAGHASHEM EL-SERAG29.70560750000000-95.3846773000000068EL-SERAG, HASHEMProfessorAuthorship 941427429703550Gawad NA, Kohner A, Ali T, Hofstetter W, Valentine APsychosomaticsValproic Acid Attenuates Postoperative Psychosis Following Aggressive Resection of an Intracardiac Carcinoid Neuroendocrine Tumor: A Case Report. Psychosomatics. 2018 11; 59(6):607-611.Psychosomatics2018-03-21T00:00:002018Valproic Acid Attenuates Postoperative Psychosis Following Aggressive Resection of an Intracardiac Carcinoid Neuroendocrine Tumor: A Case Report.Authorship 9434461530888418Nelson DB, Mitchell KG, Weston BR, Betancourt S, Maru D, Rice DC, Mehran RJ, Sepesi B, Antonoff MB, Walsh GL, Swisher SG, Roth JA, Vaporciyan AA, Blum M, Hofstetter WLDiseases of the esophagus : official journal of the International Society for Diseases of the EsophagusShould endoscopic mucosal resection be attempted for cT2N0 esophageal cancer? Dis Esophagus. 2019 Dec 13; 32(10):1-6.Dis Esophagus2019-12-13T00:00:002019Should endoscopic mucosal resection be attempted for cT2N0 esophageal cancer?Authorship 94368317Authorship 943843229235564Shimodaira Y, Slack RS, Harada K, Chen HC, Sagebiel T, Bhutani MS, Lee JH, Weston B, Elimova E, Lin Q, Amlashi FG, Mizrak Kaya D, Blum MA, Roth JA, Swisher SG, Skinner HD, Hofstetter WL, Rogers JE, Mares J, Thomas I, Maru DM, Komaki R, Walsh G, Ajani JABritish journal of cancerInfluence of induction chemotherapy in trimodality therapy-eligible oesophageal cancer patients: secondary analysis of a randomised trial. Br J Cancer. 2018 02 06; 118(3):331-337.Br J Cancer2017-12-12T00:00:002017Influence of induction chemotherapy in trimodality therapy-eligible oesophageal cancer patients: secondary analysis of a randomised trial.30268293Rajaram R, Hofstetter WLThoracic surgery clinicsMucosal Ablation Techniques for Barrett's Esophagus and Early Esophageal Cancer. Thorac Surg Clin. 2018 Nov; 28(4):473-480.Thorac Surg Clin2018-11-01T00:00:002018Mucosal Ablation Techniques for Barrett's Esophagus and Early Esophageal Cancer.Authorship 945803831004583Nelson DB, Mehran RJ, Mitchell KG, Rajaram R, Correa AM, Bassett RL, Antonoff MB, Hofstetter WL, Roth JA, Sepesi B, Swisher SG, Walsh GL, Vaporciyan AA, Rice DCThe Annals of thoracic surgeryRobotic-Assisted Lobectomy for Non-Small Cell Lung Cancer: A Comprehensive Institutional Experience. Ann Thorac Surg. 2019 08; 108(2):370-376.Ann Thorac Surg2019-04-18T00:00:002019Robotic-Assisted Lobectomy for Non-Small Cell Lung Cancer: A Comprehensive Institutional Experience.Authorship 946419431051727Kundu U, Weston B, Lee J, Hofstetter W, Krishnamurthy SJournal of the American Society of CytopathologyEvolving role of endoscopic ultrasonography-guided fine-needle aspiration in tumor staging and treatment of patients with carcinomas of the upper gastrointestinal tract. J Am Soc Cytopathol. 2014 Jan - Feb; 3(1):29-36.J Am Soc Cytopathol2013-10-22T00:00:002013Evolving role of endoscopic ultrasonography-guided fine-needle aspiration in tumor staging and treatment of patients with carcinomas of the upper gastrointestinal tract.D059248Procedures45219460.5124ChemoradiotherapyAuthorship 94722919Authorship 947851731102632Mitchell KG, Ikoma N, Nelson DB, Maru DM, Erasmus JJ, Weston BR, Vaporciyan AA, Antonoff MB, Mehran RJ, Rice DC, Roth JA, Swisher SG, Sepesi B, Walsh GL, Correa AM, Das P, Blum MA, Badgwell BD, Hofstetter WLThe Annals of thoracic surgeryMediastinal Nodal Involvement After Neoadjuvant Chemoradiation for Siewert II/III Adenocarcinoma. Ann Thorac Surg. 2019 09; 108(3):845-851.Ann Thorac Surg2019-05-15T00:00:002019Mediastinal Nodal Involvement After Neoadjuvant Chemoradiation for Siewert II/III Adenocarcinoma.31149979Nelson DB, Cata JP, Niu J, Mitchell KG, Vaporciyan AA, Antonoff MB, Hofstetter WL, Giordano SH, Sepesi B, Mehran RJ, Rice DCPainPersistent opioid use is associated with worse survival after lobectomy for stage I non-small cell lung cancer. Pain. 2019 10; 160(10):2365-2373.Pain2019-10-01T00:00:002019Persistent opioid use is associated with worse survival after lobectomy for stage I non-small cell lung cancer.Authorship 9488647Authorship 9489951931179069Nelson DB, Rice DC, Mitchell KG, Tsao AS, Vaporciyan AA, Antonoff MB, Hofstetter WL, Walsh GL, Swisher SG, Roth JA, Gomez DR, Mehran RJ, Sepesi BJournal of thoracic diseaseDefining the role of adjuvant radiotherapy for malignant pleural mesothelioma: a propensity-matched landmark analysis of the National Cancer Database. J Thorac Dis. 2019 Apr; 11(4):1269-1278.J Thorac Dis2019-04-01T00:00:002019Defining the role of adjuvant radiotherapy for malignant pleural mesothelioma: a propensity-matched landmark analysis of the National Cancer Database.31188215Harada K, Hwang H, Wang X, Abdelhakeem A, Iwatsuki M, Blum Murphy MA, Maru DM, Weston B, Lee JH, Rogers JE, Thomas I, Shanbhag N, Zhao M, Bhutani MS, Nguyen QN, Swisher SG, Ikoma N, Badgwell BD, Hofstetter WL, Ajani JAAnnals of surgeryFrequency and Implications of Paratracheal Lymph Node Metastases in Resectable Esophageal or Gastroesophageal Junction Adenocarcinoma. Ann Surg. 2021 04 01; 273(4):751-757.Ann Surg2021-04-01T00:00:002021Frequency and Implications of Paratracheal Lymph Node Metastases in Resectable Esophageal or Gastroesophageal Junction Adenocarcinoma.Authorship 950422431229485Semenkovich TR, Subramanian M, Yan Y, Hofstetter WL, Correa AM, Cassivi SD, Inra ML, Stiles BM, Altorki NK, Chang AC, Brescia AA, Darling GE, Allison F, Broderick SR, Etchill EW, Fernandez FG, Chihara RK, Litle VR, Mu?oz-Largacha JA, Kozower BD, Puri V, Meyers BFThe Annals of thoracic surgeryAdjuvant Therapy for Node-Positive Esophageal Cancer After Induction and Surgery: A Multisite Study. Ann Thorac Surg. 2019 09; 108(3):828-836.Ann Thorac Surg2019-06-20T00:00:002019Adjuvant Therapy for Node-Positive Esophageal Cancer After Induction and Surgery: A Multisite Study.Authorship 9511234331272485Hagens ERC, van Berge Henegouwen MI, van Sandick JW, Cuesta MA, van der Peet DL, Heisterkamp J, Nieuwenhuijzen GAP, Rosman C, Scheepers JJG, Sosef MN, van Hillegersberg R, Lagarde SM, Nilsson M, R?s?nen J, Nafteux P, Pattyn P, H?lscher AH, Schr?der W, Schneider PM, Mariette C, Castoro C, Bonavina L, Rosati R, de Manzoni G, Mattioli S, Garcia JR, Pera M, Griffin M, Wilkerson P, Chaudry MA, Sgromo B, Tucker O, Cheong E, Moorthy K, Walsh TN, Reynolds J, Tachimori Y, Inoue H, Matsubara H, Kosugi SI, Chen H, Law SYK, Pramesh CS, Puntambekar SP, Murthy S, Linden P, Hofstetter WL, Kuppusamy MK, Shen KR, Darling GE, Sabino FD, Grimminger PP, Meijer SL, Bergman JJGHM, Hulshof MCCM, van Laarhoven HWM, Mearadji B, Bennink RJ, Annema JT, Dijkgraaf MGW, Gisbertz SSBMC cancerDistribution of lymph node metastases in esophageal carcinoma [TIGER study]: study protocol of a multinational observational study. BMC Cancer. 2019 Jul 04; 19(1):662.BMC Cancer2019-07-04T00:00:002019Distribution of lymph node metastases in esophageal carcinoma [TIGER study]: study protocol of a multinational observational study.Authorship 95152510Authorship 95155914Authorship 951607931285952Baity M, Wang L, Correa AM, Zhang X, Zhang R, Pataer A, Wu S, Meng QH, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Zhao M, Gu J, Fang BAmerican journal of cancer researchGlutathione reductase (GSR) gene deletion and chromosome 8 aneuploidy in primary lung cancers detected by fluorescence in situ hybridization. Am J Cancer Res. 2019; 9(6):1201-1211.Am J Cancer Res2019-06-01T00:00:002019Glutathione reductase (GSR) gene deletion and chromosome 8 aneuploidy in primary lung cancers detected by fluorescence in situ hybridization.31287557Chen Y, Zhang R, Wang L, Correa AM, Pataer A, Xu Y, Zhang X, Ren C, Wu S, Meng QH, Fujimoto J, Jensen VB, Antonoff MB, Hofstetter WL, Mehran RJ, Pisimisis G, Rice DC, Sepesi B, Vaporciyan AA, Walsh GL, Swisher SG, Roth JA, Heymach JV, Fang BCancerTumor characteristics associated with engraftment of patient-derived non-small cell lung cancer xenografts in immunocompromised mice. Cancer. 2019 11 01; 125(21):3738-3748.Cancer2019-07-09T00:00:002019Tumor characteristics associated with engraftment of patient-derived non-small cell lung cancer xenografts in immunocompromised mice.31290159Corsini EM, Mitchell KG, Mehran RJ, Rice DC, Sepesi B, Walsh GL, Swisher SG, Roth JA, Hofstetter WL, Vaporciyan AA, Morris VK, Antonoff MBJournal of surgical oncologyColorectal cancer mutations are associated with survival and recurrence after pulmonary metastasectomy. J Surg Oncol. 2019 Sep; 120(4):729-735.J Surg Oncol2019-07-09T00:00:002019Colorectal cancer mutations are associated with survival and recurrence after pulmonary metastasectomy.Authorship 9521801631313820Mitchell KG, Nelson DB, Corsini EM, Vaporciyan AA, Antonoff MB, Mehran RJ, Rice DC, Roth JA, Sepesi B, Walsh GL, Bhutani MS, Maru DM, Wu CC, Nguyen QN, Ajani JA, Swisher SG, Hofstetter WLDiseases of the esophagus : official journal of the International Society for Diseases of the EsophagusMorbidity following salvage esophagectomy for squamous cell carcinoma: the MD Anderson experience. Dis Esophagus. 2020 Mar 16; 33(3).Dis Esophagus2020-03-16T00:00:002020Morbidity following salvage esophagectomy for squamous cell carcinoma: the MD Anderson experience.31319389Ajani JA, D'Amico TA, Bentrem DJ, Chao J, Corvera C, Das P, Denlinger CS, Enzinger PC, Fanta P, Farjah F, Gerdes H, Gibson M, Glasgow RE, Hayman JA, Hochwald S, Hofstetter WL, Ilson DH, Jaroszewski D, Johung KL, Keswani RN, Kleinberg LR, Leong S, Ly QP, Matkowskyj KA, McNamara M, Mulcahy MF, Paluri RK, Park H, Perry KA, Pimiento J, Poultsides GA, Roses R, Strong VE, Wiesner G, Willett CG, Wright CD, McMillian NR, Pluchino LAJournal of the National Comprehensive Cancer Network : JNCCNEsophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2019 07 01; 17(7):855-883.J Natl Compr Canc Netw2019-07-01T00:00:002019Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.Authorship 9530131931363740Shargall Y, Brunelli A, Murthy S, Schneider L, Minervini F, Bertolaccini L, Agzarian J, Linkins LA, Kestenholz P, Li H, Rocco G, Girard P, Venuta F, Samama M, Scarci M, Anraku M, Falcoz PE, Kirk A, Solli P, Hofstetter W, Okumura M, Douketis J, Litle VEuropean journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic SurgeryVenous thromboembolism prophylaxis in thoracic surgery patients: an international survey. Eur J Cardiothorac Surg. 2020 02 01; 57(2):331-337.Eur J Cardiothorac Surg2020-02-01T00:00:002020Venous thromboembolism prophylaxis in thoracic surgery patients: an international survey.Authorship 95336717Authorship 95337717Authorship 953527631384313Tong Z, Mejia A, Veeranki O, Verma A, Correa AM, Dokey R, Patel V, Solis LM, Mino B, Kathkuda R, Rodriguez-Canales J, Lin SH, Krishnan S, Kopetz S, Blum M, Ajani JA, Hofstetter WL, Maru DMTherapeutic advances in medical oncologyTargeting CDK9 and MCL-1 by a new CDK9/p-TEFb inhibitor with and without 5-fluorouracil in esophageal adenocarcinoma. Ther Adv Med Oncol. 2019; 11:1758835919864850.Ther Adv Med Oncol2019-07-25T00:00:002019Targeting CDK9 and MCL-1 by a new CDK9/p-TEFb inhibitor with and without 5-fluorouracil in esophageal adenocarcinoma.31384397Veeranki OL, Tong Z, Dokey R, Mejia A, Zhang J, Qiao Y, Singh PK, Katkhuda R, Mino B, Tailor R, Canales JR, Bassett R, Ajani J, Wu JY, Kopetz S, Blum M, Hofstetter W, Tetzlaff M, Krishnan S, Lin SH, Maru DOncotargetTargeting cyclin-dependent kinase 9 by a novel inhibitor enhances radiosensitization and identifies Axl as a novel downstream target in esophageal adenocarcinoma. Oncotarget. 2019 Jul 23; 10(45):4703-4718.Oncotarget2019-07-23T00:00:002019Targeting cyclin-dependent kinase 9 by a novel inhibitor enhances radiosensitization and identifies Axl as a novel downstream target in esophageal adenocarcinoma.31395367Nelson DB, Tayob N, Nguyen QN, Erasmus J, Mitchell KG, Hofstetter WL, Sepesi B, Antonoff MB, Mehran RJThe Journal of thoracic and cardiovascular surgeryLocal failure after stereotactic body radiation therapy or wedge resection for colorectal pulmonary metastases. J Thorac Cardiovasc Surg. 2019 10; 158(4):1234-1241.e16.J Thorac Cardiovasc Surg2019-05-11T00:00:002019Local failure after stereotactic body radiation therapy or wedge resection for colorectal pulmonary metastases.Authorship 9543273Authorship 954375531441806Mays AC, Yu P, Hofstetter W, Liu J, Xue A, Klebuc M, Chevray P, Selber JPlastic and reconstructive surgeryThe Supercharged Pedicled Jejunal Flap for Total Esophageal Reconstruction: A Retrospective Review of 100 Cases. Plast Reconstr Surg. 2019 11; 144(5):1171-1180.Plast Reconstr Surg2019-11-01T00:00:002019The Supercharged Pedicled Jejunal Flap for Total Esophageal Reconstruction: A Retrospective Review of 100 Cases.31445908Nelson DB, Niu J, Mitchell KG, Sepesi B, Hofstetter WL, Antonoff MB, Giordano SH, Mehran RJ, Rice DCThe Annals of thoracic surgeryPersistent Opioid Use Among the Elderly After Lung Resection: A SEER-Medicare Study. Ann Thorac Surg. 2020 01; 109(1):194-202.Ann Thorac Surg2019-08-22T00:00:002019Persistent Opioid Use Among the Elderly After Lung Resection: A SEER-Medicare Study.Authorship 9556396Authorship 955819731529018Chen D, Menon H, Verma V, Seyedin SN, Ajani JA, Hofstetter WL, Nguyen QN, Chang JY, Gomez DR, Amini A, Swisher SG, Blum MA, Younes AI, Barsoumian HB, Erasmus JJ, Lee JH, Bhutani MS, Hess KR, Minsky BD, Welsh JWJAMA oncologyResults of a Phase 1/2 Trial of Chemoradiotherapy With Simultaneous Integrated Boost of Radiotherapy Dose in Unresectable Locally Advanced Esophageal Cancer. JAMA Oncol. 2019 11 01; 5(11):1597-1604.JAMA Oncol2019-11-01T00:00:002019Results of a Phase 1/2 Trial of Chemoradiotherapy With Simultaneous Integrated Boost of Radiotherapy Dose in Unresectable Locally Advanced Esophageal Cancer.31539514Shewale JB, Correa AM, Brown EL, Leon-Novelo LG, Nyitray AG, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Walsh GL, Roth J, Vaporciyan AA, Swisher SG, Sepesi BThe Annals of thoracic surgeryTime Trends of Perioperative Outcomes in Early Stage Non-Small Cell Lung Cancer Resection Patients. Ann Thorac Surg. 2020 02; 109(2):404-411.Ann Thorac Surg2019-09-17T00:00:002019Time Trends of Perioperative Outcomes in Early Stage Non-Small Cell Lung Cancer Resection Patients.Authorship 9561271131559043Corsini EM, Mitchell KG, Sceusi EL, Mehran RJ, Rice DC, Sepesi B, Walsh GL, Swisher SG, Roth JA, Vaporciyan AA, Hofstetter WL, Antonoff MBJournal of thoracic diseaseMultidisciplinary treatment of thymic neuroendocrine tumors: surgery remains a key component. J Thorac Dis. 2019 Aug; 11(8):3391-3398.J Thorac Dis2019-08-01T00:00:002019Multidisciplinary treatment of thymic neuroendocrine tumors: surgery remains a key component.Authorship 957386131623814Hofstetter WLThe Journal of thoracic and cardiovascular surgeryOpen versus hybrid minimally invasive esophagectomy: Join the crowd, but do not throw away your abdominal retractors just yet. J Thorac Cardiovasc Surg. 2019 11; 158(5):1475-1478.J Thorac Cardiovasc Surg2019-08-29T00:00:002019Open versus hybrid minimally invasive esophagectomy: Join the crowd, but do not throw away your abdominal retractors just yet.true1ProfessorProfessorAuthorship 9611351931732509Veeranki OL, Tong Z, Mejia A, Verma A, Katkhuda R, Bassett R, Kim TB, Wang J, Lang W, Mino B, Solis L, Kingsley C, Norton W, Tailor R, Wu JY, Krishnan S, Lin SH, Blum M, Hofstetter W, Ajani J, Kopetz S, Maru DDisease models & mechanismsA novel patient-derived orthotopic xenograft model of esophageal adenocarcinoma provides a platform for translational discoveries. Dis Model Mech. 2019 12 17; 12(12).Dis Model Mech2019-12-17T00:00:002019A novel patient-derived orthotopic xenograft model of esophageal adenocarcinoma provides a platform for translational discoveries.Authorship 9616511731769796Agzarian J, Litle V, Linkins LA, Brunelli A, Schneider L, Kestenholz P, Li H, Rocco G, Girard P, Nakajima J, Samama CM, Scarci M, Anraku M, Falcoz PE, Bertolaccini L, Lin J, Murthy S, Hofstetter W, Okumura M, Solli P, Minervini F, Kirk A, Douketis J, Shargall YEuropean journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic SurgeryInternational Delphi survey of the ESTS/AATS/ISTH task force on venous thromboembolism prophylaxis in thoracic surgery: the role of extended post-discharge prophylaxis. Eur J Cardiothorac Surg. 2020 05 01; 57(5):854-859.Eur J Cardiothorac Surg2020-05-01T00:00:002020International Delphi survey of the ESTS/AATS/ISTH task force on venous thromboembolism prophylaxis in thoracic surgery: the role of extended post-discharge prophylaxis.Authorship 962872631857153Van Haren RM, Rajaram R, Correa AM, Mehran RJ, Antonoff MB, Hofstetter WL, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Rice DC, Roth JASeminars in thoracic and cardiovascular surgeryPreoperative Heparin for Lung Cancer Resection Increases Risk of Reoperation for Bleeding. Semin Thorac Cardiovasc Surg. 2020 Summer; 32(2):337-343.Semin Thorac Cardiovasc Surg2019-12-17T00:00:002019Preoperative Heparin for Lung Cancer Resection Increases Risk of Reoperation for Bleeding.Authorship 974689631875755Mitchell KG, Nelson DB, Corsini EM, Correa AM, Erasmus JJ, Hofstetter WL, Mehran RJ, Roth JA, Swisher SG, Sepesi B, Walsh GL, Vaporciyan AA, Rice DC, Nguyen QN, Antonoff MBInnovations (Philadelphia, Pa.)Surveillance After Treatment of Non-Small-Cell Lung Cancer: A Call for Multidisciplinary Standardization. Innovations (Phila). 2020 Jan/Feb; 15(1):57-65.Innovations (Phila)2019-12-26T00:00:002019Surveillance After Treatment of Non-Small-Cell Lung Cancer: A Call for Multidisciplinary Standardization.Authorship 975628131926682Hofstetter WThe Journal of thoracic and cardiovascular surgeryCommentary: Delayed resection for esophageal adenocarcinoma. J Thorac Cardiovasc Surg. 2020 06; 159(6):2568-2569.J Thorac Cardiovasc Surg2019-12-09T00:00:002019Commentary: Delayed resection for esophageal adenocarcinoma.Authorship 976093131955937Hofstetter WThe Journal of thoracic and cardiovascular surgeryCommentary: Fluorodeoxyglucose-positron emission tomography/computed tomography for cervical adenopathy in esophageal carcinoma, an option for the selective surgeon. J Thorac Cardiovasc Surg. 2020 08; 160(2):551-552.J Thorac Cardiovasc Surg2019-12-14T00:00:002019Commentary: Fluorodeoxyglucose-positron emission tomography/computed tomography for cervical adenopathy in esophageal carcinoma, an option for the selective surgeon.Authorship 9781145Authorship 978310232077113Corsini EM, Datar SS, Mitchell KG, Zhou N, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Blackmon SH, Loree JM, Morris VK, Antonoff MBJournal of surgical oncologyHigh mutational concordance between primary colorectal tumors and associated pulmonary metastases. J Surg Oncol. 2020 May; 121(6):984-989.J Surg Oncol2020-02-19T00:00:002020High mutational concordance between primary colorectal tumors and associated pulmonary metastases.32067548Zhou N, Hofstetter WLExpert review of molecular diagnosticsPrognostic and therapeutic molecular markers in the clinical management of esophageal cancer. Expert Rev Mol Diagn. 2020 04; 20(4):401-411.Expert Rev Mol Diagn2020-02-24T00:00:002020Prognostic and therapeutic molecular markers in the clinical management of esophageal cancer.Authorship 9784271132089476Rajaram R, Correa AM, Xu T, Nguyen QN, Antonoff MB, Rice D, Mehran R, Roth J, Walsh G, Swisher S, Hofstetter WL, Vaporciyan A, Cascone T, Tsao AS, Papadimitrakopoulou VA, Gandhi S, Liao Z, Sepesi BClinical lung cancerLocoregional Control, Overall Survival, and Disease-Free Survival in Stage IIIA (N2) Non-Small-Cell Lung Cancer: Analysis of Resected and Unresected Patients. Clin Lung Cancer. 2020 07; 21(4):e294-e301.Clin Lung Cancer2020-01-27T00:00:002020Locoregional Control, Overall Survival, and Disease-Free Survival in Stage IIIA (N2) Non-Small-Cell Lung Cancer: Analysis of Resected and Unresected Patients.Authorship 97906423Authorship 9796241532160096Lin SH, Hobbs BP, Verma V, Tidwell RS, Smith GL, Lei X, Corsini EM, Mok I, Wei X, Yao L, Wang X, Komaki RU, Chang JY, Chun SG, Jeter MD, Swisher SG, Ajani JA, Blum-Murphy M, Vaporciyan AA, Mehran RJ, Koong AC, Gandhi SJ, Hofstetter WL, Hong TS, Delaney TF, Liao Z, Mohan RJournal of clinical oncology : official journal of the American Society of Clinical OncologyRandomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for Locally Advanced Esophageal Cancer. J Clin Oncol. 2020 05 10; 38(14):1569-1579.J Clin Oncol2020-03-11T00:00:002020Randomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for Locally Advanced Esophageal Cancer.32118743Lopez A, Harada K, Chen HC, Bhutani MS, Weston B, Lee JH, Maru DM, Chin FW, Rogers JE, Thomas I, Amlashi FG, Blum-Murphy MA, Rice DC, Zhao M, Hofstetter WL, Nguyen Q, Ajani JAMedicineTaxane-based or platinum-based combination chemotherapy given concurrently with radiation followed by surgery resulting in high cure rates in esophageal cancer patients. Medicine (Baltimore). 2020 Feb; 99(9):e19295.Medicine (Baltimore)2020-02-01T00:00:002020Taxane-based or platinum-based combination chemotherapy given concurrently with radiation followed by surgery resulting in high cure rates in esophageal cancer patients.Authorship 98046512Authorship 9806261731608938Konradsson M, van Berge Henegouwen MI, Bruns C, Chaudry MA, Cheong E, Cuesta MA, Darling GE, Gisbertz SS, Griffin SM, Gutschow CA, van Hillegersberg R, Hofstetter W, H?lscher AH, Kitagawa Y, van Lanschot JJB, Lindblad M, Ferri LE, Low DE, Luyer MDP, Ndegwa N, Mercer S, Moorthy K, Morse CR, Nafteux P, Nieuwehuijzen GAP, Pattyn P, Rosman C, Ruurda JP, R?s?nen J, Schneider PM, Schr?der W, Sgromo B, Van Veer H, Wijnhoven BPL, Nilsson MDiseases of the esophagus : official journal of the International Society for Diseases of the EsophagusDiagnostic criteria and symptom grading for delayed gastric conduit emptying after esophagectomy for cancer: international expert consensus based on a modified Delphi process. Dis Esophagus. 2020 Apr 15; 33(4).Dis Esophagus2020-04-15T00:00:002020Diagnostic criteria and symptom grading for delayed gastric conduit emptying after esophagectomy for cancer: international expert consensus based on a modified Delphi process.Authorship 9861661032229762Rice D, Rodriguez-Restrepo A, Mena G, Cata J, Thall P, Milton D, Correa A, Woodard T, Antonoff M, Hofstetter W, Roth J, Sepesi B, Swisher S, Walsh G, Vaporciyan A, Mehran RAnnals of surgeryMatched Pairs Comparison of an Enhanced Recovery Pathway Versus Conventional Management on Opioid Exposure and Pain Control in Patients Undergoing Lung Surgery. Ann Surg. 2021 12 01; 274(6):1099-1106.Ann Surg2021-12-01T00:00:002021Matched Pairs Comparison of an Enhanced Recovery Pathway Versus Conventional Management on Opioid Exposure and Pain Control in Patients Undergoing Lung Surgery.Authorship 9867276Authorship 9868125Authorship 9868261132269009Corkum JP, Garvey PB, Baumann DP, Abraham J, Liu J, Hofstetter W, Butler CE, Clemens MWJournal of plastic, reconstructive & aesthetic surgery : JPRASReconstruction of massive chest wall defects: A 20-year experience. J Plast Reconstr Aesthet Surg. 2020 Jun; 73(6):1091-1098.J Plast Reconstr Aesthet Surg2020-02-17T00:00:002020Reconstruction of massive chest wall defects: A 20-year experience.32274083Van Haren RM, Correa AM, Sepesi B, Rice DC, Hofstetter WL, Roth JA, Swisher SG, Walsh GL, Vaporciyan AA, Mehran RJ, Antonoff MBJournal of thoracic diseaseHospital readmissions after pulmonary resection: post-discharge nursing telephone assessment identifies high risk patients. J Thorac Dis. 2020 Mar; 12(3):184-190.J Thorac Dis2020-03-01T00:00:002020Hospital readmissions after pulmonary resection: post-discharge nursing telephone assessment identifies high risk patients.32274099Nelson DB, Mitchell KG, Wang J, Fujimoto J, Godoy M, Behrens C, Zheng X, Zhang J, Sepesi B, Vaporciyan AA, Hofstetter WL, Mehran RJ, Rice DC, Walsh GL, Swisher SG, Moran CA, Kalhor N, Weissferdt A, Wistuba II, Roth JA, Antonoff MBJournal of thoracic diseaseImmune regulatory markers of lepidic-pattern adenocarcinomas presenting as ground glass opacities. J Thorac Dis. 2020 Mar; 12(3):329-337.J Thorac Dis2020-03-01T00:00:002020Immune regulatory markers of lepidic-pattern adenocarcinomas presenting as ground glass opacities.Authorship 98724713Authorship 9873558Authorship 9875441732279936Weissferdt A, Pataer A, Vaporciyan AA, Correa AM, Sepesi B, Moran CA, Wistuba II, Roth JA, Shewale JB, Heymach JV, Kalhor N, Cascone T, Hofstetter WL, Lee JJ, Swisher SGClinical lung cancerAgreement on Major Pathological Response in NSCLC Patients Receiving Neoadjuvant Chemotherapy. Clin Lung Cancer. 2020 07; 21(4):341-348.Clin Lung Cancer2020-03-04T00:00:002020Agreement on Major Pathological Response in NSCLC Patients Receiving Neoadjuvant Chemotherapy.32289300Zafar SN, Blum M, Chiang YJ, Ajani JA, Estrella JS, Das P, Minsky BD, Hofstetter WL, Mansfield P, Badgwell BD, Ikoma NThe Annals of thoracic surgeryPreoperative Chemoradiation Versus Chemotherapy in Gastroesophageal Junction Adenocarcinoma. Ann Thorac Surg. 2020 08; 110(2):398-405.Ann Thorac Surg2020-04-11T00:00:002020Preoperative Chemoradiation Versus Chemotherapy in Gastroesophageal Junction Adenocarcinoma.32300858Mitchell KG, Amini B, Wang Y, Carter BW, Godoy MCB, Parra ER, Behrens C, Villalobos P, Reuben A, Lee JJ, Weissferdt A, Moran CA, Fujimoto J, Sepesi B, Walsh GL, Vaporciyan AA, Hofstetter WL, William WN, Gibbons DL, Wang J, Hwu P, Swisher SG, Piwnica-Worms D, Kadara H, Wistuba II, Heymach JV, Peng W, Cascone TCancer immunology, immunotherapy : CII18F-fluorodeoxyglucose positron emission tomography correlates with tumor immunometabolic phenotypes in resected lung cancer. Cancer Immunol Immunother. 2020 Aug; 69(8):1519-1534.Cancer Immunol Immunother2020-04-16T00:00:00202018F-fluorodeoxyglucose positron emission tomography correlates with tumor immunometabolic phenotypes in resected lung cancer.Authorship 9881762Authorship 98831119Authorship 988438832340809Corsini EM, Hofstetter WL, MD Anderson Esophageal Cancer Working GroupThe Journal of thoracic and cardiovascular surgeryKetorolac use and anastomotic leak in patients with esophageal cancer. J Thorac Cardiovasc Surg. 2021 02; 161(2):448-454.J Thorac Cardiovasc Surg2020-03-21T00:00:002020Ketorolac use and anastomotic leak in patients with esophageal cancer.32347396Harada K, Hwang H, Wang X, Abdelhakeem A, Iwatsuki M, Murphy MAB, Maru DM, Weston B, Lee JH, Rogers JE, Trail A, Shanbhag N, Zhao M, Bhutani MS, Nguyen QN, Swisher SG, Ikoma N, Das P, Hofstetter WL, Badgwell BD, Ajani JAGastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer AssociationBrain metastases in patients with upper gastrointestinal cancer is associated with proximally located adenocarcinoma and lymph node metastases. Gastric Cancer. 2020 09; 23(5):904-912.Gastric Cancer2020-04-28T00:00:002020Brain metastases in patients with upper gastrointestinal cancer is associated with proximally located adenocarcinoma and lymph node metastases.32356321Shewale JB, Corsini EM, Correa AM, Brown EL, Leon-Novelo LG, Nyitray AG, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Roth J, Walsh GL, Vaporciyan AA, Swisher SG, Sepesi BJournal of surgical oncologyTime trends and predictors of survival in surgically resected early-stage non-small cell lung cancer patients. J Surg Oncol. 2020 Sep; 122(3):495-505.J Surg Oncol2020-04-30T00:00:002020Time trends and predictors of survival in surgically resected early-stage non-small cell lung cancer patients.Authorship 990452332468580Corsini EM, Mitchell KG, Hofstetter WL, Mehran RJ, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Antonoff MB, Rice DCJournal of surgical oncologyImportance of resection for locoregional disease control in Masaoka stage IVA thymic neoplasms. J Surg Oncol. 2020 Sep; 122(3):515-522.J Surg Oncol2020-05-28T00:00:002020Importance of resection for locoregional disease control in Masaoka stage IVA thymic neoplasms.Authorship 9924601232568633Shah MA, Kennedy EB, Catenacci DV, Deighton DC, Goodman KA, Malhotra NK, Willett C, Stiles B, Sharma P, Tang L, Wijnhoven BPL, Hofstetter WLJournal of clinical oncology : official journal of the American Society of Clinical OncologyTreatment of Locally Advanced Esophageal Carcinoma: ASCO Guideline. J Clin Oncol. 2020 08 10; 38(23):2677-2694.J Clin Oncol2020-06-22T00:00:002020Treatment of Locally Advanced Esophageal Carcinoma: ASCO Guideline.Authorship 993238632619781Corsini EM, Wang Q, Tran HT, Mitchell KG, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Reuben A, Vasquez ME, Bernatchez C, Wang J, Cascone T, Zhang J, Heymach JV, Gibbons DL, Haymaker CL, Sepesi BLung cancer (Amsterdam, Netherlands)Peripheral cytokines are not influenced by the type of surgical approach for non-small cell lung cancer by four weeks postoperatively. Lung Cancer. 2020 08; 146:303-309.Lung Cancer2020-06-27T00:00:002020Peripheral cytokines are not influenced by the type of surgical approach for non-small cell lung cancer by four weeks postoperatively.Authorship 9945621532675544Harada K, Wu CC, Wang X, Mizrak Kaya D, Amlashi FG, Iwatsuki M, Blum Murphy MA, Maru DM, Weston B, Lee JH, Rogers JE, Thomas I, Shanbhag N, Bhutani MS, Hofstetter WL, Nguyen QN, Ajani JAAnnals of surgeryTotal Lesion Glycolysis Assessment Identifies a Patient Fraction With a High Cure Rate Among Esophageal Adenocarcinoma Patients Treated With Definitive Chemoradiation. Ann Surg. 2020 08; 272(2):311-318.Ann Surg2020-08-01T00:00:002020Total Lesion Glycolysis Assessment Identifies a Patient Fraction With a High Cure Rate Among Esophageal Adenocarcinoma Patients Treated With Definitive Chemoradiation.Authorship 995992132744325Hofstetter WLDiseases of the esophagus : official journal of the International Society for Diseases of the EsophagusISDE presidential Bio; Tom R DeMeester, fourth president of the ISDE. Dis Esophagus. 2020 Aug 03; 33(8).Dis Esophagus2020-08-03T00:00:002020ISDE presidential Bio; Tom R DeMeester, fourth president of the ISDE.Authorship 9981941532857997Corsini EM, Mitchell KG, Zhou N, Antonoff MB, Mehran RJ, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Maru DM, Lin SH, Ajani JA, Hofstetter WLThe Annals of thoracic surgeryModified En Bloc Esophagectomy Compared With Standard Resection After Neoadjuvant Chemoradiation. Ann Thorac Surg. 2021 04; 111(4):1133-1140.Ann Thorac Surg2020-08-25T00:00:002020Modified En Bloc Esophagectomy Compared With Standard Resection After Neoadjuvant Chemoradiation.Authorship 9984526Authorship 998635332864702Corsini EM, Weissferdt A, Pataer A, Zhou N, Antonoff MB, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Cascone T, Heymach JV, Swisher SG, Sepesi BEuropean journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic SurgeryPathological nodal disease defines survival outcomes in patients with lung cancer with tumour major pathological response following neoadjuvant chemotherapy. Eur J Cardiothorac Surg. 2021 01 04; 59(1):100-108.Eur J Cardiothorac Surg2021-01-04T00:00:002021Pathological nodal disease defines survival outcomes in patients with lung cancer with tumour major pathological response following neoadjuvant chemotherapy.32883463Zhou N, Rajaram R, Hofstetter WLSurgical oncology clinics of North AmericaManagement of Locally Advanced Esophageal Cancer. Surg Oncol Clin N Am. 2020 Oct; 29(4):631-646.Surg Oncol Clin N Am2020-07-21T00:00:002020Management of Locally Advanced Esophageal Cancer.Authorship 9999151332960264M?ller PC, Kapp JR, Vetter D, Bonavina L, Brown W, Castro S, Cheong E, Darling GE, Egberts J, Ferri L, Gisbertz SS, Gockel I, Grimminger PP, Hofstetter WL, H?lscher AH, Low DE, Luyer M, Markar SR, M?nig SP, Moorthy K, Morse CR, M?ller-Stich BP, Nafteux P, Nieponice A, Nieuwenhuijzen GAP, Nilsson M, Palanivelu C, Pattyn P, Pera M, R?s?nen J, Ribeiro U, Rosman C, Schr?der W, Sgromo B, van Berge Henegouwen MI, van Hillegersberg R, van Veer H, van Workum F, Watson DI, Wijnhoven BPL, Gutschow CADiseases of the esophagus : official journal of the International Society for Diseases of the EsophagusFit-for-Discharge Criteria after Esophagectomy: An International Expert Delphi Consensus. Dis Esophagus. 2021 Jun 14; 34(6).Dis Esophagus2021-06-14T00:00:002021Fit-for-Discharge Criteria after Esophagectomy: An International Expert Delphi Consensus.Authorship 10007786Authorship 10009191133003262Nelson DB, Niu J, Mitchell KG, Antonoff MB, Giordano SH, Hofstetter WL, Vaporciyan AA, Sepesi B, Mehran RJ, Rice DCThe Journal of thoracic and cardiovascular surgeryPerioperative outcomes among chronic opioid users who receive lobectomy for non-small cell lung cancer. J Thorac Cardiovasc Surg. 2020 02; 159(2):691-702.e5.J Thorac Cardiovasc Surg2019-09-27T00:00:002019Perioperative outcomes among chronic opioid users who receive lobectomy for non-small cell lung cancer.32980327Corsini EM, Zhou N, Antonoff MB, Mehran RJ, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Hofstetter WLThe Annals of thoracic surgeryPostoperative Bleeding and Acute Kidney Injury in Esophageal Cancer Patients Receiving Ketorolac. Ann Thorac Surg. 2021 04; 111(4):1111-1117.Ann Thorac Surg2020-09-24T00:00:002020Postoperative Bleeding and Acute Kidney Injury in Esophageal Cancer Patients Receiving Ketorolac.Authorship 1002024733010880Corsini EM, Foo WC, Mitchell KG, Zhou N, Maru DM, Ajani JA, Hofstetter WL, Esophageal Adenocarcinoma Working Group, Correa AM, Antonoff MB, Lin SH, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GLThe Journal of thoracic and cardiovascular surgeryEsophageal adenocarcinoma with any component of signet ring cells portends poor prognosis and response to neoadjuvant therapy. J Thorac Cardiovasc Surg. 2021 Nov; 162(5):1404-1412.e2.J Thorac Cardiovasc Surg2020-09-05T00:00:002020Esophageal adenocarcinoma with any component of signet ring cells portends poor prognosis and response to neoadjuvant therapy.Authorship 100427714Authorship 10043648Authorship 10044621133129774Corsini EM, Mitchell KG, Zhou N, Antonoff MB, Mehran RJ, Mena GE, Rajaram R, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Rice DC, Hofstetter WLThe Annals of thoracic surgeryLiposomal Bupivacaine Intercostal Block Is Important for Reduction of Pulmonary Complications. Ann Thorac Surg. 2021 08; 112(2):423-429.Ann Thorac Surg2020-10-28T00:00:002020Liposomal Bupivacaine Intercostal Block Is Important for Reduction of Pulmonary Complications.33138060Kim BJ, Chiang YJ, Das P, Minsky BD, Blum MA, Ajani JA, Estrella JS, Hofstetter WL, Tzeng CD, Badgwell BD, Mansfield PF, Ikoma NJournal of clinical medicineTreatment Patterns for Gastroesophageal Junction Adenocarcinoma in the United States. J Clin Med. 2020 Oct 29; 9(11).J Clin Med2020-10-29T00:00:002020Treatment Patterns for Gastroesophageal Junction Adenocarcinoma in the United States.33148307Gironda DJ, Adams DL, He J, Xu T, Gao H, Qiao Y, Komaki R, Reuben JM, Liao Z, Blum-Murphy M, Hofstetter WL, Tang CM, Lin SHJournal of translational medicineCancer associated macrophage-like cells and prognosis of esophageal cancer after chemoradiation therapy. J Transl Med. 2020 11 04; 18(1):413.J Transl Med2020-11-04T00:00:002020Cancer associated macrophage-like cells and prognosis of esophageal cancer after chemoradiation therapy.Authorship 10098021Authorship 10098441633485656Hofstetter WLThe Journal of thoracic and cardiovascular surgeryDiscussion. J Thorac Cardiovasc Surg. 2021 Mar; 161(3):842-843.J Thorac Cardiovasc Surg2021-01-21T00:00:002021Discussion.33487592Song S, Chen Q, Li Y, Lei G, Scott A, Huo L, Li CY, Estrella JS, Correa A, Pizzi MP, Ma L, Jin J, Liu B, Wang Y, Xiao L, Hofstetter WL, Lee JH, Weston B, Bhutani M, Shanbhag N, Johnson RL, Gan B, Wei S, Ajani JAGutTargeting cancer stem cells with a pan-BCL-2 inhibitor in preclinical and clinical settings in patients with gastroesophageal carcinoma. Gut. 2021 12; 70(12):2238-2248.Gut2021-01-24T00:00:002021Targeting cancer stem cells with a pan-BCL-2 inhibitor in preclinical and clinical settings in patients with gastroesophageal carcinoma.Authorship 10108454Authorship 10109171333551083Betancourt-Cuellar SL, Benveniste MFK, Palacio DP, Hofstetter WLRadiologic clinics of North AmericaEsophageal Cancer: Tumor-Node-Metastasis Staging. Radiol Clin North Am. 2021 Mar; 59(2):219-229.Radiol Clin North Am2021-03-01T00:00:002021Esophageal Cancer: Tumor-Node-Metastasis Staging.33555525Corsini EM, Mitchell KG, Zhou N, Antonoff MB, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Hofstetter WLJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary TractIntestinal Metaplasia in the Esophageal Remnant Is Rare After Ivor Lewis Esophagectomy. J Gastrointest Surg. 2021 09; 25(9):2185-2191.J Gastrointest Surg2021-02-08T00:00:002021Intestinal Metaplasia in the Esophageal Remnant Is Rare After Ivor Lewis Esophagectomy.Authorship 101181435Authorship 10123361133603241Cascone T, William WN, Weissferdt A, Leung CH, Lin HY, Pataer A, Godoy MCB, Carter BW, Federico L, Reuben A, Khan MAW, Dejima H, Francisco-Cruz A, Parra ER, Solis LM, Fujimoto J, Tran HT, Kalhor N, Fossella FV, Mott FE, Tsao AS, Blumenschein G, Le X, Zhang J, Skoulidis F, Kurie JM, Altan M, Lu C, Glisson BS, Byers LA, Elamin YY, Mehran RJ, Rice DC, Walsh GL, Hofstetter WL, Roth JA, Antonoff MB, Kadara H, Haymaker C, Bernatchez C, Ajami NJ, Jenq RR, Sharma P, Allison JP, Futreal A, Wargo JA, Wistuba II, Swisher SG, Lee JJ, Gibbons DL, Vaporciyan AA, Heymach JV, Sepesi BNature medicineNeoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial. Nat Med. 2021 03; 27(3):504-514.Nat Med2021-02-18T00:00:002021Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial.33633208Parra ER, Zhai J, Tamegnon A, Zhou N, Pandurengan RK, Barreto C, Jiang M, Rice DC, Creasy C, Vaporciyan AA, Hofstetter WL, Tsao AS, Wistuba II, Sepesi B, Haymaker CScientific reportsIdentification of distinct immune landscapes using an automated nine-color multiplex immunofluorescence staining panel and image analysis in paraffin tumor tissues. Sci Rep. 2021 02 25; 11(1):4530.Sci Rep2021-02-25T00:00:002021Identification of distinct immune landscapes using an automated nine-color multiplex immunofluorescence staining panel and image analysis in paraffin tumor tissues.Authorship 1013450433684226Feldman HA, Zhou N, Antonoff MB, Hofstetter WL, Rajaram R, Rice DC, Sepesi B, Vaporciyan AA, Zorrilla-Vaca A, Mehran RJJournal of surgical oncologySimultaneous versus staged resections for bilateral pulmonary metastases. J Surg Oncol. 2021 Jun; 123(7):1633-1639.J Surg Oncol2021-03-08T00:00:002021Simultaneous versus staged resections for bilateral pulmonary metastases.Authorship 10137181433127408Bryan DS, Ferguson MK, Antonoff MB, Backhus LM, Birdas TJ, Blackmon SH, Boffa DJ, Chang AC, Chmielewski GW, Cooke DT, Donington JS, Gaissert HA, Hagen JA, Hofstetter WL, Kent MS, Kim KW, Krantz SB, Lin J, Martin LW, Meyerson SL, Mitchell JD, Molena D, Odell DD, Onaitis MW, Puri V, Putnam JB, Seder CW, Shrager JB, Soukiasian HJ, Stiles BM, Tong BC, Veeramachaneni NKThe Annals of thoracic surgeryConsensus for Thoracoscopic Left Upper Lobectomy-Essential Components and Targets for Simulation. Ann Thorac Surg. 2021 08; 112(2):436-442.Ann Thorac Surg2020-10-27T00:00:002020Consensus for Thoracoscopic Left Upper Lobectomy-Essential Components and Targets for Simulation.Authorship 1014406433755097Kamarajah SK, Phillips AW, Ferri L, Hofstetter WL, Markar SRThe British journal of surgeryNeoadjuvant chemoradiotherapy or chemotherapy alone for oesophageal cancer: population-based cohort study. Br J Surg. 2021 04 30; 108(4):403-411.Br J Surg2021-04-30T00:00:002021Neoadjuvant chemoradiotherapy or chemotherapy alone for oesophageal cancer: population-based cohort study.Authorship 1015324533774003Olive JK, Zhou N, Mitchell KG, Corsini EM, Hofstetter WL, Mehran RJ, Rice DC, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Antonoff MBThe Annals of thoracic surgeryImpact of Psychiatric Comorbidities on Surgical Outcomes for Non-Small Cell Lung?Cancer. Ann Thorac Surg. 2022 03; 113(3):1008-1014.Ann Thorac Surg2021-03-25T00:00:002021Impact of Psychiatric Comorbidities on Surgical Outcomes for Non-Small Cell Lung?Cancer.Authorship 1016084433838123Zhou N, Corsini EM, Antonoff MB, Hofstetter WL, Mehran RJ, Rajaram R, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Rice DCThe Annals of thoracic surgeryRobotic Surgery and Anatomic Segmentectomy: An Analysis of Trends, Patient Selection, and Outcomes. Ann Thorac Surg. 2022 03; 113(3):975-983.Ann Thorac Surg2021-04-07T00:00:002021Robotic Surgery and Anatomic Segmentectomy: An Analysis of Trends, Patient Selection, and Outcomes.Authorship 10171201133905733Zhao H, Misariu AM, Ramirez-GarciaLuna JL, Nobel T, Mueller C, Cools-Lartigue J, Spicer J, Molena D, Bains M, Swisher S, Hofstetter W, Ferri LThe Annals of thoracic surgerySynchronous Esophageal and Lung Cancers-Is Combined Anatomic Resection Appropriate? Ann Thorac Surg. 2022 04; 113(4):1354-1360.Ann Thorac Surg2021-04-24T00:00:002021Synchronous Esophageal and Lung Cancers-Is Combined Anatomic Resection Appropriate?Authorship 1018192833971174Zhou N, Rice DC, Tsao AS, Lee PP, Haymaker CL, Corsini EM, Antonoff MB, Hofstetter WL, Rajaram R, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Mehran RJ, Sepesi BThe Annals of thoracic surgeryExtrapleural Pneumonectomy Versus Pleurectomy/Decortication for Malignant Pleural Mesothelioma. Ann Thorac Surg. 2022 01; 113(1):200-208.Ann Thorac Surg2021-05-08T00:00:002021Extrapleural Pneumonectomy Versus Pleurectomy/Decortication for Malignant Pleural Mesothelioma.true1Associate ProfessorAssociate ProfessorAuthorship 1020005634057733Corsini EM, Mitchell KG, Zhou N, Bernatchez C, Forget MA, Haymaker CL, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Amaria RN, Jazaeri AA, Antonoff MBJournal of surgical oncologyPulmonary resection for tissue harvest in adoptive tumor-infiltrating lymphocyte therapy: Safety and feasibility. J Surg Oncol. 2021 Sep; 124(4):699-703.J Surg Oncol2021-05-31T00:00:002021Pulmonary resection for tissue harvest in adoptive tumor-infiltrating lymphocyte therapy: Safety and feasibility.Authorship 10205871534095952Zhou N, Mitchell KG, Corsini EM, Truong VTT, Antonoff MB, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Ajani JA, Hofstetter WLThe British journal of surgeryAnalysis of trimodal and bimodal therapy in a selective-surgery paradigm for locally advanced oesophageal squamous cell carcinoma. Br J Surg. 2021 10 23; 108(10):1207-1215.Br J Surg2021-10-23T00:00:002021Analysis of trimodal and bimodal therapy in a selective-surgery paradigm for locally advanced oesophageal squamous cell carcinoma.Authorship 102379320Authorship 1024194334160587D'Journo XB, Boulate D, Fourdrain A, Loundou A, van Berge Henegouwen MI, Gisbertz SS, O'Neill JR, Hoelscher A, Piessen G, van Lanschot J, Wijnhoven B, Jobe B, Davies A, Schneider PM, Pera M, Nilsson M, Nafteux P, Kitagawa Y, Morse CR, Hofstetter W, Molena D, So JB, Immanuel A, Parsons SL, Larsen MH, Dolan JP, Wood SG, Maynard N, Smithers M, Puig S, Law S, Wong I, Kennedy A, KangNing W, Reynolds JV, Pramesh CS, Ferguson M, Darling G, Schr?der W, Bludau M, Underwood T, van Hillegersberg R, Chang A, Cecconello I, Ribeiro U, de Manzoni G, Rosati R, Kuppusamy M, Thomas PA, Low DE, International Esodata Study GroupJAMA surgeryRisk Prediction Model of 90-Day Mortality After Esophagectomy for Cancer. JAMA Surg. 2021 09 01; 156(9):836-845.JAMA Surg2021-09-01T00:00:002021Risk Prediction Model of 90-Day Mortality After Esophagectomy for Cancer.34191461van der Wilk BJ, Eyck BM, Hofstetter WL, Ajani JA, Piessen G, Castoro C, Alfieri R, Kim JH, Kim SB, Furlong H, Walsh TN, Nieboer D, Wijnhoven BPL, Lagarde SM, Lanschot JJBVAnnals of surgeryChemoradiotherapy Followed by Active Surveillance Versus Standard Esophagectomy for Esophageal Cancer: A Systematic Review and Individual Patient Data Meta-analysis. Ann Surg. 2022 03 01; 275(3):467-476.Ann Surg2022-03-01T00:00:002022Chemoradiotherapy Followed by Active Surveillance Versus Standard Esophagectomy for Esophageal Cancer: A Systematic Review and Individual Patient Data Meta-analysis.Authorship 10249202Authorship 1024995434252403Blumenthaler AN, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Strange CD, Antonoff MBThe Annals of thoracic surgeryPreoperative Maximum Standardized Uptake Value Associated With Recurrence Risk in Early Lung Cancer. Ann Thorac Surg. 2022 06; 113(6):1835-1844.Ann Thorac Surg2021-07-09T00:00:002021Preoperative Maximum Standardized Uptake Value Associated With Recurrence Risk in Early Lung Cancer.34255246Kamarajah SK, Phillips AW, Griffiths EA, Ferri L, Hofstetter WL, Markar SRAnnals of surgical oncologyEsophagectomy or Total Gastrectomy for Siewert 2 Gastroesophageal Junction (GEJ) Adenocarcinoma? A Registry-Based Analysis. Ann Surg Oncol. 2021 Dec; 28(13):8485-8494.Ann Surg Oncol2021-07-13T00:00:002021Esophagectomy or Total Gastrectomy for Siewert 2 Gastroesophageal Junction (GEJ) Adenocarcinoma? A Registry-Based Analysis.Authorship 10268971434358522Bayley EM, Zhou N, Mitchell KG, Antonoff MB, Mehran RJ, Rice DC, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Cinciripini PM, Karam-Hage M, Roth JA, Hofstetter WLThe Annals of thoracic surgeryModern Perioperative Practices May Mitigate Effects of Continued Smoking Among Lung Cancer Patients. Ann Thorac Surg. 2022 07; 114(1):286-292.Ann Thorac Surg2021-08-03T00:00:002021Modern Perioperative Practices May Mitigate Effects of Continued Smoking Among Lung Cancer Patients.Authorship 1027959234406872Shah MA, Hofstetter WL, Kennedy EB, Locally Advanced Esophageal Carcinoma Guideline Expert PanelJournal of clinical oncology : official journal of the American Society of Clinical OncologyImmunotherapy in Patients With Locally Advanced Esophageal Carcinoma: ASCO Treatment of Locally Advanced Esophageal Carcinoma Guideline Rapid Recommendation Update. J Clin Oncol. 2021 10 01; 39(28):3182-3184.J Clin Oncol2021-08-18T00:00:002021Immunotherapy in Patients With Locally Advanced Esophageal Carcinoma: ASCO Treatment of Locally Advanced Esophageal Carcinoma Guideline Rapid Recommendation Update.Authorship 1029278434494925Blumenthaler AN, Zhou N, Parikh K, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Antonoff MBInnovations (Philadelphia, Pa.)Optimizing Discharge After Shorter Hospitalizations: Lessons Learned Through After-Hours Calls with Thoracic Surgical Patients. Innovations (Phila). 2021 Nov-Dec; 16(6):529-535.Innovations (Phila)2021-09-08T00:00:002021Optimizing Discharge After Shorter Hospitalizations: Lessons Learned Through After-Hours Calls with Thoracic Surgical Patients.Authorship 10313921234634240Feldman HA, Erasmus JJ, Zhou N, Antonoff MB, Mehran RJ, Rajaram R, Rice DC, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Hofstetter WL, Betancourt Cuellar SLThe Annals of thoracic surgeryClinical Significance of [18F] Fluoro-2-Deoxy-d-Glucose/Computed Tomographic Avid Hilar Lymph Nodes in Esophageal Carcinoma Patients. Ann Thorac Surg. 2022 10; 114(4):1183-1188.Ann Thorac Surg2021-10-09T00:00:002021Clinical Significance of [18F] Fluoro-2-Deoxy-d-Glucose/Computed Tomographic Avid Hilar Lymph Nodes in Esophageal Carcinoma Patients.Authorship 10322591834688617Erwin PA, Lee AC, Ahmad U, Antonoff M, Arndt A, Backhus L, Berry M, Birdas T, Cassivi SD, Chang AC, Cooke DT, Crabtree T, DeCamp M, Donington J, Fernandez F, Force S, Gaissert H, Hofstetter W, Huang J, Kent M, Kim AW, Lin J, Martin LW, Meyerson S, Mitchell JD, Molena D, Odell D, Onaitis M, Puri V, Putnam JB, Reddy R, Schipper P, Seder CW, Shrager J, Tong B, Veeramachaneni N, Watson T, Whyte R, Ferguson MKThe Annals of thoracic surgeryConsensus for Thoracoscopic Lower Lobectomy: Essential Components and Targets for Simulation. Ann Thorac Surg. 2022 11; 114(5):1895-1901.Ann Thorac Surg2021-10-21T00:00:002021Consensus for Thoracoscopic Lower Lobectomy: Essential Components and Targets for Simulation.Authorship 1033757634740455Zorrilla-Vaca A, Rice D, Brown JK, Antonoff M, Sepesi B, Hofstetter W, Swisher S, Walsh G, Vaporciyan A, Mehran R, Hagberg C, Mena GESurgerySustained reduction of discharge opioid prescriptions in an enhanced recovery after thoracic surgery program: A multilevel generalized linear model. Surgery. 2022 02; 171(2):504-510.Surgery2021-11-02T00:00:002021Sustained reduction of discharge opioid prescriptions in an enhanced recovery after thoracic surgery program: A multilevel generalized linear model.Authorship 1034809634839424Kamarajah SK, Griffiths EA, Phillips AW, Ruurda J, van Hillegersberg R, Hofstetter WL, Markar SRAnnals of surgical oncologyASO Author Reflections: Modern-Day Implementation of Robotic Esophagogastric Cancer Surgery. Ann Surg Oncol. 2022 05; 29(5):2826-2827.Ann Surg Oncol2021-11-27T00:00:002021ASO Author Reflections: Modern-Day Implementation of Robotic Esophagogastric Cancer Surgery.Authorship 10351312Authorship 1035211634883083Zhou N, Hofstetter WL, Esophageal Squamous Cell Carcinoma Working Group, Mitchell KG, Bayley EM, Ajani JA, Antonoff MB, Betancourt SL, Blum-Murphy M, Feldman HA, Lin SH, Maru DM, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Weston BRThe Annals of thoracic surgerySalvage Esophagectomy Definition Influences Comparative Outcomes in Esophageal Squamous Cell Cancers. Ann Thorac Surg. 2022 12; 114(6):2032-2040.Ann Thorac Surg2021-12-06T00:00:002021Salvage Esophagectomy Definition Influences Comparative Outcomes in Esophageal Squamous Cell Cancers.34890023Kamarajah SK, Griffiths EA, Phillips AW, Ruurda J, van Hillegersberg R, Hofstetter WL, Markar SRAnnals of surgical oncologyRobotic Techniques in Esophagogastric Cancer Surgery: An Assessment of Short- and Long-Term Clinical Outcomes. Ann Surg Oncol. 2022 May; 29(5):2812-2825.Ann Surg Oncol2021-12-10T00:00:002021Robotic Techniques in Esophagogastric Cancer Surgery: An Assessment of Short- and Long-Term Clinical Outcomes.Authorship 10353715Authorship 103542014Authorship 1035816434894636Zorrilla-Vaca A, Feldman H, Antonoff M, Sepesi B, Hofstetter W, Rajaram R, Swisher S, Mena G, Vaporciya A, Mehran R, Rice DThe Thoracic and cardiovascular surgeonSingle Chest Drain Practice Reduces Discharge Opioid Prescriptions in Thoracic Surgery. Thorac Cardiovasc Surg. 2022 08; 70(5):422-429.Thorac Cardiovasc Surg2021-12-11T00:00:002021Single Chest Drain Practice Reduces Discharge Opioid Prescriptions in Thoracic Surgery.34897440Bostock IC, Zhou N, Antonoff MB, Murphy MB, Lin S, Maru D, Mehran R, Rajaram R, Rice D, Sepesi B, Swisher S, Vaporciyan A, Walsh G, Hofstetter WDiseases of the esophagus : official journal of the International Society for Diseases of the EsophagusProlonged neutrophilia is associated with worse outcomes after Esophagectomy. Dis Esophagus. 2022 Apr 19; 35(4).Dis Esophagus2022-04-19T00:00:002022Prolonged neutrophilia is associated with worse outcomes after Esophagectomy.34933771Zhou N, Lee KH, Pedroza C, Hofstetter WLThe Journal of thoracic and cardiovascular surgeryBayesian post-hoc analysis of chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Thorac Cardiovasc Surg. 2022 09; 164(3):688-693.e1.J Thorac Cardiovasc Surg2021-11-29T00:00:002021Bayesian post-hoc analysis of chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus.Authorship 10382418Authorship 103953015Authorship 10398622Authorship 10400427Authorship 10404192Authorship 10407943Authorship 104086513Authorship 1041536635130500Ajani JA, D'Amico TA, Bentrem DJ, Chao J, Cooke D, Corvera C, Das P, Enzinger PC, Enzler T, Fanta P, Farjah F, Gerdes H, Gibson MK, Hochwald S, Hofstetter WL, Ilson DH, Keswani RN, Kim S, Kleinberg LR, Klempner SJ, Lacy J, Ly QP, Matkowskyj KA, McNamara M, Mulcahy MF, Outlaw D, Park H, Perry KA, Pimiento J, Poultsides GA, Reznik S, Roses RE, Strong VE, Su S, Wang HL, Wiesner G, Willett CG, Yakoub D, Yoon H, McMillian N, Pluchino LAJournal of the National Comprehensive Cancer Network : JNCCNGastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022 02; 20(2):167-192.J Natl Compr Canc Netw2022-02-01T00:00:002022Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.35038676Deboever N, McGrail DJ, Lee Y, Tran HT, Mitchell KG, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Bernatchez C, Vailati Negrao M, Zhang J, Wistuba II, Heymach JV, Cascone T, Gibbons DL, Haymaker CL, Sepesi BLung cancer (Amsterdam, Netherlands)Surgical approach does not influence changes in circulating immune cell populations following lung cancer resection. Lung Cancer. 2022 02; 164:69-75.Lung Cancer2022-01-08T00:00:002022Surgical approach does not influence changes in circulating immune cell populations following lung cancer resection.35190177Sepesi B, Zhou N, William WN, Lin HY, Leung CH, Weissferdt A, Mitchell KG, Pataer A, Walsh GL, Rice DC, Roth JA, Mehran RJ, Hofstetter WL, Antonoff MB, Rajaram R, Negrao MV, Tsao AS, Gibbons DL, Lee JJ, Heymach JV, Vaporciyan AA, Swisher SG, Cascone TThe Journal of thoracic and cardiovascular surgerySurgical outcomes after neoadjuvant nivolumab or nivolumab with ipilimumab in patients with non-small cell lung cancer. J Thorac Cardiovasc Surg. 2022 11; 164(5):1327-1337.J Thorac Cardiovasc Surg2022-01-23T00:00:002022Surgical outcomes after neoadjuvant nivolumab or nivolumab with ipilimumab in patients with non-small cell lung cancer.35279419Pieretti AC, Ozambela M, Westerman ME, Nogueras-Gonzalez GM, Segarra LA, Zacharias NM, Vaporciyan A, Hofstetter W, Huynh T, Aldousari S, Matin SF, Karam JAClinical genitourinary cancerPredictors of Survival in Patients Undergoing Surgery for Renal Cell Carcinoma and Inferior Vena Cava Tumor Thrombus. Clin Genitourin Cancer. 2022 08; 20(4):e330-e338.Clin Genitourin Cancer2022-02-09T00:00:002022Predictors of Survival in Patients Undergoing Surgery for Renal Cell Carcinoma and Inferior Vena Cava Tumor Thrombus.35184889De Silva Sewastjanow M, Rogers JE, Hofstetter WL, Ajani JAThe Journal of thoracic and cardiovascular surgeryEsophageal cancer: Is the CROSS strategy ready for history books? J Thorac Cardiovasc Surg. 2023 03; 165(3):901-905.J Thorac Cardiovasc Surg2022-01-22T00:00:002022Esophageal cancer: Is the CROSS strategy ready for history books?35070369Bostock IC, Hofstetter W, Mehran R, Rajaram R, Rice D, Sepesi B, Swisher S, Vaporciyan A, Walsh G, Antonoff MBJournal of thoracic diseaseBarriers to surveillance imaging adherence in early-staged lung cancer. J Thorac Dis. 2021 Dec; 13(12):6848-6854.J Thorac Dis2021-12-01T00:00:002021Barriers to surveillance imaging adherence in early-staged lung cancer.35157612Schaverien MV, Hofstetter WL, Hall MS, Chen DN, Selber JCPlastic and reconstructive surgeryJejunal Mesenteric Vascularized Lymph Node Transplantation for Lymphedema: Outcomes and Technical Modifications. Plast Reconstr Surg. 2022 Apr 01; 149(4):700e-710e.Plast Reconstr Surg2022-04-01T00:00:002022Jejunal Mesenteric Vascularized Lymph Node Transplantation for Lymphedema: Outcomes and Technical Modifications.35252897Antonoff MB, Feldman HA, Mitchell KG, Farooqi A, Ludmir EB, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Sepesi B, Swisher SG, Walsh GL, Gandhi S, Gomez DR, Vaporciyan AAJTO clinical and research reportsSurgical Complexity of Pulmonary Resections Performed for Oligometastatic NSCLC. JTO Clin Res Rep. 2022 Mar; 3(3):100288.JTO Clin Res Rep2022-02-04T00:00:002022Surgical Complexity of Pulmonary Resections Performed for Oligometastatic NSCLC.Authorship 1043815435414141Khaitan PG, Holliday T, Carroll A, Hofstetter WL, Bayley EM, Zhou N, Desale S, Watson TJJournal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary TractCan Clinical Response Predict Pathologic Response Following Neoadjuvant Chemoradiation for Esophageal Cancer? J Gastrointest Surg. 2022 07; 26(7):1345-1351.J Gastrointest Surg2022-04-12T00:00:002022Can Clinical Response Predict Pathologic Response Following Neoadjuvant Chemoradiation for Esophageal Cancer?Authorship 1044824335489217Deboever N, Feldman HA, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Antonoff MBThe Journal of surgical researchThe Role of Surgery in the Treatment of Melanoma Pulmonary Metastases in the Modern Era. J Surg Res. 2022 09; 277:125-130.J Surg Res2022-04-27T00:00:002022The Role of Surgery in the Treatment of Melanoma Pulmonary Metastases in the Modern Era.Authorship 1051020435861351Cools-Lartigue J, Markar S, Mueller C, Hofstetter W, Nilsson M, Ilonen I, Soderstrom H, Rasanen J, Gisbertz S, Hanna GB, Elliott J, Reynolds J, Kisiel A, Griffiths E, Van Berge Henegouwen M, Ferri LAnnals of surgeryAn International Cohort Study of Prognosis Associated With Pathologically Complete Response Following Neoadjuvant Chemotherapy Versus Chemoradiotherapy of Surgical Treated Esophageal Adenocarcinoma. Ann Surg. 2022 11 01; 276(5):799-805.Ann Surg2022-07-21T00:00:002022An International Cohort Study of Prognosis Associated With Pathologically Complete Response Following Neoadjuvant Chemotherapy Versus Chemoradiotherapy of Surgical Treated Esophageal Adenocarcinoma.Authorship 10543344Authorship 10603622Authorship 106051411Authorship 10618085Authorship 105446913Authorship 10571582Authorship 106174218Authorship 10600242Authorship 10625064Authorship 10608846Authorship 1057424735926641Mills AC, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Antonoff MBThe Annals of thoracic surgeryRepeated Pulmonary Metastasectomy: Third?Operations and Beyond. Ann Thorac Surg. 2023 03; 115(3):679-685.Ann Thorac Surg2022-08-02T00:00:002022Repeated Pulmonary Metastasectomy: Third?Operations and Beyond.36562692Betancourt Cuellar SL, Benveniste MF, Truong M, Nguyen QN, Atiyah A, Hofstetter WL, Erasmus JJAmerican journal of clinical oncologyLiver Injury in Patients With Distal Esophageal Carcinoma After Precision Radiation Therapy: Systematic Review of FDG-PET/CT Patterns. Am J Clin Oncol. 2023 01 01; 46(1):25-30.Am J Clin Oncol2022-11-16T00:00:002022Liver Injury in Patients With Distal Esophageal Carcinoma After Precision Radiation Therapy: Systematic Review of FDG-PET/CT Patterns.36412619Vassilakopoulou M, Chen HC, Wang X, Harada K, Iwatsuki M, Das P, Blum Murphy M, Matamoros A, Sagebiel T, Devine C, Thomas I, Sanders EM, Shanbhag N, Rogers JE, Lee JH, Weston B, Bhutani MS, Hofstetter W, Nguyen QN, Badgwell BD, Ajani JAOncologyLocalized Gastroesophageal Adenocarcinoma in the Elderly: Is Age a Factor Associated with Suboptimal Treatment? Oncology. 2023; 101(3):153-158.Oncology2022-11-21T00:00:002022Localized Gastroesophageal Adenocarcinoma in the Elderly: Is Age a Factor Associated with Suboptimal Treatment?36052678Bayley EM, Ivy ML, Shewale JB, Ge PS, Antonoff MB, Francis AM, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Vaporciyan AA, Walsh GL, Lee JJ, Louie BE, Swisher SGAnnals of surgeryHigh-Risk Features of Esophageal Adenocarcinoma Following Neoadjuvant Chemoradiation: Patients for Whom Surgery Should Not Be Delayed. Ann Surg. 2023 05 01; 277(5):721-726.Ann Surg2022-09-02T00:00:002022High-Risk Features of Esophageal Adenocarcinoma Following Neoadjuvant Chemoradiation: Patients for Whom Surgery Should Not Be Delayed.36524701Shenson JA, Zafereo ME, Lee M, Contrera KJ, Feng L, Boonsripitayanon M, Gross N, Goepfert R, Maniakas A, Wang JR, Grubbs L, Vaporciyan A, Hofstetter W, Swisher S, Mehran R, Rice D, Sepesi B, Antonoff M, Cabanillas M, Busaidy N, Dadu R, Silver NLHead & neckClinical outcomes of combined cervical and transthoracic surgical approaches in patients with advanced thyroid cancer. Head Neck. 2023 03; 45(3):547-554.Head Neck2022-12-16T00:00:002022Clinical outcomes of combined cervical and transthoracic surgical approaches in patients with advanced thyroid cancer.36590745Feldman HA, Zhou N, Deboever N, Hofstetter W, Mehran R, Rajaram R, Rice D, Roth JA, Sepesi B, Swisher S, Vaporciyan A, Walsh G, Godoy M, Strange C, Antonoff MBJTCVS openIntraoperative challenges after induction therapy for non-small cell lung cancer: Effect of nodal disease on technical complexity. JTCVS Open. 2022 Dec; 12:372-384.JTCVS Open2022-10-25T00:00:002022Intraoperative challenges after induction therapy for non-small cell lung cancer: Effect of nodal disease on technical complexity.36607524Deboever N, Hofstetter WLAnnals of surgical oncologyFrom NLR to TIN: What Can't Neutrophils Tell Us About Prognosis in Resectable Esophageal Cancer? Ann Surg Oncol. 2023 03; 30(3):1295-1296.Ann Surg Oncol2023-01-06T00:00:002023From NLR to TIN: What Can't Neutrophils Tell Us About Prognosis in Resectable Esophageal Cancer?36404141Nelson DB, Mehran RJ, Mena GE, Hofstetter WL, Vaporciyan AA, Antonoff MB, Rice DCThe Journal of thoracic and cardiovascular surgeryEnhanced recovery after surgery improves postdischarge recovery after pulmonary lobectomy. J Thorac Cardiovasc Surg. 2023 05; 165(5):1731-1740.e5.J Thorac Cardiovasc Surg2022-10-26T00:00:002022Enhanced recovery after surgery improves postdischarge recovery after pulmonary lobectomy.36519935Shargall Y, Wiercioch W, Brunelli A, Murthy S, Hofstetter W, Lin J, Li H, Linkins LA, Crowther M, Davis R, Rocco G, Morgano GP, Sch?nemann F, Muti-Sch?nemann G, Douketis J, Sch?nemann HJ, Litle VREuropean journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic SurgeryJoint 2022 European Society of Thoracic Surgeons and The American Association for Thoracic Surgery guidelines for the prevention of cancer-associated venous thromboembolism in thoracic surgery. Eur J Cardiothorac Surg. 2022 Dec 02; 63(1).Eur J Cardiothorac Surg2022-12-02T00:00:002022Joint 2022 European Society of Thoracic Surgeons and The American Association for Thoracic Surgery guidelines for the prevention of cancer-associated venous thromboembolism in thoracic surgery.36497224Bhutani MS, Ejaz S, Cazacu IM, Singh BS, Shafi M, Stroehlein JR, Mehran RJ, Walsh G, Vaporciyan A, Swisher SG, Hofstetter WCancersEndoscopic Intrapyloric Botulinum Toxin Injection with Pyloric Balloon Dilation for Symptoms of Delayed Gastric Emptying after Distal Esophagectomy for Esophageal Cancer: A 10-Year Experience. Cancers (Basel). 2022 Nov 23; 14(23).Cancers (Basel)2022-11-23T00:00:002022Endoscopic Intrapyloric Botulinum Toxin Injection with Pyloric Balloon Dilation for Symptoms of Delayed Gastric Emptying after Distal Esophagectomy for Esophageal Cancer: A 10-Year Experience.36609126Eisenberg MA, Hofstetter WLThe Journal of thoracic and cardiovascular surgeryCommentary: Complexity in rare disease: A look at surgical outcomes in tracheobronchial adenoid cystic carcinoma. J Thorac Cardiovasc Surg. 2023 06; 165(6):1965-1966.J Thorac Cardiovasc Surg2022-12-15T00:00:002022Commentary: Complexity in rare disease: A look at surgical outcomes in tracheobronchial adenoid cystic carcinoma.Authorship 1063018536737380Zhou N, Bell CS, Feldman HA, Haymaker CL, Hofstetter WL, Tsao AS, Mehran RJ, Rice DC, Sepesi B, Mesothelioma Immune Genomic GroupThe Journal of thoracic and cardiovascular surgeryTumor thickness in mesothelioma predicts differential response to neoadjuvant therapy and survival. J Thorac Cardiovasc Surg. 2023 08; 166(2):362-371.e9.J Thorac Cardiovasc Surg2022-12-14T00:00:002022Tumor thickness in mesothelioma predicts differential response to neoadjuvant therapy and survival.Authorship 1064443636801207Zhou N, Niu J, Nelson D, Feldman HA, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Sepesi B, Swisher SG, Walsh GL, Giordano SH, Rajaram RThe Annals of thoracic surgerySurgical Approach and Persistent Opioid Use in Medicare Patients Undergoing Lung Cancer Resection. Ann Thorac Surg. 2023 Nov; 116(5):1020-1027.Ann Thorac Surg2023-02-16T00:00:002023Surgical Approach and Persistent Opioid Use in Medicare Patients Undergoing Lung Cancer Resection.Authorship 1065456536895083Shargall Y, Wiercioch W, Brunelli A, Murthy S, Hofstetter W, Lin J, Li H, Linkins LA, Crowther M, Davis R, Rocco G, Morgano GP, Sch?nemann F, Muti-Sch?nemann G, Douketis J, Sch?nemann HJ, Litle VRThe Journal of thoracic and cardiovascular surgeryJoint 2022 European Society of Thoracic Surgeons and The American Association for Thoracic Surgery guidelines for the prevention of cancer-associated venous thromboembolism in thoracic surgery. J Thorac Cardiovasc Surg. 2023 03; 165(3):794-824.e6.J Thorac Cardiovasc Surg2022-12-15T00:00:002022Joint 2022 European Society of Thoracic Surgeons and The American Association for Thoracic Surgery guidelines for the prevention of cancer-associated venous thromboembolism in thoracic surgery.Authorship 10656683736928818Cascone T, Leung CH, Weissferdt A, Pataer A, Carter BW, Godoy MCB, Feldman H, William WN, Xi Y, Basu S, Sun JJ, Yadav SS, Rojas Alvarez FR, Lee Y, Mishra AK, Chen L, Pradhan M, Guo H, Sinjab A, Zhou N, Negrao MV, Le X, Gay CM, Tsao AS, Byers LA, Altan M, Glisson BS, Fossella FV, Elamin YY, Blumenschein G, Zhang J, Skoulidis F, Wu J, Mehran RJ, Rice DC, Walsh GL, Hofstetter WL, Rajaram R, Antonoff MB, Fujimoto J, Solis LM, Parra ER, Haymaker C, Wistuba II, Swisher SG, Vaporciyan AA, Lin HY, Wang J, Gibbons DL, Jack Lee J, Ajami NJ, Wargo JA, Allison JP, Sharma P, Kadara H, Heymach JV, Sepesi BNature medicineNeoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial. Nat Med. 2023 03; 29(3):593-604.Nat Med2023-03-16T00:00:002023Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial.Authorship 10680385Authorship 106837713Authorship 10681561837015332Ajani JA, D'Amico TA, Bentrem DJ, Cooke D, Corvera C, Das P, Enzinger PC, Enzler T, Farjah F, Gerdes H, Gibson M, Grierson P, Hofstetter WL, Ilson DH, Jalal S, Keswani RN, Kim S, Kleinberg LR, Klempner S, Lacy J, Licciardi F, Ly QP, Matkowskyj KA, McNamara M, Miller A, Mukherjee S, Mulcahy MF, Outlaw D, Perry KA, Pimiento J, Poultsides GA, Reznik S, Roses RE, Strong VE, Su S, Wang HL, Wiesner G, Willett CG, Yakoub D, Yoon H, McMillian NR, Pluchino LAJournal of the National Comprehensive Cancer Network : JNCCNEsophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2023 04; 21(4):393-422.J Natl Compr Canc Netw2023-04-01T00:00:002023Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.37116780Deboever N, Correa AM, Feldman H, Mathur U, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Sepesi B, Swisher SG, Walsh GL, Vaporciyan AA, Antonoff MB, Rajaram RThe Journal of thoracic and cardiovascular surgeryDisparities in early-stage lung cancer outcomes at minority-serving hospitals compared with nonminority serving hospitals. J Thorac Cardiovasc Surg. 2024 Jan; 167(1):329-337.e4.J Thorac Cardiovasc Surg2023-04-26T00:00:002023Disparities in early-stage lung cancer outcomes at minority-serving hospitals compared with nonminority serving hospitals.37080372Mitchell KG, Bayley EM, Ikoma N, Antonoff MB, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Maru DM, Erasmus JJ, Weston BR, Ajani JA, Badgwell BD, Hofstetter WLThe Annals of thoracic surgeryGastric Extent of Tumor Predicts Peritoneal Metastasis in Siewert II Adenocarcinoma. Ann Thorac Surg. 2024 Feb; 117(2):320-326.Ann Thorac Surg2023-04-18T00:00:002023Gastric Extent of Tumor Predicts Peritoneal Metastasis in Siewert II Adenocarcinoma.Authorship 10728694Authorship 1073432237356476Deboever N, Eisenberg MA, Antonoff MB, Hofstetter WL, Mehran RJ, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Rajaram RThe Journal of thoracic and cardiovascular surgeryPerspectives, risk factors, and coping mechanisms in patients with self-reported financial burden following lung cancer surgery. J Thorac Cardiovasc Surg. 2024 Feb; 167(2):478-487.e2.J Thorac Cardiovasc Surg2023-06-24T00:00:002023Perspectives, risk factors, and coping mechanisms in patients with self-reported financial burden following lung cancer surgery.37249193Deboever N, Eisenberg M, Hofstetter WL, Mehran RJ, Rice DC, Roth J, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Antonoff MB, Rajaram RAnnals of surgeryFinancial Toxicity in Patients With Resected Lung Cancer. Ann Surg. 2023 12 01; 278(6):1038-1044.Ann Surg2023-05-30T00:00:002023Financial Toxicity in Patients With Resected Lung Cancer.Authorship 10748623237477039Chidambaram S, Owen R, Sgromo B, Chmura M, Kisiel A, Evans R, Griffiths EA, Castoro C, Gronnier C, MaoAwyes MA, Gutschow CA, Piessen G, Degisors S, Alvieri R, Feldman H, Capovilla G, Grimminger PP, Han S, Low DE, Moore J, Gossage J, Voeten D, Gisbertz SS, Ruurda J, van Hillegersberg R, D'Journo XB, Chmelo J, Phillips AW, Rosati R, Hanna GB, Maynard N, Hofstetter W, Ferri L, Berge Henegouwen MI, Markar SRAnnals of surgeryDelayed Surgical Intervention After Chemoradiotherapy in Esophageal Cancer: (DICE) Study. Ann Surg. 2023 11 01; 278(5):701-708.Ann Surg2023-07-21T00:00:002023Delayed Surgical Intervention After Chemoradiotherapy in Esophageal Cancer: (DICE) Study.Authorship 1075640437495170Deboever N, Bayley EM, Eisenberg MA, Hofstetter WL, Mehran RJ, Rice DC, Rajaram R, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Bednarski BK, Morris VK, Antonoff MBThe Journal of thoracic and cardiovascular surgeryLung surveillance following colorectal cancer pulmonary metastasectomy: Utilization of clinicopathologic risk factors to guide strategy. J Thorac Cardiovasc Surg. 2024 Mar; 167(3):814-819.e2.J Thorac Cardiovasc Surg2023-07-24T00:00:002023Lung surveillance following colorectal cancer pulmonary metastasectomy: Utilization of clinicopathologic risk factors to guide strategy.Authorship 107896211Authorship 10775245Authorship 10790395Authorship 1078755537619884Deboever N, Mitchell KG, Farooqi A, Ludmir EB, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Heymach JV, Gomez DR, Gandhi SJ, Antonoff MBThe Journal of thoracic and cardiovascular surgeryPerioperative and oncologic outcomes of pulmonary resection for synchronous oligometastatic non-small cell lung cancer: Evidence for surgery in advanced disease. J Thorac Cardiovasc Surg. 2023 Aug 22.J Thorac Cardiovasc Surg2023-08-22T00:00:002023Perioperative and oncologic outcomes of pulmonary resection for synchronous oligometastatic non-small cell lung cancer: Evidence for surgery in advanced disease.37637041Deboever N, Zhou N, McGrail DJ, Tomczak K, Oliva JL, Feldman HA, Parra E, Zhang J, Lee PP, Antonoff MB, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Roth JA, Swisher SS, Vaporciyan AA, Altan M, Weissferdt A, Tsao AS, Haymaker CL, Sepesi BFrontiers in oncologyRadiographic response to neoadjuvant therapy in pleural mesothelioma should serve as a guide for patient selection for cytoreductive operations. Front Oncol. 2023; 13:1216999.Front Oncol2023-08-11T00:00:002023Radiographic response to neoadjuvant therapy in pleural mesothelioma should serve as a guide for patient selection for cytoreductive operations.37696428Eisenberg MA, Deboever N, Mills AC, Egyud MR, Hofstetter WL, Mehran RJ, Rice DC, Rajaram R, Sepesi B, Swisher SG, Walsh GL, Vaporciyan AA, Antonoff MBThe Journal of thoracic and cardiovascular surgeryImpact of travel distance on receipt of indicated adjuvant therapy in resected non-small cell lung cancer. J Thorac Cardiovasc Surg. 2023 Sep 09.J Thorac Cardiovasc Surg2023-09-09T00:00:002023Impact of travel distance on receipt of indicated adjuvant therapy in resected non-small cell lung cancer.37690624Antonoff MB, Kui N, Sun R, Deboever N, Hofstetter W, Mehran RJ, Morris VK, Rice DC, Swisher SG, Vaporciyan AA, Walsh GL, Rajaram RThe Journal of thoracic and cardiovascular surgeryFactors associated with receipt of pulmonary metastasectomy in patients with lung-limited metastatic colorectal cancer: Disparities in care and impact on overall survival. J Thorac Cardiovasc Surg. 2023 Sep 09.J Thorac Cardiovasc Surg2023-09-09T00:00:002023Factors associated with receipt of pulmonary metastasectomy in patients with lung-limited metastatic colorectal cancer: Disparities in care and impact on overall survival.Authorship 1080335737788788McKay SC, Louie BE, Molena D, Andrews WG, Boerner T, Hofstetter WL, Yeung J, Darling GE, Sharata A, Peyre CG, Dunn C, Lipham JC, Marginean H, DeMeester SRThe Journal of thoracic and cardiovascular surgeryTumor differentiation impacts response to neoadjuvant therapy and survival in patients with esophageal adenocarcinoma. J Thorac Cardiovasc Surg. 2023 Oct 01.J Thorac Cardiovasc Surg2023-10-01T00:00:002023Tumor differentiation impacts response to neoadjuvant therapy and survival in patients with esophageal adenocarcinoma.Authorship 10810279Authorship 10809761237816395Feldman H, Sepesi B, Leung CH, Lin H, Weissferdt A, Pataer A, William WN, Walsh GL, Rice DC, Roth JA, Mehran RJ, Hofstetter WL, Antonoff MB, Rajaram R, Gibbons DL, Lee JJ, Heymach JV, Vaporciyan AA, Swisher SG, Cascone TThe Journal of thoracic and cardiovascular surgerySurgical outcomes after chemotherapy plus nivolumab and chemotherapy plus nivolumab and ipilimumab in patients with non-small cell lung cancer. J Thorac Cardiovasc Surg. 2024 Apr; 167(4):1444-1453.e4.J Thorac Cardiovasc Surg2023-10-08T00:00:002023Surgical outcomes after chemotherapy plus nivolumab and chemotherapy plus nivolumab and ipilimumab in patients with non-small cell lung cancer.37806335Goltsov AA, Maru DM, Katkhuda R, Duose DY, Luthra R, Correa AM, Wang F, Futreal PA, Hofstetter WLThe Annals of thoracic surgeryANPEP/CD13 Expression as a Marker of?Lymphovascular Invasion and Survival in?Esophageal Adenocarcinoma. Ann Thorac Surg. 2023 Oct 06.Ann Thorac Surg2023-10-06T00:00:002023ANPEP/CD13 Expression as a Marker of?Lymphovascular Invasion and Survival in?Esophageal Adenocarcinoma.Authorship 10825549Authorship 10825529Authorship 1082695437921736Worrell SG, Goodman KA, Altorki NK, Ashman JB, Crabtree TD, Dorth J, Firestone S, Harpole DH, Hofstetter WL, Hong TS, Kissoon K, Ku GY, Molena D, Tepper JE, Watson TJ, Williams T, Willett CPractical radiation oncologyThe Society of Thoracic Surgeons/American Society for Radiation Oncology Updated Clinical Practice Guidelines on Multimodality Therapy for Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction. Pract Radiat Oncol. 2024 Jan-Feb; 14(1):28-46.Pract Radiat Oncol2023-11-02T00:00:002023The Society of Thoracic Surgeons/American Society for Radiation Oncology Updated Clinical Practice Guidelines on Multimodality Therapy for Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction.37876311Deboever N, Bayley EM, Eisenberg MA, Hofstetter WL, Mehran RJ, Rice DC, Rajaram R, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Bednarski BK, Morris VK, Antonoff MBJournal of surgical oncologyDo resected colorectal cancer patients need early chest imaging? Impact of clinicopathologic characteristics on time to development of pulmonary metastases. J Surg Oncol. 2024 Feb; 129(2):331-337.J Surg Oncol2023-10-24T00:00:002023Do resected colorectal cancer patients need early chest imaging? Impact of clinicopathologic characteristics on time to development of pulmonary metastases.37921794Worrell SG, Goodman KA, Altorki NK, Ashman JB, Crabtree TD, Dorth J, Firestone S, Harpole DH, Hofstetter WL, Hong TS, Kissoon K, Ku GY, Molena D, Tepper JE, Watson TJ, Williams T, Willett CThe Annals of thoracic surgeryThe Society of Thoracic Surgeons/American Society for Radiation Oncology Updated Clinical Practice Guidelines on Multimodality Therapy for Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction. Ann Thorac Surg. 2024 Jan; 117(1):15-32.Ann Thorac Surg2023-11-02T00:00:002023The Society of Thoracic Surgeons/American Society for Radiation Oncology Updated Clinical Practice Guidelines on Multimodality Therapy for Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction.Authorship 1083822337969292Deboever N, Eisenberg M, Hofstetter WL, Mehran RJ, Rajaram R, Rice DC, Roth J, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Antonoff MBJournal of thoracic diseaseCirculomic variables predict pathologic staging preoperatively in treatment-na?ve non-small cell lung cancer. J Thorac Dis. 2023 Oct 31; 15(10):5507-5516.J Thorac Dis2023-10-20T00:00:002023Circulomic variables predict pathologic staging preoperatively in treatment-na?ve non-small cell lung cancer.Authorship 108924727Authorship 10893541338386238Kitagawa Y, Matsuda S, Gotoda T, Kato K, Wijnhoven B, Lordick F, Bhandari P, Kawakubo H, Kodera Y, Terashima M, Muro K, Takeuchi H, Mansfield PF, Kurokawa Y, So J, M?nig SP, Shitara K, Rha SY, Janjigian Y, Takahari D, Chau I, Sharma P, Ji J, de Manzoni G, Nilsson M, Kassab P, Hofstetter WL, Smyth EC, Lorenzen S, Doki Y, Law S, Oh DY, Ho KY, Koike T, Shen L, van Hillegersberg R, Kawakami H, Xu RH, Wainberg Z, Yahagi N, Lee YY, Singh R, Ryu MH, Ishihara R, Xiao Z, Kusano C, Grabsch HI, Hara H, Mukaisho KI, Makino T, Kanda M, Booka E, Suzuki S, Hatta W, Kato M, Maekawa A, Kawazoe A, Yamamoto S, Nakayama I, Narita Y, Yang HK, Yoshida M, Sano TGastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer AssociationClinical practice guidelines for esophagogastric junction cancer: Upper GI Oncology Summit 2023. Gastric Cancer. 2024 Feb 22.Gastric Cancer2024-02-22T00:00:002024Clinical practice guidelines for esophagogastric junction cancer: Upper GI Oncology Summit 2023.38391198Deboever N, Feldman H, Eisenberg M, Antonoff MB, Mehran RJ, Rajaram R, Rice DC, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Hofstetter WLDiseases of the esophagus : official journal of the International Society for Diseases of the EsophagusOctreotide's role in the management of post-esophagectomy chylothorax. Dis Esophagus. 2024 Feb 22.Dis Esophagus2024-02-22T00:00:002024Octreotide's role in the management of post-esophagectomy chylothorax.Authorship 1089586938408631Fick CN, Dunne EG, Sihag S, Molena D, Cytryn SL, Janjigian YY, Wu AJ, Worrell SG, Hofstetter WL, Jones DR, Gray KDThe Annals of thoracic surgeryImmunotherapy for Resectable Locally Advanced Esophageal Carcinoma. Ann Thorac Surg. 2024 Feb 24.Ann Thorac Surg2024-02-24T00:00:002024Immunotherapy for Resectable Locally Advanced Esophageal Carcinoma.true1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1Assistant ProfessorAssistant Professortrue1Associate ProfessorAssociate Professor18582880Leung KK, Maru D, Abraham S, Hofstetter WL, Mehran R, Anandasabapathy SGastrointestinal endoscopyOptical EMR: confocal endomicroscopy-targeted EMR of focal high-grade dysplasia in Barrett's esophagus. Gastrointest Endosc. 2009 Jan; 69(1):170-2.Gastrointest Endosc2008-06-25T00:00:002008Optical EMR: confocal endomicroscopy-targeted EMR of focal high-grade dysplasia in Barrett's esophagus.18670347Maru DM, Khurana H, Rashid A, Correa AM, Anandasabapathy S, Krishnan S, Komaki R, Ajani JA, Swisher SG, Hofstetter WLThe American journal of surgical pathologyRetrospective study of clinicopathologic features and prognosis of high-grade neuroendocrine carcinoma of the esophagus. Am J Surg Pathol. 2008 Sep; 32(9):1404-11.Am J Surg Pathol2008-09-01T00:00:002008Retrospective study of clinicopathologic features and prognosis of high-grade neuroendocrine carcinoma of the esophagus.19021684Cen P, Correa AM, Lee JH, Le JH, Maru D, Anandasabapathy S, Liao Z, Hofstetter WL, Swisher SG, Komaki R, Ross WA, Vaporciyan A, Ajani JADiseases of the esophagus : official journal of the International Society for Diseases of the EsophagusAdenocarcinoma of the lower esophagus with Barrett's esophagus or without Barrett's esophagus: differences in patients' survival after preoperative chemoradiation. Dis Esophagus. 2009; 22(1):32-41.Dis Esophagus2008-11-19T00:00:002008Adenocarcinoma of the lower esophagus with Barrett's esophagus or without Barrett's esophagus: differences in patients' survival after preoperative chemoradiation.19156915Maru DM, Luthra R, Correa AM, White-Cross J, Anandasabapathy S, Krishnan S, Guha S, Komaki R, Swisher SG, Ajani JA, Hofstetter WL, Rashid ACancerFrequent loss of heterozygosity of chromosome 1q in esophageal adenocarcinoma: loss of chromosome 1q21.3 is associated with shorter overall survival. Cancer. 2009 Apr 01; 115(7):1576-85.Cancer2009-04-01T00:00:002009Frequent loss of heterozygosity of chromosome 1q in esophageal adenocarcinoma: loss of chromosome 1q21.3 is associated with shorter overall survival.19342367Maru DM, Singh RR, Hannah C, Albarracin CT, Li YX, Abraham R, Romans AM, Yao H, Luthra MG, Anandasabapathy S, Swisher SG, Hofstetter WL, Rashid A, Luthra RThe American journal of pathologyMicroRNA-196a is a potential marker of progression during Barrett's metaplasia-dysplasia-invasive adenocarcinoma sequence in esophagus. Am J Pathol. 2009 May; 174(5):1940-8.Am J Pathol2009-03-26T00:00:002009MicroRNA-196a is a potential marker of progression during Barrett's metaplasia-dysplasia-invasive adenocarcinoma sequence in esophagus.24906622Song S, Ajani JA, Honjo S, Maru DM, Chen Q, Scott AW, Heallen TR, Xiao L, Hofstetter WL, Weston B, Lee JH, Wadhwa R, Sudo K, Stroehlein JR, Martin JF, Hung MC, Johnson RLCancer researchHippo coactivator YAP1 upregulates SOX9 and endows esophageal cancer cells with stem-like properties. Cancer Res. 2014 Aug 01; 74(15):4170-82.Cancer Res2014-06-06T00:00:002014Hippo coactivator YAP1 upregulates SOX9 and endows esophageal cancer cells with stem-like properties.AARONTHRIFTAARON THRIFT8175THRIFT, AARONAssociate Professor